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The parasite life cycle 
 
Protozoa are single eukaryotic cells in which all of the organelles required for life are 
contained. Most protozoa are free-living organisms while a small fraction are parasites living 
at the expense of a host. Some protozoa cause disease due to the parasitic relationship they 
establish with their host. Malaria is a vector-borne disease caused by species of the 
protozoan parasite Plasmodium. Among the species of Plasmodium that cause malaria in 
humans, P. falciparum is accountable for the most severe and lethal forms. This parasite 
infects human and mosquito cells invading different cell types and tissues undergoing 
different morphological transformations (Figure 1). Upon female mosquito feeding of human 
blood, P. falciparum parasites contained in the mosquito saliva, named salivary gland 
sporozoites, migrate from the skin to the liver, invade and multiply in hepatocytes (liver 
sporozoites/stages) and emerge about 15 days later in the bloodstream as merozoites, the 
erythrocyte-invading form. Growth in erythrocytes from the invading merozoites to ring and 
trophozoite covers the first 24 hours of the erythrocytic cycle. Mitotic division of the parasite 
with multiplication of DNA and cellular organelles occurs through the schizont stage, leading 
to the formation of 8 to 32 new parasites per infected red blood cell (iRBC). These roughly 48 
hour cyclic rounds of multiplication within erythrocytes, termed the iRBC cycle (also referred 
as asexual or intraerythrocytic cycle), entail changes in the RBCs that underlie some malarial 
symptoms that can eventually cause severe complications. For example, infected RBCs 
cluster at vascular sites by cytoadherence to host receptors, a process mediated by P. 
falciparum erythrocyte membrane protein PfEMP1 antigens, which are encoded by the var 
multigene family. Switching between PfEMP1 antigens leads to antigenic variation, which is 
critical to host immune evasion and chronic infection (Pasternak and Dzikowski 2008). This 
in turn exacerbates sequellae that contribute to morbidity and mortality. 
A fraction of P. falciparum merozoites that invade erythrocytes undergo an alternate 
cycle termed gametocytogenesis. These ‘committed’ merozoites develop into trophozoites 
which are sequestered in blood vessels within organs, and undergo five morphological 
stages of sexual differentiation resulting in mature male or female gametocytes. Mature 
gametocytes emerge in the human blood and are taken up by the mosquito when feeding on 
an infected human, thus perpetuating the life cycle. The mosquito Anophelinae (A. stephensi) 
is the definitive host of the parasite. It is in mosquito’s midgut that P. falciparum fertilization 
and sexual reproduction takes place. Gametocytes initiate gametogenesis and differentiate 
to gametes. Upon fusion of male and female gametes (fertilization), a diploid zygote is 
formed. The zygote undergoes meiosis, without cell division, within 4 hours of fertilization 
and transforms into a motile ookinete. The ookinete escapes the mosquito midgut traversing 
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the epithelium and maturates to an oocyst. Upon several rounds of mitotic division the oocyst 
breaks releasing thousands of sporozoites that are trafficked to the mosquito salivary glands. 
Mosquito saliva sporozoites re-enter the human while the female mosquito takes a blood 
meal, reinitiating the cycle and spreading the disease (see Aly et al. 2010 and Miller et al. 
2002 for reviews). 
 
Figure 1. The Plasmodium falciparum life cycle. Trends in Parasitology, Bannister L and Mitchell G, The ins, 
outs and roundabouts of malaria, vol 19, 209-213, Copyright © 2003, with permission from Elservier 
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P. falciparum: lessons from the genome, transcriptome and proteome  
 
The 23.26Mbp parasite genome is predicted to encode 6372 genes, of which 5524 are 
protein encoding, with an average size of 2.2 kb (Gardner et al. 2002, www.Plasmodb.org). 
This is comparable to the genomes of other single-cell eukaryotes such as yeast. The P. 
falciparum genome is divided over 14 chromosomes containing genes with common 
eukaryotic features such as promoters, introns and 5’ and 3’ UTRs. Subtelomeric regions of 
chromosomes contain large multigene families, such as the var, rifin, stevor. The most 
remarkable feature of the genome is its extremely high AT content, which ranges from an 
average 76% in exons up to an average 86% at intergenic regions (Gardner et al. 2002). The 
excessive homopolymeric AT tracts present within open reading frames translate into 
proteins with long hydrophobic stretches and amino acid repeats, hampering direct protein 
functional assignments by sequence comparison and leading to a large fraction (over 50%) 
of the annotated genes predicted as hypothetical proteins. Nevertheless, several of these 
uncharacterized genes are conserved within Plasmodium species (Carlton et al. 2002; 85% 
synteny between P. falciparum and rodents species, Kooij et al. 2005), other protozoan 
parasites (Abrahamsen et al. 2004) and even plants (e. g. ApiAP2 transcription factors, Balaji 
et al. 2006). 
Global gene expression was first assessed by two parallel studies using microarrays 
containing 95% (Le Roch et al. 2003) and 80% (Bozdech et al. 2003) of the annotated 
genes. The first, a comparative transcriptome study of salivary gland sporozoites, 
gametocyte and iRBC stages, evidenced expression of the majority of genes (88%) in at 
least one part of the life cycle, with 43% of the genes assigned as stage-specific (Le Roch et 
al. 2003). For example, iRBC stages express genes related to glycolysis, protein 
biosynthesis and haemoglobin catabolism; gametocytes shift from glycolysis to the 
mitochondrial TCA cycle and abundantly express, among others, the transmission-blocking 
target antigens pfs48/45 and pfs230, and the ookinete surface antigen pfs25. Sporozoites 
contain abundant RNA of the sporozoite surface protein 2 (ssp2) and the circumsporozoite 
protein (csp). A detailed study of the iRBC cycle at one hour intervals (Bozdech et al. 2003) 
detected changes in RNA abundance for ~3000 genes (80% of the genes contained in the 
array) and uncovered a highly organized gene expression programme for a large part of the 
detected transcripts (2714 genes) (Bozdech et al. 2003). Transcripts of genes with related 
function peak or dip at common developmental time windows creating what was originally 
called a ‘cascade of gene expression’ (Bozdech et al. 2003). In rings and early trophozoites, 
there is a broad induction of the transcription and translation machinery, glycolisis and 
ribonucleotide biosynthesis, which shifts to deoxyribonucleotide biosynthesis and DNA 
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replication related genes in late trophozoites and early schizonts. In mid and late schizonts, 
expression of transcripts encoding the proteosome is followed by expression of erythrocyte-
invasion related genes, merozoite surface proteins, serine proteases, cysteine proteases 
(such as sera5) and actin-myosin motors. Recent experiments using the superior resolution, 
quantitation and coverage of full transcriptome sequencing (RNA-Seq) extended the picture 
of transcribed genes, showing changes in RNA transcript abundance from as much as 90% 
of the genes during the iRBC stages (Bártfai et al. 2010; Otto et al. 2010). Together, the 
abundance of RNA species found in these studies confirms the exceptionally broad 
transcriptional activity of the parasite genome during the iRBC cycle. Importantly, highly 
similar periodic patterns of RNA abundance were observed by microarray analysis performed 
using other laboratory cultured strains, field isolates (Llinas et al. 2006) as well as patient-
collected parasites (Lemieux et al. 2009). 
Further transcriptome analyses of other human and mosquito stages of P. falciparum 
have in general lent support to the first published data (Le Roch et al. 2003) and have 
advanced our knowledge of parasite gene regulation. The processes of early gametocyte 
differentiation and maturation are the result of upregulated expression of over 246 
gametocyte-specific genes, most of which-75%-are hypothetical proteins (Young et al. 2005). 
It is important to note that akin to other stages of the parasite cycle, there is a 
developmentally coordinated expression of genes where early gametocyte upregulated 
genes (pfg27, pfs45/48) differ from those of more mature gametocytes (pfs25, pfs28, pf77) 
(Young et al. 2005). Distinctive early and mature gametocyte gene expression patterns have 
been recently confirmed by an analysis at the protein level, where 94 of the gametocyte 
transcripts were detected as proteins (Silvestrini et al. 2010). 
The first two global proteomic exploratory studies of P. falciparum 
(trophozoites/schizonts, gametocytes and gametes, Lasonder et al. 2002; merozoites, 
trophozoite, gametocyte and sporozoites, Florens et al. 2002) revealed the expression of 
24% and 46% of the encoded protein complement, respectively. In line with the coordinated 
expression of transcripts through the iRBC cycle, these studies showed that Plasmodium 
protein abundance changes according to the stage of development and coincides with the 
physiology of each stage. Nevertheless, transcriptome changes have been only partially 
evidenced at the proteome level. This limited overlap has been explained by technical 
constraints-protein solubility, low abundance or post-translational changes (Natalang et al. 
2008)-as well as by the discrepancy between transcript frequency and protein levels for 
many genes during the iRBC stages (Shock et al. 2007). Further investigation of 
gametocytes (Lasonder et al.  2002; Khan et al. 2005; Silvestrini et al. 2010) and stages 
leading to sporozoite maturation (Lasonder et al. 2008) have revealed a picture containing 
General Introduction 
 15 
stage-specific ‘specialized function’ proteins (12%-28% depending on stage) and redundant 
metabolic processes-related proteins (Lasonder et al. 2008).  
Early gametocyte differentiation is marked at the protein level by an overall 
abundance of export proteins (to the parasitophorous vacuole and/or erythrocyte cytoplasm), 
chaperonins and their regulators and host cells remodeling proteins (Silvestrini et al. 2010), 
which may contribute to the adhesive phenotype of early gametocytes and to the longevity of 
this stage of the cycle. Differential analysis-of genetically identical-mature male and female 
P. berghei gametocytes revealed sex-specific proteomes: ribosomal and mitochondrial 
proteins enriched in female gametocytes and flagellar-based motility and DNA replication in 
male gametocytes with very few proteins in common (Khan et al. 2005). 
Plasmodium sporozoites from either the mosquito midgut or salivary glands are 
morphologically undistinguishable. Nevertheless, distinct protein arsenals direct the 
specialized functional differences between them (Lasonder et al. 2008). The membrane 
antigen erythrocyte binding like protein (MAEBL) is the major expressed protein in oocyst 
derived sporozoites. In agreement with their increased infectiousness to human, salivary 
gland sporozoites abundantly express proteins involved in hepatocyte transversal and 
invasion (SPECT1 and 2, CelTOS, AMA1). Other proteins such as circumsporozoite protein 
(CSP), trombospondin-related anonymous protein (SSP2 or TRAP) and myosin A which are 
important for sporozoites maturation are shared among oocyst and sporozoites. 
 
Control of gene expression: transcriptional mechanisms 
 
The molecular machinery that controls gene expression at the transcriptional, post-
transcriptional and epigenetic levels in eukaryotes appears to be conserved to a large degree 
in Plasmodium (Horrocks et al. 2009, Bischoff and Vaquero, 2010). Direct evidence of control 
at the level of transcription initiation has been documented but only for a small number of 
genes (reviewed by Horrocks et al. 2009). Therefore, the picture of the players involved in 
this layer of control and of the mechanisms that orchestrate stage-specific gene expression 
is very incomplete. Transcriptional activity/regulation is generally defined by the interplay 
among DNA regulatory elements (promoters/enhancers), their accessibility, the protein 
components of the basal transcription machinery and specific transcription factors (TFs). As 
mentioned in the previous section, Plasmodium gene expression undergoes significant 
changes at each developmental stage feeding the assumption that, as in all eukaryotes, 
transcriptional control plays a large role in cycle progression. In silico predictions comparing 
the P. falciparum proteome to a number of crown eukaryote group genomes have led to the 
conclusion that the basal transcription machinery is largely conserved in the parasite 
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(Coulson et al. 2004, Callebaut et al. 2005). A classical, eukaryotic promoter structure has 
been described but admittedly for a small number of genes (reviewed by Horrocks et al. 
2009). Few eukaryotic specific transcription factors (mainly Zinc-finger containing proteins) 
could initially be identified on the basis of domain conservation (Aravind et al. 2003, Coulson 
et al. 2004). Subsequently, a sensitive sequence profile analysis method allowed the 
discovery of the family of plant Apetala AP2-related factors in apicomplexans, termed ApiAp2 
transcription factors (Balaji et al. 2006). The expression of several of these ApiAP2 
transcription factors during the RBC infection appeared coordinated with cell cycle 
progression, hinting to the hypothesis that ApiAP2 transcription factors may act as master 
regulators of Plasmodium gene expression (Balaji et al. 2006). De Silva and colleagues 
showed that the ApiAP2 proteins PF14_0633 and PFF0200c in vitro bind specific DNA motifs 
and thus may participate in the regulation of stage-specific gene expression (De Silva et al. 
2008). Recently, in vivo functional studies in P. berghei have shown that members of the 
AP2 TFs (Pf orthologues PF11_0442 and PF14_0633) are responsible for activation of the 
ookinete-specific genes involved in mosquito midgut invasion (Yuda et al. 2009) and the 
transcription of sporozoite-specific genes (Yuda et al. 2010), supporting the hypothesis that 
each factor regulates putatively definite groups of stage-specific genes. Moreover, a recent 
study found that the AP2 TF PfSIP2 (PFF0200c) is involved in heterochromatin formation, 
demonstrating that the functions of AP2 TFs might extend beyond stage-specific gene 
expression (Flueck et al. 2010). 
 
Post-transcriptional mechanisms 
 
Post-transcriptional regulation refers to the control of gene expression at the RNA level, 
involving the (de)stabilisation and distribution of transcripts by RNA binding proteins which 
control the various steps and rates of the transcripts: alternative splicing, nuclear degradation 
and processing, nuclear export, translational repression by sequestration in P bodies for 
storage or degradation, and ultimately translation (Alberts et al. 2007). Studies of mRNA 
stability in iRBC stages showed lengthening of mRNA half life (reduced decay) as the cycle 
progresses, reaching the longest transcript half life at schizonts (Shock et al. 2007). This 
pattern of high to low mRNA decay did not correlate to transcript abundance or peaking of 
gene expression, but was rather consistent with higher expression of the decay machinery 
during the ring and early trophozoite, albeit at RNA level (Shock et al. 2007). Global increase 
in RNA Pol II activity at the late stages of the intraerythrocytic cycle (multinucleate schizonts) 
has been described by nuclear run-on analysis (Sims et al. 2009). In this study, small groups 
of genes were identified showing either good correlation between transcriptional activity and 
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RNA levels or strong discrepancy implying that indeed both transcriptional and post-
transcriptional components play important roles in gene regulation (Sims et al. 2009). A 
clearer picture of the mechanism controlling gene expression is awaiting and could be 
obtained by genomic profiling of transcriptional initiation and elongation factors and 
correlating them to steady-state RNA levels. 
Aside the timely coordinated mRNA to protein transition observed for a large number 
of Plasmodium proteins, there is a discrepancy i.e. between the appearance of steady state 
RNA and the detection of protein. This occurs at some stages of the life cycle and only for a 
subset of the transcripts. Limitations of the experimental approaches used for these studies 
may be responsible for the apparent discrepancy. Le Roch et al. 2004 evidenced an actual 
delay in protein translation for a small number of proteins in iRBC stages (Le Roch et al. 
2004). Translational repression has been shown to play a more apparent role in Plasmodium 
sexual development. It was initially shown for 6 genes with abundant transcript levels in 
gametocytes of P. berghei, whose protein products could only be detected in ookinetes. 
These transcripts appear to share a specific 3’UTR motif involved in temporal silencing (Hall 
et al. 2005). This motif is present in a total 29 P. berghei genes and although 22 of these 
have orthologs in P. falciparum, a sequence related to the P. berghei motif is not present 
(Hall et al. 2005). Fertilization in metazoans involves the storage in oocytes of translationally 
repressed mRNAs to be subsequently translated into proteins used in post-fertilization 
events. Alike metazoans, Plasmodium female gametocytes accumulate silent mRNAs to be 
translated after fertilization at the zygote to ookinete transformation (Mair et al. 2006, 2010). 
Functional analysis of P. berghei RNA helicase DOZI, up-regulated in female gametocytes, 
allowed its identification as a translational repressor (Mair et al. 2006). Affinity purification of 
messenger-ribonucleotide protein complexes allowed the identification of other protein 
factors involved in the assembly of P. berghei cytoplasmic P bodies (Mair et al. 2010). 
Additionally, individual knock outs of DOZI and its associated protein CITH, allowed the 
identification of an overall ~ 7% of downregulated/destabilized transcripts in their absence 
(Mair et al. 2010). 
 
The epigenetic component of gene expression 
 
The Plasmodium falciparum genome encodes the information necessary for parasites to 
develop within various host cell types adopting different morphologies and functions. In 
eukaryotes, the extra layer of information that in addition to the DNA sequence controls 
which genes are expressed defining cellular phenotypes is termed epigenetic control. The 
epigenome is the sum of all chemical modifications and factors associated with the genome: 
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DNA methylation, histone post-translational modifications (PTMs), nucleosome remodeling, 
incorporation of histone variants and non-coding RNAs (Altucci and Stunnenberg 2009). The 
different components of the epigenome strongly impact on genome function by regulating 
accessibility to the underlying DNA sequence. Little is known about the P. falciparum 
epigenome, but the epigenetic factors and their role in gene regulation has started to be 
addressed (reviewed by Scherf et al. 2008; Bougdour et al. 2010; Cui and Miao 2010; this 
thesis).  
The basic unit of the epigenome is the nucleosome, a protein octamer consisting of 2 
histone H2A-H2B dimers and one histone H3-H4 tetramer, around which 150 bp of DNA is 
folded. Nucleosomes must be densely packed to fit within the nucleus but also sufficiently 
dynamic to allow DNA sequences accessible to DNA–binding proteins which regulate active 
processes. Microccocal nuclease digestion approaches evidenced that Plasmodium 
nucleosomes organize as typically for other eukaryotes (Lanzer et al. 1994a; 1994b) and 
protein sequence allowed the identification of the four major types of P. falciparum histones 
(Longhurst and Holder 1997). A high number of chromatin components, chromatin structure 
and remodeling factors as well as histone modifying enzymes were predicted in the 
Plasmodium genome (Coulson et al. 2004). However, the types of histone modifications and 
the way these modifications relate to nucleosomal outputs were open questions. Histone 
proteins can be post-translationally modified by the addition of a variety of chemical groups 
(i.e. acetyl, methyl, phosphoryl, ubiquityl). These modifications act either by altering the 
physical properties of nucleosomes (acetylation) or by creating binding sites for other 
proteins that have specific effects on chromatin (methylation) (Waterborg 2002; Deal and 
Henikoff 2010). Epigenetic modifications were earlier referred to as the histone code in which 
chromatin is regarded as an integrative platform where combinations of multiple histone 
modifications instruct specific outputs (Jenuwein and Allis 2001). More recently, this proposal 
of a code has been contested and a model in which histone modifications are the result of 
the dynamic processes affecting nucleosomes stability and access to DNA is emerging 
(Henikoff and Shilatifard 2011).  
A number of P. faciparum histone PTMs have been described by means of antibody 
recognition and later the whole set of modifications was mapped by mass spectrometry 
(Miao et al. 2006; this thesis). The localization patterns of a number of histone PTMs across 
the genome have led to insights into parasite genomic processes (Cui et al. 2007; Lopez-
Rubio et al. 2009; Bartfai et al. 2010; this thesis). A picture emerged in that H3K4me3 and 
H3K9ac tend to co-occur at most euchromatic intergenic regions of the genome and are 
subject to changes during intraerythrocytic development (Bartfai et al. 2010; this thesis), and 
that H3K9me3 associates to silenced chromosomal domains (Lopez-Rubio et al. 2009; this 
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thesis). Histone variants contribute to the diversification of the chromatin landscape. P. 
falciparum possess the histone variants H2AZ, H2Bv, H3.3 and CenH3. H2AZ is widely 
distributed over most intergenic regions of the epigenome throughout the intraerythrocytic 
cycle (Bartfai et al. 2010), contrasting with the transcription start site-proximal localization in 
other eukaryotes (Barski et al. 2007). The proposed model is that H2AZ demarcates genome 
regulatory regions and may act as a guide to chromatin modifiers (Bartfai et al. 2010). 
Histone modifications are catalyzed by the opposing action of enzymes that add or 
remove chemical tags and are bound by specific effector proteins which can be either 
involved in repressing or sustaining transcription via different chromatin-remodeling 
complexes (Kouzarides 2007). The current knowledge on P. falciparum chromatin 
remodeling and modifying factors was recently reviewed by Cui and Miao (2010). In 
Plasmodium, few factors interacting with histone PTMs are experimentally characterized. 
The only demonstrated interactions are between H3K9ac and the transcriptional activator 
and histone acetylase Gcn5 (Cui et al. 2007), Gcn5 and the histone deacetylase ADA2 (Fan 
et al. 2004), and between H3K9me3 and heterochromatin protein 1 (HP1) (Flueck et al. 
2009). These interacting factors appeared to be conserved with those in other eukaryotes 
and thus it is tempting to speculate that the function of the PTM and the molecular 
mechanisms are conserved. Interestingly, it was experimentally evidenced that the 
H3K9me3-HP1 interaction demarcates P. falciparum heterochromatin regions spreading over 
most subtelomeres and few chromosome internal islands (Flueck et al. 2009; this thesis). 
The importance of the heterochromatic regions lies in the genes that they encode: the 
antigenic variant gene families var, rifin, stevor and pfmc-2tm which undergo expression 
switching (reviewed by Chookajorn et al. 2008; Scherf et al. 2008; Dzikowski and Deitsch 
2009). 
var genes encode the major variable antigen expressed on the surface of infected 
RBCs, PfEMP1. The 60 members of this family of genes are localized in subtelomeric and 
intrachromosomal regions and are expressed in a mutual exclusive manner. The var gene 
promoter is sufficient to guarantee monoallelic expression (Voss et al. 2006). The single var 
intron which directs the expression of non-coding RNA appears also to be involved in gene 
silencing (Frank et al. 2006; Epp et al. 2009). var genes form clusters at the nuclear 
periphery (Freitas-Junior et al. 2005) and their activation appears to require nuclear 
relocalization (Duraisingh et al. 2005). var genes are subject to epigenetic regulation (Scherf 
et al. 1998). Histone modifications such as H3K9ac and H3K4me3 and the histone variant 
H2AZ correlate with the mutually exclusive temporal expression of individual var genes 
(Lopez-Rubio et al. 2007; Petter et al. 2011). H3K4me2 is suggested to play a role in 
propagating the active var gene status to daughter cells (Lopez-Rubio et al. 2007). 
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Conversely, the H3K9me3-HP1 and the HDACs Sir2A and Sir2B interactions appear to be 
essential for maintaining the silenced var gene status (Duraisingh et al. 2005; Chookajorn et 
al. 2007; Flueck et al. 2009; Lopez-Rubio et al. 2009; Perez-Toledo et al. 2009; Tonkin et al. 
2009). Altogether, the complex mechanisms of var gene regulation exemplify the multiple 
layers of control of gene expression acting in the parasite. 
 
Outline of the thesis 
 
The aim of this thesis was to explore the epigenetic component of gene regulation in the 
parasite focusing on the contribution of histone post-translational modifications to the 
patterns of intraerythrocytic gene expression. The following chapters have laid down relevant 
technical and knowledge foundations in the rising field of Plasmodium epigenetics. In 
Chapter 2, the compendium of the complexity of covalent histone post-translational 
modifications utilized by P. falciparum is presented. Histone-enriched fractions analyzed by 
high-accuracy mass spectrometry showed a characteristic predominance of transcriptionally 
permissive PTMs. Chapter 3 describes the genome-wide mapping of a representative subset 
of the most abundant H3 PTMs found in Chapter 2: H3K9ac, H3K4me3 and H3K9me3 using 
high-density microarrays during the iRBC stages, as well as a gene mapping of these PTMs 
at the ring and schizont stages. This work defined the novel epigenomic profile of P. 
falciparum PTMs and showed its dynamic nature during the iRBC cycle. In Chapter 4 the 
hypothesis that altering the HDAC activity involved in maintaining chromatin domains–i.e. the 
central H3K9 deacetylase-impact on chromatin structure and thus in the transcriptional 
events that ultimately regulate the expression of genes was tested. Chapter 5 reviews the 
first comprehensive analyses of the P. falciparum epigenome. The studies which revealed a 
largely euchromatic chromatin landscape with well defined heterochromatic regions, and the 
epigenetic players that regulate the silencing of virulence determinant genes located within 
heterochromatic domains are reviewed. Finally, in chapter 6 the outcome of this thesis is 
summarized and discussed. 
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Characterization of P. falciparum histone modifications 
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Abstract 
 
Post-translational modifications (PTMs) of histone tails play a key role in epigenetic 
regulation of gene expression in a range of organisms from yeast to human, however, little is 
known about histone proteins from the parasite that causes malaria in humans, Plasmodium 
falciparum. We characterized P. falciparum histone PTMs using advanced mass 
spectrometry driven proteomics. Acid-extracted proteins were resolved in SDS-PAGE, in-gel 
trypsin digested and analyzed by reversed-phase LC-MS/MS. Through the combination of Q-
TOF and LTQ-FT mass spectrometry we obtained high mass accuracy of both precursor and 
fragment ions, which is a prerequisite for high-confidence identifications of multisite peptide 
modifications. We utilize MS/MS fragment marker ions to validate the identification of histone 
modifications and report the m/z 143 ion as a novel MS/MS marker ion for monomethylated 
lysine. We identified all known Plasmodium falciparum histones and mapped 44 different 
modifications, providing a comprehensive view of epigenetic marks in the parasite. 
Interestingly, the parasite exhibits a histone modification pattern that is distinct from its 
human host. A general preponderance for modifications associated with a transcriptionally 
permissive state was observed. Additionally, a novel differentiation in the modification pattern 
of the two histone H2B variants (H2B and H2Bv) was observed, suggesting divergent 
functions of the two H2B variants in the parasite. Taken together, our results provide a first 
comprehensive map of histone modifications in Plasmodium falciparum and highlight the 
utility of tandem MS for detailed analysis of peptides containing multiple PTMs. 
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Introduction 
 
Histone proteins are the core units of nucleosomes and they are inherently important for 
chromatin packaging and structural organization (Marino-Ramirez et al. 2005; Robinson and 
Rhodes 2006). Histones also play an important role in regulation of all aspects of DNA 
function, such as transcriptional control (Khorasanizadeh 2004) and DNA damage response 
(Wurtele and Verreault 2006). The evolutionary origins of the eukaryotic histones can be 
traced back to the archaeal kingdom. In evolutionary early organisms, only a single or two 
histone gene products were responsible for the structural organization of DNA. Since then, 
the histone family has evolved into the four core histone classes H2A, H2B, H3, H4 and the 
linker histone H1 (Malik and Henikoff 2003). The amino acid sequences of the four core 
histones are strikingly similar among distantly related species, which makes them some of 
the most conserved proteins in nature (Malik and Henikoff 2003). 
The core nucleosomal histones have similar structures consisting of a basic N-
terminal tail, a globular domain characterized by the histone fold and a C-terminal tail (Luger 
et al. 1997). The basic N-terminal tail extends from the globular domain and plays an 
important role in regulating higher order chromatin structure. Basic amino acids like lysine 
and arginine are common in these tails and heavily modified by reversible enzymatic 
reactions (Carroza et al. 2003; Lachner et al. 2003). Acetylations, methylations, 
phosphorylations and ubiquitylation are among the most common PTM’s observed on 
histone proteins. The pattern of modifications on histones is often referred to as the histone 
code (Strahl and Allis 2000). There is some debate, however, concerning to the actual code 
nature of the modification pattern in a strict scientific sense (Henikoff 2005; Dion et al. 2005).  
Malaria in humans is caused by infection with eukaryotic parasites of which 
Plasmodium falciparum is the most predominant. The parasite has a complex life cycle, with 
several different life stages in both its mosquito vector (Anopheles gambiae) and in humans. 
The pathogenesis of the parasite is related to the massive infection of red blood cells and this 
stage is referred to as the asexual stage of the parasite life cycle (Miller et al. 2002). 
With the P. falciparum genome sequenced in 2002, 8 histone genes were predicted 
(Gardner et al. 2002) (www.plasmodb.org). H2A and H2A.Z genes were located but no 
H2A.X gene. Contrary to higher eukaryotes, two distinct H2B genes were found in the 
parasite genome and their protein products are denoted histone H2B and histone H2Bv. All 
three previously described histone H3 variants exist in P. falciparum i.e histone H3, histone 
H3.3 and histone H3 centromeric. Only a single histone H4 gene was located in the genome 
(www.plasmodb.org). 
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Little is known about P. falciparum histone proteins and their modifications. The 
discovery of an almost complete battery of proteins in P. falciparum homologous to known 
histone modifying enzymes has provided a clear indication for a full-blown histone code in 
the parasite (Aravind et al. 2003). Longhurst and Holder were first to report in 1997 that they 
had purified all four classes of histones from P. falciparum. Trouble sequencing the N-
terminus of the P. falciparum histone H2A and H4 prompted the investigators to suspect that 
N-acetylation could be the cause (Longhurst and Holder 1997). The expression of most of 
the histone proteins from P. falciparum has subsequently been confirmed by mass 
spectrometry in global proteomic studies (Florens et al. 2002; Lasonder et al. 2002), but 
these studies did not reveal putative modifications of the histones. A number of modifications 
have recently been identified by modification specific antibodies such as H3K9 acetylation 
and H3K4 and K9 mono, di, trimethylation (Cui et al. 2007; Chookajorn et al. 2007), however, 
only few modifications have been identified by mass spectrometry (Miao et al. 2006). 
Tandem mass spectrometry is the favored technique for identification and precise 
mapping of protein modifications today (Jensen 2006; Larsen et al. 2006). Histones from 
various organisms have been intensively studied with great success by mass spectrometry in 
order to map the plethora of modifications known to exist on those proteins (Zhang et al. 
2002a; 2002b; Hirota et al. 2003; Gehrig et al. 2004; Garcia el at. 2006; Miao et al. 2006; 
Trelle and Jensen 2007). 
Modification specific fragment ions and neutral losses are very useful for identification 
of histone modifications. A list of histone modifications and corresponding ∆m values, marker 
ions and neutral losses is shown in Table 1. Marker ions have for instance been used in 
identification of peptides containing ϵ-acetylated lysine. The acetylated lysine immonium ion 
at m/z 143 (Borchers et al. 1999) and its derivative at m/z 126, generated by loss of ammonia 
(Kim et al. 2002), are very useful when assigning this modification (Trelle and Jensen 2008). 
In addition, lysine residues in histones can be mono-, di- or trimethylated, whereas arginine 
residues may become mono- or dimethylated. Lysine and arginine methylated peptides also 
produce fragment marker ions and neutral losses when subjected to CID (Garcia et al. 2007). 
High accuracy mass determination is vital in the analysis of histone modifications. 
Modifications on particular residues may have nearly the same mass or modified residues 
might have the same mass as other unmodified residues. For instance, acetylation and 
trimethylation of lysine residues differ by 0.036 Da and the mass of dimethylated lysine differ 
from arginine by only 0.025 Da. The use of Fourier Transform Ion Cyclotron Resonance 
(FTICR) mass spectrometry has been employed in a number of histone studies (Syka et al. 
2004; Garcia et al. 2005; Hake et al. 2006) due to its excellent mass accuracy, which can 
routinely be kept within 2-5 ppm, allowing to distinguish between for instance acetylation and 
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trimethylation of lysines.  
 
Table 1. List of common histone modifications. 
Modification 
Abbreviation 
X = residue 
number 
∆m 
Marker ions 
(m/z) 
Neutral loss 
(Da) 
Lysine acetylation Kxac 42.011 84.081, 143.118, 126.091 - 
Lysine 
monomethylation Kxme 14.016 
84.081, 98.096, 
143.118* - 
Lysine 
dimethylation Kxme2 
28.031 
 
84.081 - 
Lysine 
trimethylation Kxme3 42.047 84.081, 143.154 
59.073, 
60.081 
Lysine 
ubiquitylation Kxub1 114.043 - - 
Arginine 
monomethyaltion Rxme 14.016 
32.049, 74.071, 
57.055 
31.042, 
56.037, 
73.064 
Arginine 
asymmetric 
dimethylation 
Rxme2a 28.031 46.065, 71.060, 88.087 
45.058, 
70.066, 
87.080 
Arginine 
symmetric 
dimethylation 
Rxme2s 28.031 32.049, 71.060, 88.087 
31.042,  
70.066, 
87.080 
* Novel MS/MS marker ion for peptides containing monomethylated lysine. 
 
 
Here we set out to perform an in-depth exploration of the modifications on P. 
falciparum histones through mass spectrometry driven proteomic analysis. We investigated 
the advantages and disadvantages of using Q-TOF and FT-ICR (LTQ-FT) tandem mass 
spectrometry technologies for detailed analysis of Plasmodium falciparum histones. 
Specifically, we aimed at exploring high quality peptide fragment data and high mass 
accuracy on both precursor and fragment ions for precise mapping of histone post-
translational modifications. 
 
Materials and Methods 
 
Parasite production and histone extraction 
Plasmodium falciparum strain NF54 parasites were cultured with human red blood cells using 
a semi-automated culture system. After 48 hours, a mixture of asexual stages (rings, 
trophozoites and schizonts) was collected by centrifugation at low speed. Parasites were 
released from erythrocytes by treatment with saponin 0.06% and the dark pellet was washed 
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several times with PBS. Nuclei were prepared by addition of a 10mM Tris-HCl pH 8.0, 3 mM 
MgCl hypotonic buffer (plus 0.2% NP-40 and 0.25M sucrose in the presence of a protease 
inhibitor cocktail (PI)), followed by homogenization by several strokes with a douncer pestle 
B. The homogenate was centrifuged at 500 g, followed by two washes of the pellet in the 
same lysis buffer and one wash in buffer without NP-40. The pelleted nuclei were slowly 
resuspended in 0.8 M NaCl, 10mM Tris, 1 mM EDTA and PI, incubated for 10 minutes on ice 
and pelleted again. Histones were acid extracted by suspending the nuclei pellet in 0.25M 
HCl with brief sonication in order to achieve homogenization. The suspension was rotated for 
1 hour at 4˚C and the histone-enriched supernatant collected by centrifugation at 11000 g. All 
the safety precautions that apply to biosafety class 3 infectious agents were kept during 
parasite culture and red blood cell lysis. The Plasmodium falciparum asexual stages used in 
this study remain live exclusively in red blood cells. After saponin lysis of the red blood cells 
membrane, the experimental procedures were carried out under standard laboratory 
conditions, as they pose no risk of infection. 
 
SDS-PAGE and in-gel digestion 
20 µg of the HCl extracted histones and dissolved in sample buffer (20 mM Tris-Hcl, pH 6.8, 
10 % glycerol, 2 % (w/v) SDS, 5 % 2-mercaptoethanol and 0.05 % (w/v) bromophenol blue) 
and pH adjusted with NaOH until the blue color of the bromophenol blue reappeared. SDS-
PAGE was run on either 15 or 20 % gels and stained with coomassie blue R-250. Protein 
bands were cut into small pieces and washed in several changes of water and 50 % 
acetonitrile. The liquid was removed and 100% acetonitrile added. The acetonitrile was 
removed and the proteins reduced by rehydration of the gel plugs in 10 mM dithiotreitol 
(DTT), 0.05 M ammonium bicarbonate and incubated at 56˚C for 45 min. After reduction, 
excess liquid was removed and cysteins were alkylated by treatment with iodoacetamide for 
30 min. at 30˚C in the dark (55mM iodoacetamide and 0.1 M ammonium bicarbonate). The 
washing in water and acetonitrile was repeated. 100 % acetonitrile was added in order to 
extract all liquid from the gel plugs. In-gel digestion was accomplished by rehydration of the 
gel plugs in 50 mM ammonium bicarbonate containing 12.5 ng/µl trypsin (Promega modified 
trypsin) and overnight incubation at 37˚C. The peptides were dried down and dissolved in 5% 
formic acid. 
 
LC-MS/MS 
LC-MS/MS was performed on 2 different instrumental setups using either Q-TOF or LTQ-FT 
tandem mass spectrometers. The Q-TOF consisted of nanoflow-HPLC system from LC-
Packings (Ultimate; Switchos2; Famos; LC packings, Amsterdam, The Netherlands) coupled 
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on-line to a Q-TOF Ultima instrument (Waters/Micromass UK Ltd., Manchester UK). The 
LTQ-FT system consisted of an Agilent 1100 Series nanoflow-HPLC system (Agilent 
technologies inc., Palo Alto, US) coupled online to a LTQ-FT (Thermo, Bremen, Germany). 
Fused silica capillaries were used for the nanoflow-HPLC systems. Transport capillaries had 
a 20 µm inner diameter and analytical columns were packed inside 50 µm inner diameter 
capillaries. All HPLC systems were operated with a flow of 200 nL/min. Samples were 
injected directly from the autosampler onto a 10 cm long analytical column packed with C18 
material (Zorbax® SB-C18 3.5 µm resin, Agilent technologies inc., Palo Alto, US). Solvents 
used were; A = aqueous solution of 0.6% formic acid, 0.5 % acetic acid and 0.05 % HFBA. B 
= 90 % acetonitrile, 0.6% formic acid, 0.5 % acetic acid and 0.05 % HFBA. Each sample was 
fractionated by ramping the B content to 40 % over a period of 40 or 90 minutes. Both setups 
were operated in data-dependent acquisition mode where cycles of MS and MS/MS 
experiments were conducted. On the Q-TOF the 3 most intense peaks were selected for 
fragmentation, whereas the 2 most intense ion signals were selected on the LTQ-FT. 
Simultaneously with the MS/MS experiment in the LTQ a high resolution (R = 50000 at m/z 
400) SIM scan was performed in the FT-ICR cell. 
 
Data analysis 
Peak list files were created using Masslynx 4.0 (Waters/Micromass UK Ltd., Manchester UK), 
using the following processing parameters: No background subtraction; smoothing: Savitzky 
Golay, 3 channels, 2 smooths; Centroiding: min. peak with at half hight = 4, centroid top, 80 
%; No deconvolution. Data analysis was based on comparative database search against a P. 
falciparum – human IPI fusion database containing 131000 sequences (PlasmoDB release 
5.0 from www.plasmodb.org and ipi.HUMAN.v3.18 from European Bioinformatics Institute) 
using an in-house licensed MASCOT server v2.2 (Matrix science Ltd., London, UK) and 
VEMS v3.0 (Matthiesen et al. 2005). Search parameters were: Q-TOF data: 50 ppm peptide 
mass tolerance, 0.8 Da fragment ion mass tolerance. LTQ-FT data: 5 ppm peptide mass 
tolerance, 2 Da fragment ion mass tolerance. Both Q-TOF and LTQ-FT data: 6 missed 
cleavages. Fixed modifications: Cystein carbamidomethyl. Variable modifications: acetylation 
(K, N-terminal), methylations (K and R), dimethylation (K and R), trimethylation (K), 
Phosphorylation (S and T), ubiquitylation (K).  Q-TOF data was searched using MASCOT 
and VEMS software whereas LTQ-FT data was searched using MASCOT. Peak list files 
were recalibrated based on search results using in-house developed Perl scripts. Database 
search results were subjected to manual validation based on visual inspection of all MS/MS 
spectra. Validations were based on mass accuracy of precursor and fragment ions, presence 
of sequence ions (a, b and y-ions) and a sequence tag, presence of immonium ions and 
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related small fragments and absence of un-explained peaks. Detailed descriptions of spectra 
interpretation of modified peptides is given in the results section. 
 
Results 
 
Mass spectrometry mapping of post-translational modifications in P. falciparum 
histones  
In order to facilitate the exploration of epigenetic regulation in P. falciparum we set out to 
map histone modifications in the asexual stage of the parasite life cycle. Parasites were 
cultured in human red blood cells. Histones were extracted by strong acid, separated by 
SDS-PAGE (Figure 1A), in-gel digested and analyzed by LC-MS/MS using both Q-TOF and 
FT-ICR technologies. All 8 known P. falciparum histones were identified (Table 2) as well as 
a large number of other human and P. falciparum proteins (data not shown). The identified 
histones were histone H2A and H2A.Z, histone H2B and H2Bv, histone H3, H3.3 and H3 
centromeric, and finally histone H4. All histone peptides identified are listed and aligned to 
the histone sequences in supplementary Figure 1, available online. It should be noted that 
P. falciparum appears to lack histone H1 because no gene encoding H1 has been located in 
the genome (Gardner et al. 2002). A complete list of relevant peptide data (observed 
masses, theoretical masses, deviation, charge state, peptide scores etc.) can be found in 
supplementary Figure 2, available online. 
 
 This is the first study to identify all known P. falciparum histones by mass 
spectrometry including the low abundant histone H3 centromeric. All histones were identified 
with better than 56% sequence coverage apart from histone H3 centromeric (Table 2). The 
histone N-termini were identified and mapped by many overlapping peptides, thereby 
revealing many post-translational modifications (Figure 1B and supplementary Figure 1). 
Most of the histone regions that were not mapped by our method could be explained by the 
presence of amino acid sequences that either lack trypsin cleavage sites (K and R residues) 
or have clusters of these residues. Tryptic proteolysis of these regions may not produce 
identifiable peptides by the mass spectrometry methods applied in this study. Histone H3 
centromeric was identified by just 4 unique peptides (Table 2) indicating a low abundance of 
this histone variant. Histone H3 centromeric is primarily located at chromosome centromeric 
regions and involved in regulation of chromatin condensation (Palmer et al. 1991). It is 
therefore expected to be present at lower levels compared to the canonical histones. 
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Table 2. Summary of all post-translational modifications identified on P. falciparum histones. 
Histone 
Uniquea 
peptides 
identifie
d 
Sequence 
coverage 
Total 
number of  
PTM’s 
PTM’s 
Histone H2A 12 56% 3 N-term-ac, K3ac, K5ac 
Histone H2A.Z 27 70% 8 N-term-ac, K11ac, K15ac,  K19ac, K25ac, K28ac, K30ac, K35ac 
Histone H2B 20 96% 1 K112ub1 
Histone H2Bv 21 85,2% 6 N-term-ac, K3ac, K8ac, K13ac, K14ac, K18ac 
Histone H3 16 66% 9 (12c) 
K4me, K4me2, K4me3, K9-Ac, K9me3, 
K14ac, R17me, R17me2s,  
K16ac, K23ac, K27ac, K56ac 
Histone H3.3 19 65% 7 (10c) K4me, K4me2, K4me3, K9ac, K14ac, R17me, R17me2s, K16ac, K23ac, K27ac 
Histone H3 
centromeric 4 30% 0  
Histone H4 30 87% 7 N-term-ac, R3me, K5ac, 
 K8ac, K12ac, K16ac, K20me3 
a Unique indicate that the peptide is specific for this histone variant. Many peptides are shared by 
different histone variants. c under assumption that K4me, K4me2 and K4me3 are present on both H3 
variants. 
 
In summary, we identified and located 44 different modifications on P. falciparum 
histones including acetylation sites (lysine and N-terminal), methylation sites (lysine and 
arginine) and a single ubiquitylation site (lysine). All identified modifications are listed in 
Table 2 and a graphical illustration of the identity and position of the modifications within the 
histone sequences is shown in Figure 1C. In total, 84 unique modified peptides were 
identified indicating that many modifications were identified by overlapping peptides 
(supplementary Figure 1). Additionally, 53 peptides (63%) contained multiple modifications, 
making data analysis and interpretation rather challenging. A total of 57 peptides contained 
only acetylations, six peptides contained only methylations whereas 20 peptides contained 
both acetylations and methylations. One ubiquitylation site was proposed (Figure 1B).  
 
 
 
 
Figure 1. A. SDS-PAGE separation of acid extracted histones from P. falciparum. Proteins were 
stained with coomassie blue. Histone protein bands are indicated.  
B. Summary of identified modified histone peptides.  
C. Graphical overview of the modifications observed in histones, illustrating the identity and position of 
each modification. ac = acetylation (lysine or N-terminal), me = methylations (lysine or arginine, 1x = 
mono, 2x = di and 3x = tri) and ub1 = ubiquitylation. 
Characterization of P. falciparum histone modifications 
 
31 
 
| 
|
-
N
-
SA
K
G
K
T
G
R
K
K
A
SK
G
T
SN
SA
K
-
3 
5
| 
 
 
| 
 
 
| 
 
 
 
 
| 
 
| 
| 
 
 
 
|
-
N
-
M
E
V
P
G
K
V
I
G
G
K
V
G
G
K
V
G
G
K
V
L
G
L
G
K
G
G
K
G
K
T
G
SG
K
T
K
-
11
 
 
15
 
 
19
 
 
 
 
25
 
 
 
 
 
 
 
 
35
N
-
V
SK
K
P
A
K
A
K
K
T
G
T
G
P
D
G
K
K
K
R
K
K
SR
-
| 
 
 
 
| 
 
 
 
||
 
 
 
|
-
N
-
SG
K
G
P
A
QK
SQ
A
A
K
K
T
A
G
K
T
L
G
P
R
H
K
R
K
R
-
3 
 
 
 
8 
 
 
 
 
 
 
 
 
18
| 
 
 
 
| 
 
 
 
| 
 
 
| 
 
 
 
| 
 
 
| 
 
 
 
 
 
 
 
 
N
-
A
R
T
K
QT
A
R
K
ST
A
G
K
A
P
R
K
QL
A
SK
A
A
R
K
SA
P
I
SA
G
I
K
K
P
H
R
-
4 
 
 
 
9 
 
 
 
14
 
 
 
 
 
 
 
23
 
 
27
| 
 
 
 
| 
 
 
 
| 
 
 
| 
 
 
 
| 
 
 
| 
 
 
 
 
 
 
 
 
N
-
A
R
T
K
QT
A
R
K
ST
G
G
K
A
P
R
K
QL
A
SK
A
A
R
K
SA
P
V
ST
G
I
K
K
P
H
K
-
4 
 
 
 
9 
 
 
 
14
 
 
 
 
 
 
 
23
 
 
27
 
 
 
 
 
 
| 
| 
 
| 
 
 
| 
 
 
| 
 
 
|
-
N
-
SG
R
G
K
G
G
K
G
L
G
K
G
G
A
K
R
H
R
K
I
L
R
D
N
I
QG
I
T
K
P
A
I
R
R
-
3 
5 
 
8 
 
 
12
 
 
16
 
 
20
 
 
 
 
 
 
 
 
 
13
14
18
H
2A
.
Z
H
2A H
2B
H
3 H3
.
3
H
4
H
2B
v
Ac
et
yl
at
ed
 
o
n
ly
(57
)
Ac
et
yl
at
ed
 
an
d 
m
et
hy
la
te
d
(20
)
m
et
hy
la
te
d 
o
n
ly
(6)
Ub
iq
u
iti
n
yl
at
ed
(1)
M
W
94
 
 
-
-
-
-
-
-
67
 
 
-
-
-
-
-
-
43
 
 
-
-
-
-
-
-
20
.
1-
-
-
-
-
14
.
4-
-
-
-
-
H
Cl
 
ex
tr
ac
t
H
2A
.
Z,
 
H
3 
ce
n
tr
o
m
er
ic
H
3,
 
H
3.
3
H
2A
, 
H
2B
v
H
2B
H
4
A B
C
84
 
u
n
iq
u
e 
m
o
di
fie
d 
pe
pt
id
es
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
ca
c
a
c
a
c
a
c
a
c
a
c a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
m
e
1x 2x
m
e
3x
m
e
1x 2x 3x
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
m
e
1x 2x
m
e
1x 2x 3x
a
c
a
c
a
c
a
c
a
c
a
c
a
c
a
c
m
e
1x
m
e
3x
| K 11
2
u
b1
| K 56acac
17
18
17
28
30
Chapter 2 
 
32 
 
 Both of the canonical histone H2A and the histone H2A.Z variant contained lysine 
acetylation sites in their N-termini. Histone H2A was acetylated at K3 and K5 whereas H2A.Z 
was acetylated at K11, K15, K19, K25, K28, K30 and K35. H2A.Z acetylation of K25, K30 
and K35 was previously reported (Miao et al. 2006), whereas the other H2A and H2A.Z 
acetylation sites are novel. Histone H2A and H2A.Z were both found to be N-terminally 
acetylated confirming a previous report (Longhurst and Holder 1997). N-terminal acetylation 
of Histone H2A was observed in other organisms previously, including yeast and human 
(Song et al. 2003; Boyne et al. 2006). 
Histone H2B subtypes within the same organism are normally very similar in their 
amino acid sequence, although a few exceptions are evident (Poccia and Green 1992; Aul 
and Oko 2002). Two distinct Histone H2B subtypes are present in P. falciparum and as a 
unique feature of the parasite they are very differently modified (Figure 1B and Table 2). The 
H2Bv protein displayed abundant lysine acetylations on K3, K8, K13, K14 and K18, of which 
K13 and K18 acetylation has previously been reported (Miao et al. 2006). N-terminal 
acetylation was also observed on H2Bv. No acetylation of H2B was observed. Our data 
suggested ubiquitylation of K112, which is also observed on the C-terminal H2B domain in 
other species (Thorne et al. 1987). Thus, the novel differences in the post-translational 
modification state reported here may indicate distinct functions of the two P. falciparum 
histone H2B subtypes (see Discussion). 
A plethora of modifications were identified on P. falciparum histone H3 and H3.3 in 
this study (Figure 1C). Histone H3 and H3.3 were both acetylated at residues K9, K14, K18, 
K23 and K27, some of which have previously been reported (Miao et al. 2006). Additionally, 
histone H3 was acetylated at K56, a modification that has also been reported in yeast histone 
H3 (Ozdemir et al. 2005). Methylations were identified on K4 (H3 and/or H3.3K4me, K4me2 
and K4me3), K9 (H3K9me3) and R17 (H3 and H3.3R17me and R17me2s). Based on the 
identified modifications (supplementary Figure 1), it appears, that there is preponderance 
for modifications associated with transcriptional activation (K4me, K9ac, K14ac, R17me and 
K23ac) and absence (or low level) of modifications associated with transcriptional repression 
(K9me, K27me, K36me and K79me) on P. falciparum histone H3 as compared to human 
histone H3 (see Discussion). 
For histone H4 we detected acetylation of lysines K5, K8, K12 and K16 as well as N-
terminal acetylation. Additionally, we observed monomethylation of R3 and trimethylation of 
K20. K8 and K12 acetylation was also observed previously (Miao et al. 2006). Notably, K16 
acetylation, which is reported to be the preferred acetylation site of histone H4 in yeast and 
human (Zhang et al. 2002b; Smith et al. 2003), did not seem to be the preferred acetylation 
site in P. falciparum. Instead, K8 and K12 appear to be the primary sites of acetylation in P. 
Characterization of P. falciparum histone modifications 
 
33 
 
falciparum. This is evident from the acetylated peptides observed from the H4 N-terminus 
(supplementary Figure 1) and from individual peptide ion abundances (data not shown). 
 
m/z 126 and m/z 143 are marker ions for acetylated lysine residues 
Acetyl-lysine containing peptides can be identified by MS through the implied mass 
increment of 42.011 Da. However, trimethylation, which is another frequent histone 
modification, leads to a mass increment of 42.047 Da. These two types of modification can 
be distinguished by accurate mass measurements but it requires MS instrumentation capable 
of resolving the 0.036 Da mass difference, such as the LTQ-FT (see below). Other means of 
distinguishing the two modifications is through the presence of modification specific fragment 
ions in MS/MS spectra. The acetyllysine immonium ion (m/z 143) and the related ion 
resulting from loss of ammonia (m/z 126.1) were previously reported to be marker ions for 
acetylated peptides (Borchers et al. 1999; Kim et al. 2002; Trelle and Jensen 2008). 
A total of 77 acetylated peptides were identified in this study. The Q-TOF MS/MS 
spectrum, assigned to the acetylated histone H2B peptide TAGKAcTLGPR, is shown in 
Figure 2A. The mass increment between y5 and y6 (and between b3 and b4) of ~170 Da, 
together with the intact peptide mass, matches either an acetylation or a trimethylation event 
at the lysine amino acid residue, however, the mass accuracy obtained with the Q-TOF was 
insufficient for discrimination between the two. The presence of the diagnostic ions for 
acetylated lysine at m/z 143 and m/z 126 provides a strong indication for lysine acetylation. 
High-precision mass measurement by the LTQ-FT instrument confirmed the acetylation on 
the histone H2B peptide shown in Figure 2A (supplementary Figure 2). 
In order to evaluate the usability of the m/z 143 and m/z 126 ions as marker ions for 
lysine acetylation we have investigated the presence of these ions in MS/MS spectra of 
acetylated peptides. We found dramatic differences in the presence of these ions between 
spectra recorded on the Q-TOF and spectra recorded on the LTQ-FT and these differences 
can readily be explained by the low mass cut-off commonly observed with ion trap mass 
spectrometers. 85.3 % of spectra of acetylated peptides obtained on the Q-TOF showed an 
m/z 126 ion and also 85.3 % of spectra showed the presence of the m/z 143 ion. A 
conservative threshold intensity of 3 % of the base peak intensity was chosen. In spectra of 
acetylated peptides acquired on the LTQ-FT only 14.5 % contained the m/z 126.1 ion and 
11.3 % contained the m/z 143 ion. These data indicate that both the m/z 126 and the m/z 143 
ion are useful marker ions for acetylated lysine, when MS/MS data are acquired on the Q-
TOF. A more detailed study was published elsewhere (Trelle and Jensen 2008). A closer 
evaluation of the LTQ-FT spectra revealed that for precursor masses above m/z 450 the 
recovery of fragment ions below m/z 150 was extremely low explaining the general absence 
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Figure 2. A. Q-TOF MS/MS spectrum of the lysine acetylated P. falciparum histone H2B peptide 
TAGKacTLGPR ([M+2H]2+ = 471.797). Kac = acetylated lysine immonium ion (m/z 143). 0 = H2O loss 
from ion, * = NH3 loss from ion. 
B. LTQ-FT MS/MS spectrum of the lysine acetylated P. falciparum histone H2A.Z peptide 
VGGKacVGGKacVLGLGKacGGKacGKacTGSGKacTK ([M+3H]3+ = 869.82898, Mr(measured) = 
2606.46513, Mr(theoretical) = 2606.47540, deviation = 3.94 ppm). 
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of m/z 126 and 143 in the spectra of acetylated peptides from this instrument.  
 
Mapping of multiple modifications in peptides by tandem mass spectrometry 
In this study we took advantage of the very good to excellent mass accuracy of TOF and FT-
ICR mass analyzers for accurate molecular weight determination of modified peptides. In 
addition, we applied Q-TOF and LTQ tandem mass spectrometry to achieve efficient 
sequencing of modified peptides. Precise localization of single or multiple modifications in 
individual peptides necessitates high quality MS/MS data, i.e. the generation of 
representative peptide fragment ions and diagnostic immonium ions. In addition, incomplete 
digestion of N-terminal tails of histones by trypsin generates different peptide species that 
allow independent confirmation of modified amino acid residues.  In fact, the presence of 
modifications (acetylation, methylation) on Lys and Arg residues will in most cases prohibit or 
inhibit trypsin cleavage, leading to generation of larger, modified peptide species. In the 
following sections we highlight the analytical advantages of using high-performance tandem 
mass spectrometry for accurate mapping of individual and multiple modifications in peptides 
derived from histones. 
Many histone peptides containing multiple acetylations were identified in this study. A 
prominent example is show in Figure 2B. This LTQ-FT MS/MS spectrum was assigned to a 
histone H2A.Z peptide containing 6 acetylated lysines. As expected the m/z 126 ion is not 
observed due to the low mass cut-off, however, even if it was present it would only indicate 
the presence of at least one acetylation and say nothing about the remaining five. Hence, 
accurate mass determination was the only way to confirm the presence of all 6 acetylations 
and that was provided by the LTQ-FT (deviation (theoretical Mr - measured Mr) = 3.94 ppm). 
The many overlapping peptides identified from this region of histone H2A.Z further validate 
this assignment (supplementary Figure 1). 
 
Distinguishing H3K9 acetylation and H3K9 trimethylation 
H3K9 can be either acetylated or trimethylated in a range of different eukaryotes [23]. 
Distinguishing these two types of modifications presents a significant analytical challenge. 
We found evidence that H3K9 in Plasmodium falciparum can be either acetylated or 
trimethylated. LTQ-FT MS and MS/MS data of the Plasmodium falciparum histone H3 
peptides KAcSTAGKAcAPR and K3MeSTAGKAcAPR are shown in Figure 3. The observed m/z 
difference between the two peptides (Figure 3A) fits the mass difference between acetylation 
and trimethylation with a very small deviation (0.00005 Da, 0.05 ppm). The assignment of the 
doubly acetylated peptide (Figure 3B, upper) is readily validated based on the almost 
complete series of y- and b-ions. The assignment of the trimethyl-lysine containing peptide is 
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validated by the complete y-ion series and the observations of an almost complete series of 
fragments corresponding to neutral loss of trimethylamine ((CH3)3N, 59 Da) from b-ions. This 
validates the presence of a trimethylated lysine in the peptide and specifically maps it to the 
N-terminal lysine. Accordingly, no loss of 59 Da is observed from the y-ions. An intense peak 
at m/z 940.24 corresponding to the doubly protonated peptide ion - trimethylammonia 
((M+2H)2+ - ((CH3)3NH)+) was observed.  
 
Observation of m/z 143 is a novel marker ion for lysine monomethylation 
The observation of mono-, di- and trimethylation of histone H3K4 and/or H3.3K4 in 
Plasmodium falciparum allowed us to evaluate the fragmentation pattern of peptides carrying 
each of these modifications. Q-TOF MS/MS spectra of a mono-, di- and trimethylated lysine 
containing peptide TKQTAR from histone H3 are shown in Figure 4. The C-terminal 
fragments of the four peptides are identical up to the y4-ion, whereas the y5-ion and all the b-
ions masses are increased by the mass of the added methyl groups in increments of 14 Da. 
A weak signal of the monomethyl-lysine specific immonium ion at m/z 98 reinforces the 
identification of the monomethylated peptide (Figure 4A). Interestingly, an intense signal is 
observed at m/z 143 for the monomethylated peptide spectrum, which is not observed in the 
di and trimethylated peptide spectra (Figure 4B and C). This ion signal has, to our 
knowledge, not previously been reported for monomethylated lysine containing peptides. We 
propose that this signal arises from the methyl-lysine residue and could be the equivalent of 
the m/z 129 signal often observed for unmodified lysine. However, this ion signal is not 
specific for monomethylated lysine since several other modifications might produce such a 
signal, including acetylated or trimethylated lysines. The combination of a 14 Da mass shift 
on a lysine and the presence of both an m/z 98 and m/z 143.1 ion signals may, however, be 
diagnostic for monomethylated lysine containing peptides. 
No specific fragment ions were identified in the spectrum of the dimethylated peptide 
(Figure 4B) and to our knowledge no diagnostic fragments has previously been reported for 
dimethylated lysine containing peptides. A number of ions corresponding to neutral losses of 
trimethylamine (59 Da) from several y-, b-, and a-ions were observed in the spectrum of the 
trimethylated peptide (Figure 4C). The loss of trimethylammonia from the intact precursor 
ion, observed in the trimethylated peptide shown in Figure 3, was not observed here. Similar 
observations were made by Bradbury and coworkers and they proposed that the loss of 
trimethylamine from the intact peptide ion is favored when the trimethylated lysine is situated 
N-terminally (Zhang et al. 2004). Clearly, the data presented here supports this hypothesis. 
The accurate precursor mass obtained with the LTQ-FT on this peptide further confirms the 
presence of trimethylation rather than acetylation (Mr(theoretical) = 745.4446, Mr(measured) 
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= 745.44481, deviation = 0.27 ppm).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. A. LTQ-FT MS spectra of the P. falciparum histone H3 peptides: (upper) KacSTAGKacAPR 
([M+2H]2+ = 500.28247) and (lower) Kme3STAGKacAPR. (left) Range = m/z 500.0-501.5, (right) 
Range = m/z 500.25-500.32. The theoretical ∆m is calculated as the mass difference between a 
trimethylation and an acetylation (42.04695 - 42.010565 = 0.03693).  
B. LTQ-FT MS/MS spectra of (upper) KacSTAGKacAPR and (lower) Kme3STAGKacAPR. 0 = H2O 
loss from ion, @ = (CH3)3N loss from ion, & = [(CH3)3NH]+ loss from ion. 
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Figure 4. Q-TOF MS/MS spectra of the P. falciparum histone H3 peptides TKxmeQTAR (x = 1-3).  
A., B. and C. are spectra of the mono- ([M+2H]2+ = 359.73), di- ([M+2H]2+ = 366.74) and trimethylated 
peptide ([M+2H]2+ = 373.75). Kme = monomethylated lysine immonium ion (m/z 115.1) 0 = H2O loss 
from ion, * = NH3 loss from ion, @ = (CH3)3N loss from ion, $ = 28 Da addition to ion (presumably CO). 
 
 
Deciphering the methyl configuration on H3R17 
Arginine methylations are common on histone N-termini, however, distinction between the 
isobaric symmetric (Rme2s) and asymmetric (Rme2a) dimethyl-arginine residues requires 
careful evaluation of MS/MS spectra generated by fragmentation of methylated arginine 
containing peptides. We identified monomethylation and symmetric dimethylation of histone 
H3R17 and H3.3R17 as well as monomethylation of histone H4R3 in Plasmodium 
falciparum. An example of a Q-TOF MS/MS spectrum of arginine-methylated peptides is 
given in Figure 5. Based on the y- and b-ion series and the intact peptide masses it is 
possible to assign the spectra to the Plasmodium falciparum histone H3 peptides 
KAcSTAGKAcAPRnMeK (n = 1 or 2). The high accuracy peptide mass, obtained from a similar 
LTQ-FT experiment on the dimethylated peptide (supplementary Figure 2), together with 
the presence of the m/z 126 ion validates the assignment of acetyl groups on the lysines. 
Due to the absence of the y2-ion, the y- and b-ions do not provide conclusive evidence for the 
precise position and distribution of the suggested methylations on the N-terminal part of the 
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peptide. However, the presence of all but one possible internal fragments generated by 
concomitant C-terminal rearrangement and a “y-ion”-type backbone cleavage indicate 
arginine methylation. The C-terminal rearrangement is favored by the internal arginine and 
results in a [b+H2O]+-type cleavage. The result of this fragmentation is a series of pseudo-y-
ions with an arginine pseudo-C-terminal. This type of rearrangements has previously been 
described for un-modified basic amino acids (Gonzalez et al. 1996), however, the data 
shown here clearly indicate that the rearrangement reaction is possible for methylated 
arginines as well. This is expected, since methylation of the arginine guanidino group serves 
to further increase the basicity of the arginine side-chain, which theoretically should work in 
favor of the rearrangement. The spectra of both mono- and dimethylated peptides contain 
peaks that can be attributed to neutral loss of small molecules from the modified arginine 
side chain. In the spectrum of the monomethylated peptide (Figure 5A) peaks corresponding 
to the loss of methylamine (-31 Da) from y3 and y4 are observed, which reinforces the 
assignment of monomethylated arginine. In the spectrum of the dimethylated peptide (Figure 
5B and 5C) peaks corresponding to the loss of methylamine from many y-ions are observed 
(- 31 Da), indicating that the methyl-groups are symmetrically positioned on the guanidino-
group. Additionally, peaks corresponding to the loss of dimethylcarbodiimide (-70 Da) from y6 
and y8 further validate the dimethylation on the arginine. The observation of neutral losses 
from the methylated arginine side-chain is in good agreement with previous reports (Gehrig 
et al. 2004; Rappsilber et al. 2003), however, none of the corresponding low molecular 
weight ions, resulting from retention of a proton on the arginine side-chain fragment, were 
observed.  
 
 
Discussion 
 
The Plasmodium falciparum genome sequence not only revealed a full set of nucleosomal 
histone genes but also a large number of genes encoding histone modifying proteins 
(Gardner et al. 2002; Aravind et al. 2003) These observations indicate a level of histone 
mediated chromatin regulation that is comparable to higher eukaryotes, including human. An 
apparent lack of sequence specific transcription factors was evident when searching for 
homologous domains of known specific eukaryotic transcription factors like homeo, bZip, 
bHLH and Fkh domains. This observation is intriguing in light of the complex life cycle of the 
parasite, which inevitably will require a tight gene regulation. It can be speculated, that the 
parasite may possess sequence specific transcription factors that are different from any other 
class of transcription factors known. Alternatively, the parasite regulates its gene expression 
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through other mechanisms, such as epigenetic regulation or post-transcriptional regulation 
using non-coding RNA. Emerging evidence for a novel lineage of specific transcription 
factors, which were not picked up in the initial screens, argues for a layer of transcription 
factor-dependent gene regulation in the parasite (Balaji et al. 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Q-TOF MS/MS spectra of the P. falciparum histone H3 peptides  
A. KacSTAGKacAPRmeK ([M+2H]2+ = 571.35) and B. KacSTAGKacAPRme2s K ([M+2H]2+ = 578.37).  
Label 1-7 = internal fragments of increasing length with an arginine pseudo C-terminus, 0 = H2O loss 
from ion, * = NH3 loss from ion, § = CH3NH2 loss from ion, # = CH3NCHNH2 loss from ion, £ = 
(CH3)3NCHNH2 loss from ion.  
C. expanded view of the m/z  620-1020 range of the spectrum in B. 
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 Very little is known about P. falciparum epigenetics, including histone modifications 
and function. In order to provide a starting point for the discovery of epigenetic regulatory 
mechanisms in the parasite, we set out to map the histone modifications using mass 
spectrometry. Here we report the identification of all 8 known histone proteins in P. 
falciparum and a comprehensive characterization of novel post-translational modifications. 
Most of the modifications reported here have not been identified by mass spectrometry 
before although a subset were identified by Cui and coworkers, including acetylation of 
H2A.ZK25 and K30, H2BvK13 and K18, H3K9, K14, K18 and K27, H3.3K9 and K14, H4K8 
and K12 as well as H3R17 methylation (Miao et al. 2006). A few modifications were reported 
exclusively in the Cui study, including H2A.ZK28 methylation, H2BT84 phosphorylation, 
H3K14 methylation, H4K5, K16 and R17 methylation. This discrepancy is interesting and 
calls for further independent confirmation of these modification sites. 
The P. falciparum histone H2A N-terminal sequence is well conserved from P. 
falciparum to human and acetylation of N-terminal lysines appears to be conserved (Schiltz 
et al. 1999; Bonenfant et al. 2006; Boyne et al. 2006). The N-terminal tail of P. falciparum 
H2A.Z is extended as compared to mammalian H2A.Z. Accordingly, the high level of 
acetylation observed clearly distinguish the P. falciparum H2A.Z modification state from its 
human hosts. A similar N-terminal extension and abundant acetylation is found in 
Tetrahymena thermophila (Allis et al. 1986; Ren and Gorovsky 2001; 2003). Thus, the 
extensive acetylation of the extended histone H2A.Z N-terminus is intriguing since it is clearly 
divergent from the H2A.Z phenotype observed in higher eukaryotes. Even though, H2A.Z is 
also found to be the most acetylated H2A variant in humans (Bonenfant et al. 2006; Boyne et 
al. 2006), the relative levels of acetylation are much lower than what is observed in P. 
falciparum. H2A.Z is known to be associated with marking of transcriptionally competent 
regions of the genome and protection of euchromatic regions from spread of silent 
heterochromatin (Stargell et al. 1993; Meneghini et al. 2003). As mentioned previously, the 
Tetrahymena thermophila Histone H2A.Z N-terminal tail and acetylation level resembles that 
observed in Plasmodium falciparum. Ren and Gorowsky investigated the lethality of 
Tetrahymena thermophila histone H2A and H2A.Z N-terminal tail mutants, where lysines 
were substituted for arginines or glutamic acid. The investigation revealed that H2A 
acetylation was non-essential for viability, indicating that these modifications cannot play 
important functions in genome-wide chromatin regulation. The investigation of the H2A.Z N-
terminal tail revealed that a complete lack of the tail was non-lethal, whereas an exchange of 
all lysines for arginines in the tail was lethal (Ren and Gorovsky 2001 and 2003). We 
speculate that acetylation of H2A.Z functions to neutralize positive charges, which may 
facilitate a more “open” chromatin structure and accessible DNA template, rather than 
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providing a binding site for other proteins. If these observations are applicable to Plasmodium 
falciparum, what is then the reason for a highly extended, highly acetylated but yet 
dispensable H2A.Z tail? In the light of the very few sequence specific transcription factors 
discovered in the Plasmodium falciparum genome the parasite may depend more strongly on 
epigenetic regulation of transcriptional activation and repression. The histone H2A.Z N-
terminal tail may provide extra flexibility for such a regulatory system.  
Canonical Histone H2B is often present in a number of nearly identical subtypes in 
higher eukaryotes and there is, so far, no evidence of specific functions of each of the 
subtypes (Malik and Henikoff 2003; Kamakaka and Biggins 2005). Very few functional 
variants of H2B have been reported in nature and those that are reported completely replace 
the canonical H2B and have very specialized functions related to gametogenesis (Poccia and 
Green 1992; Aul and Oko 2002). The observation of two fairly distinct H2B subtypes 
proposes a completely novel differentiation of H2B function in Plasmodium falciparum. The 
dramatic difference in N-terminal lysine acetylation levels between H2B and H2Bv reported 
here further supports this proposition. 
The histone H3 variants in Plasmodium falciparum are very similar to H3 sequences 
found in higher eukaryotes, which reflects the very constrained evolution of Histone H3 (Malik 
and Henikoff 2003). It was therefore expected to find, if not an identical, then at least a very 
similar modification pattern in human and Plasmodium falciparum. To our surprise, this was 
not entirely the case. Even though all the modifications identified resembles known 
modifications in human there were substantial differences in their abundances. High peptide 
ion abundances was observed for ‘active’ marks, such as K4-me and K9-ac, whereas 
‘repressive’ marks were either not detected (K27-me, K36-me and K79-me) or present at low 
levels (K9-me). H3K9 methylation is a hallmark of silenced heterochromatin in a range of 
organisms and important for recruitment of HP1 proteins (Lachner et al. 2001). K9 
trimethylation was observed in this study, however, the number and intensity of peptides 
containing this modification were much lower than the analogous peptides containing 
acetylated K9. In contrast, K9 and K36 are reported to be 20-35% methylated and K27 to be 
70-100% methylated in mammalian histone H3 (Spencer and Davie 1999). These 
observations prompted a more detailed exploration by chromatin immunoprecipitation (ChIP) 
of the genome-wide distribution of selected histone H3 modification and this work will be 
published separately elsewhere (Salcedo-Amaya et al. 2009, Chapter 2). 
Neither of the eukaryotic phosphorylation sites, S10 and S28, were found in the 
phosphorylated state in Plasmodium falciparum histone H3 and H3.3 by mass spectrometry. 
Furthermore we were unable to obtain a signal with available H3-S10 and H3S28  
phosphorylation specific antibodies (Upstate 06-570 and Upstate 07-145) in both immunoblot 
Characterization of P. falciparum histone modifications 
 
43 
 
and immunoflourescence experiments (data not shown). Both phosphorylation sites have 
previously been associated with chromosome condensation during mitosis (Goto et al. 1999; 
Sassone-Corsi et al. 1999). There are at least two possible explanations for the lack of 
recovered S10 and S28 phosphorylations. First, Plasmodium falciparum chromosomes do 
not condense prior to mitosis and hence may not require specialized histone marks for such 
a process. Second, the phosphorylations may be present at levels too low to be detected by 
the methods applied in this study. 
Histone H4 is highly conserved from P. falciparum to human, with only 8 amino acid 
substitutions in the entire sequence. As expected, the modifications sites and types observed 
on Plasmodium falciparum histone H4 resemble those found on human histones. However, 
significant differences in the abundance of especially N-terminal lysine acetylations highlight 
a unique histone modification pattern in the parasite. The most remarkable finding was that 
K16 is not the favored acetylation site in Plasmodium falciparum histone H4, which 
contradicts what is observed in most other organisms (Zhang et al. 2002b; Smith et al. 2003). 
Instead, acetylation of K8 and K12 was frequently observed (supplementary Figure 1). 
Generally, our observations point towards a high level of modifications associated 
with a transcriptionally permissive state in the parasite and low levels of modifications 
associated with a transcriptionally repressed state. Microarray analysis of transcription have 
shown that up to 60 % of the genes are actively transcribed in the asexual state of the 
parasite life cycle (Bozdech et al. 2003; Le Roche et al. 2003). In comparison, only 15 % of 
yeast or human genes are actively transcribed during cell cycle (Spellman et al. 1998; 
Whitfield et al. 2002). The unique modification pattern that we report for Plasmodium 
falciparum may be explained, in part, by the much higher rate of ongoing transcription 
compared to yeast and human.  
State-of-the art LC-MS/MS was used in this study to obtain high quality peptide 
fragment spectra of the modified peptides that enabled localization of individual and multiple 
post-translational modifications in peptides. A variety of diagnostic fragment ions for modified 
peptides were utilized in the validation of MS/MS data. We show that a prerequisite for 
optimal characterization of acetylated and methylated peptides by tandem mass 
spectrometry is good sensitivity of low-molecular weight ions. As illustrated here, many side-
chain specific ions, and thus modification specific ions, are situated in the low m/z region. 
While Q-TOF type instruments normally meet this requirement, quadrupole ion traps 
generally suffer from a low mass cut-off in MS/MS mode. Recent advances in ion trap 
instruments and scan modes have partially overcome this limitation (Griffin et al. 2007) as 
has the introduction of the high-resolution Orbitrap mass analyzer (Olsen et al. 2007). 
Conversely, FT-ICR instruments deliver supreme mass accuracy, which is often sufficient for 
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unambiguous identification of peptide modifications. Clearly, a combination of high mass 
accuracy in both MS mode and MS/MS mode and good MS/MS fragmentation efficiency 
across the entire m/z range is highly desirable, especially when studying complex biological 
samples. It will be a challenge for the future to improve the tools available for analysis of 
protein modifications by mass spectrometry. Clearly, much benefit can be drawn from 
specific enrichment strategies used with the purpose of simply increasing the available 
amount of modified peptide and reducing the level of unmodified peptides. Such strategies 
have been developed to recover, for example, phosphopeptides and glycopeptides (reviewed 
in Jensen 2006) and also enrichment of acetylated peptides has been reported (Kim et al. 
2006). This study clearly shows that abundant structural information is available in the 
fragment spectra of modified peptides. Future work should be targeted at a continued 
investigation of these fragmentation patterns in order to reveal as much hidden information 
as possible. This information might turn out to be crucial in the validation of modified peptide 
identifications. 
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Abstract 
 
Epigenome profiling has led to the paradigm that promoters of active genes are decorated 
with H3K4me3 and H3K9ac marks. To explore the epigenome of Plasmodium falciparum 
asexual stages, we performed MS analysis of histone modifications and found a general 
preponderance of H3/H4 acetylation and H3K4me3. ChIP-on-chip profiling of H3, H3K4me3, 
H3K9me3, and H3K9ac from asynchronous parasites revealed an extensively euchromatic 
epigenome with heterochromatin restricted to variant surface antigen gene families (VSA) 
and a number of genes hitherto unlinked to VSA. Remarkably, the vast majority of the 
genome shows an unexpected pattern of enrichment of H3K4me3 and H3K9ac. Analysis of 
synchronized parasites revealed significant developmental stage specificity of the 
epigenome. In rings, H3K4me3 and H3K9ac are homogenous across the genes marking 
active and inactive genes equally, whereas in schizonts, they are enriched at the 5′ end of 
active genes. This study reveals an unforeseen and unique plasticity in the use of the 
epigenetic marks and implies the presence of distinct epigenetic pathways in gene 
silencing/activation throughout the erythrocytic cycle. 
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Introduction 
 
Plasmodium falciparum, the protozoan parasite causing malaria, exhibits a complex life cycle 
characterized by invasion of different cell types and hosts. During the ≈48 h of the 
intraerythrocytic cycle, a merozoite invades a red blood cell (RBC) and develops into the ring 
stage, which is followed by the trophozoite stage. Nuclear division marks the beginning of the 
schizont stage, which results in the formation of up to 32 merozoites that can invade new 
RBCs (Arnot and Gull 1998). Global analysis of transcription (Bozdech et al. 2003; Le Roche 
et al. 2003) and protein expression (Florens et al. 2002; Lasonder et al. 2002) of the parasite 
have revealed a high level of coordination in gene expression during the different stages of 
the life cycle. The absence of chromosomal clustering among genes with similar transitory 
expression profiles indicates that genes are regulated individually. The organization of 
Plasmodium spp. promoters is rather ill defined, and only a few DNA-binding proteins are 
known to control transcription (Gardner et al. 2002; Coulson et al. 2004; De Silva et al. 
2008). Plasmodium spp. genomes encode epigenetic modifiers such as histone 
acetyltransferases (HATs), deacetylases (HDACs), and methyltransferases (HMTs) (Aravind 
et al. 2003; Horrocks et al. 2009). Studies from yeast to humans have shown a strong 
correlation among active promoters and H3K4me3 and H3K9ac (Schubeler et al. 2004; 
Schneider et al. 2004; Bernstein et al. 2005; Liu et al. 2005; Pokholok et al. 2005). However, 
recent studies challenge this notion by showing the occurrence of H3K4me3 at the promoter 
of inactive genes (Guenther et al. 2007). In turn, H3K9me, H3K27me and H4K20me mark 
inactive genes and are involved in heterochromatin formation (Martens et al. 2005). In P. 
falciparum, epigenetic mechanisms have been implicated in the control of antigenic variation, 
a mechanism of immune evasion that contributes to pathogenicity (Duraisingh et al. 2005; 
Freitas-Junior et al. 2005; Frank et al. 2006; Voss et al. 2006; Chookajorn et al. 2007; Lopez-
Rubio et al. 2007; Lopez-Rubio et al. 2009). H3K9me3 has been described as the silenced 
var gene mark in targeted ChIP (Chookajorn et al. 2007; Lopez-Rubio et al. 2007) and 
H3K4me2–3 and H3K9ac as the active var gene marks (Lopez-Rubio et al. 2007). At other 
genomic locations, Cui et al. (2007) analyzed H3K9me3 and H3K9ac and reported that 
acetylation is enriched at active stage-specific genes in the parasite (Cui et al. 2007). 
Comprehensive characterizations of the histone post-translational modifications (PTMs) and 
full-genome epi-landscaping of histone PTMs are lacking.  
 
Here, we determined histone PTMs by MS in asexual stages and profiled their 
localization patterns using high-resolution microarray analysis. We identified an extensively 
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euchromatic P. falciparum epigenome with limited and well defined heterochromatic islands. 
The vast majority of the genome displayed patterns of H3K4me3 and H3K9ac enrichment 
upstream but also downstream of genes. Analysis of synchronous ring and schizont 
parasites revealed a dynamic epigenome wherein H3K4me3 and H3K9ac are spread evenly 
across active and inactive genes in the ring stage and associate distinctively with the 5′ end 
of active genes at the post-replicative stage. The findings here suggest that H3K4me3 and 
H3K9ac are cycle-regulated at P. falciparum genes and challenge the notion that these 
marks are solely reflective of the transcriptional status in the parasite.  
 
 
Material and Methods  
 
Parasites preparation 
P. falciparum NF54 was cultured using a semiautomated culture system. Mixtures of asexual 
parasites contained ≈10% ring parasitemia and 10% trophozoite-schizont parasitemia. For 
MS, parasites were filtered to remove white blood cells (WBC) and further purified using the 
VarioMacs system. Synchronous asexual cultures were obtained by sequential use of at 
least 2 rounds of 5% Sorbitol and 63% Percoll. Rings were collected ≈14 –18 h post-infection 
and mature schizonts ≈4 h pre-egress. Parasites were released from erythrocytes by 
treatment with saponin 0.06% or RBC Lysing Buffer Hybri-Max (Sigma–Aldrich).  
 
Antisera 
H3 (Abcam ab1791), H3K4me2 (Abcam 7766), H3K4me3 (Abcam ab8580), H3K9ac 
(Upstate 06942), H3ac (Upstate 06–599), H3K9me3 [#4861; (Peters et al. 2003)], 
H3R17me2 (Abcam ab8284), H3K18ac (Abcam ab1191), H4ac (Upstate 17–211), H4K8ac 
(Upstate 06–760), H4K12ac (Upstate 06–761), H4K20me1 and H4K20me3 (Schotta et al. 
2004). 
 
Chromatin immunoprecipitation 
Cross-linked and native chromatin were prepared as described in supplementary Methods.  
 
Microarray analyses 
A microarray was designed for whole-genome analysis based on the P. falciparum National 
Center for Biotechnology Information genomic sequence (May 2005) with a mean probe 
spacing of 47 bp. The procedure for oligo selection is described in supplementary Methods. 
For ChIP-on-chip hybridization, total and ChIP DNA were amplified starting from similarly low 
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DNA concentrations using T7 Linear Amplification method (Liu et al. 2003). We used G 
tailing instead of T tailing and a T7C9B primer. Three to five micrograms of amplified RNA 
were reverse-transcribed using N6 primers. Double-strand DNA was synthesized according 
to enzyme manufacturer protocols. Labeling of dsDNA was performed using 5′-Cy3 or Cy5 
labeled random heptamers (TriLink Biotechnologies). For transcriptional profiling of iRBC 
stages, cDNA obtained from RNA (supplementary Methods) and sonicated genomic DNA 
(obtained from early rings) were directly labeled with random heptamers and hybridized.  
 
Data analysis 
Log2 ratios were computed for each sample pair and adjusted using Tukey biweight (affy-
package version 1.6.7, Bioconductor). General feature format (GFF) tracks were visualized 
using SignalMap (NimbleGen Inc.). Data presented for asynchronous asexual stages are the 
mean of: H3 (4), H3K4me3 (2), H3K9ac (3), cDNA (1), and H3K9me (1) biological replicas. 
For synchronized ring and schizont stages, each factor was done once. Average gene plots 
were generated based on the gene annotation of National Center for Biotechnology 
Information's Gene database (Sequence release May 2005). Only genes covered by >5 
probes were included. For the resulting 5,266 genes, we calculated the average H3, 
H3K4me3, H3K9ac, and H3K4me3 to H3K9ac plots and ratio values. For detection of 
H3K9me3 enriched genes, genes covered by >2 probes were included. Outliers with 
H3K9me3 deviating from the genome average were defined as those with values >3 times 
the interquantile range and grouped according to gene name and/or function. Genes in the 
outlier group were rank-ordered according to the median H3K9me3 ratios. 
For transcriptional analysis, the expression value per gene was calculated by 
averaging the cDNA/gDNA non-log ratio of all of the probes mapping to the exons of the 
gene. 
 
 
Results 
 
We set out to study the epigenetic makeup and the role of histone PTMs in gene regulation. 
Acid-extracted histones from heterogeneous and highly purified parasites from infected RBC 
(iRBC) were subjected to Western blot analysis and high-accuracy MS analysis (for a 
detailed MS analysis of histone PTMs, see Trelle et al. 2009). These analyses showed that 
P. falciparum H3 and H4 are extremely rich in euchromatin-associated PTMs and largely 
devoid of heterochromatin-associated marks (supplementary Figure S1), as observed in 
other unicellular eukaryotes (Garcia et al. 2007).  
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H3, H3K4me3, H3K9ac, and H3K9me3 genomic profiles 
Post-translational modification of histones and changes in chromatin structure are involved in 
establishment and maintenance of the expression status of genes. To gain insight into 
epigenetic control of gene expression in P. falciparum, we performed ChIP and ChIP-on-chip 
analyses during the intraerythrocytic cycle using antibodies that recognize H3 core, 
H3K4me3, H3K9me3, and H3K9ac. Assays were performed on cross-linked sonicated 
chromatin (XChIP) (H3, H3K4me3, and H3K9ac) or native chromatin (NChIP) (H3K9me3) 
obtained from cultures of asynchronous asexual parasites (50% ring, 50% trophozoites-
schizont). In addition, we collected and mined cDNA expression data (iRBC stages) on the 
microarray. To investigate the extent to which P. falciparum fragmented DNA can be reliably 
amplified, we tested 3 different amplification methods used in ChIP-on-chip studies. An 
optimized terminal transferase T7 amplification method (Liu et al. 2003) amplified the highly 
AT-rich DNA in the most reproducible and near-linear fashion (supplementary Figure S2). A 
representative chromosomal view of the P. falciparum ChIP-on-chip landscape is shown in 
Figure 1A.  
 Histone H3 displays a rather even distribution throughout the genome with minor 
enrichment at telomeric and other regions. The general distribution pattern of H3K4me3 that 
we observe in P. falciparum is remarkable, because the modification does not appear to be 
restricted to specific regions, as in other eukaryotes, but rather enriched in a large fraction of 
the genome. H3K9ac yields a pattern that resembles the H3K4me3 pattern. Strikingly, 
extensively hypoacetylated transcriptionally silent regions are present at telomeric and 
discrete chromosome internal loci (Figure 1A). Plotting ChIP/input ratios of H3K4me3 
against H3K9ac at the single-probe level and at the mean value computed per ORF revealed 
a high correlation of H3K4me3 with H3K9ac for most of the P. falciparum genome, with the 
exception of a group of outliers that is strongly hypoacetylated but displays normal H3K4me3 
(Figure 1B). 
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Figure 1. Profiling H3, H3K4me3, H3K9ac and H3K9me3.  
A. ChIP-on-chip and transcriptome profiles. SignalMap view of the epigenetic landscape of 
chromosome 12. The data are plotted as log2 ratios of ChIP/input. Coordinates are according to 
GenBank annotation release May 2005. B. Scatter plot of log2 ratios (ChIP/input) of H3K9ac versus 
H3K4me3. Each dot represents the median ratio calculated per gene. C. As in B for H3K9ac vs. 
H3K9me3. D. Boxplot distribution of genes grouped according to gene annotation and ranked by their 
log2 H3K9me3 median ratio calculated per gene. E. Genomic localization of 
hypoacetylated/hypermethylated genes. The chromosomal map positions of hypoacetylated ‘outlier’ 
genes. In red: var, rifin, stevor, and pfmc-2tm genes and their pseudogenes. In blue: Other known-
function and hypothetical protein genes that show a similar hypoacetylation/hypermethylation 
described in the text and supplementary Table S1 (available at 
http://www.pnas.org/content/suppl/2009/06/02/0902515106.DCSupplemental/0902515106SI.pdf).  
 
 
 
H3K9me3-heterochromatin is restricted to subtelomeric and discrete interspersed 
intrachromosomal islands 
We detected very low levels of H3K9me3 in our MS analysis and could not unambiguously 
determine its presence by XChIP because of poor recoveries and signal-to-noise ratios. We 
reasoned that H3K9me3 may be shielded by chromatin-associated proteins in XChIP. 
Therefore, we have established a modified native ChIP (NChIP) protocol, which in our hands 
considerably improves the efficiency and accuracy of the ChIP analysis for H3K9me3. At var 
genes, we observe a 6-fold enrichment of H3K9me3 when compared with the active hsp70 
gene and a near-perfect inverse correlation with H3K9ac (supplementary Figure S3). 
NChIP-on-chip analysis of H3K9me3 showed that this PTM is common to all H3K9ac 
hypoacetylated, silent “outlier” genes (Figure 1A), with a strong anticorrelation between 
H3K9ac and H3K9me3 (Figure 1C). The H3K9 hypoacetylated and hypertrimethylated 
regions are located either close to telomeres or in intrachromosomal clusters (Figure 1E). 
These regions comprise nearly all members of variant surface antigen families (VSA), var, 
rifin, stevor, and pfmc-2tm, and other subtelomeric gene families such as pfacs, surfins, clag, 
and many members of exported proteins families such as hyp, dnaj, gbp130, and phist 
genes. Thirty-five hypothetical proteins and 12 known function proteins that are hitherto not 
linked in any way to VSA genes also share this marking (Figure 1D and supplementary 
Table S1 available at www.pnas.org/contents/suppl/2009/06/0902515106.DCSupplemental/0 
902515106SI.pdf).These genes are flanked by or adjacent to antigenic variation genes 
(Figure 1E), with the exception of a small number of isolated single genes (i.e., 
chromosomes 10, 11, and 12 shown in Figure 1E). Interestingly, 27 of these 35 hypothetical 
proteins are P. falciparum-specific and not conserved in any of the other sequenced 
Plasmodium species.  
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var genes are implicated in host–parasite interactions and pathogenicity and are 
subject to mutually exclusive expression: only 1 var gene is active in individual parasites 
(Scherf et al. 1998; Horrocks et al. 2004). Although several var genes may be active in 
different subsets of the parasites, in our cultures, they are on average silent, as corroborated 
by expression profiling (Figure 1A). Silent var genes have been reported to be trimethylated 
on H3K9 (Chookajorn et al. 2007; Lopez-Rubio et al. 2007). qPCR validation and our 
positional map for the average silent var gene corroborate and extend that H3K9me3 and 
H3K4me3 are elevated over these genes (supplementary Figure S3). In contrast, H3K9ac 
is strongly depleted at the var genes.  
 
H3K4me3 and H3K9ac are highly correlated and enriched at intergenic regions and 
depleted at the majority of genes in P. falciparum 
In all organisms studied thus far, H3K4me3 and H3K9ac localize with active or poised 
promoters providing positional and probably also functional information for gene expression 
(Schubeler et al. 2004; Schneider et al. 2004; Bernstein et al. 2005; Liu et al. 2005; Pokholok 
et al. 2005, Vermeulen et al. 2007). During RBC infection, at least 60% of all P. falciparum 
genes are found expressed in a highly coordinated manner in which functionally similar 
groups of transcripts are produced when needed during the RBC cycle (Bozdech et al. 2003; 
Le Roch et al. 2003). Zooming into the mixed asexual parasites profiles to the gene level, 
core histone H3 displayed minimal patterns of enrichment that correlate with ORFs (Figure 
2A). In contrast, H3K4me3 and H3K9ac display clear patterns that correlate well with the 
gene annotation, i.e., high at intergenic regions (IGRs) and low at ORFs (Figure 2). This 
pattern, best discernable at large ORFs, is characterized by high signals upstream of the 
ORF, which decrease within the gene and increase again toward the 3′ end, as shown by the 
computed averaged modification profiles over all ORFs (Figure 2B). ChIP-qPCR 
experiments using primers ≈1 kb upstream from the ORF and within the gene bodies of 
transcriptionally active and inactive genes validate this finding (supplementary Figure S4). 
Remarkably, the ChIP recoveries are similar between active and inactive genes in terms of 
H3, H3K4me3, and H3K9ac. For example, the mosquito stage-specific genes, ssp2 and csp, 
whose transcript levels are very low to undetectable in iRBC stages, are acetylated and 
methylated to an extent and in a pattern similar to those of the highly transcribed hsp70 and 
hsp 86 genes (supplementary Figure S4). Analysis by re-ChIP, carrier ChIP-like 
approaches, and NChIP showed the same results at these genomic regions (supplementary 
Figure S5).  
 
 
Dynamic histone H3 epigenome marking 
 57 
 
 
 
Figure 2. H3K4me3 and H3K9ac 
analysis in asexual RBC stages. 
A. SignalMap view of a section of 
chromosome 2 as described in Fig. 2A 
showing increased marking at 
intergenic regions and depletion at 
ORFs.  
B. Composite epigenetic profiles of 
H3, H3K4me3, and H3K9ac averaged 
over P. falciparum genes. The 
averaged gene organization is 
depicted. Only genes with gene-free 
upstream region larger than 0.8 kb 
and >4 probes spanning it were 
analyzed. Probes located within 0.8 kb 
upstream of the ORF were assigned 
into 5 bins of equal length. ORFs were 
divided into 20 bins. The middle 
position of the probe was used to 
assign probes to bins.  
C. Composite profile of H3K4me3/H3 
and H3K9ac/H3 ratios of the 500 
highest expressed genes in iRBCs. 
Each ORF was divided into 20 bins of 
equal size. Genes larger than 0.8 kb 
with upstream gene-free region larger 
than 0.8 kb were used for the analysis.  
D. As in C for the 500 least expressed 
genes.  
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To further investigate the relationship between gene expression and histone 
modifications, we compared the marking of the 500 most active genes in iRBCs with that of 
the 500 most inactive genes extracted on the basis of our expression study and excluding 
the “outlier” group. The calculated average profiles revealed that H3K4me3 and H3K9ac 
extend into the 5′ region of the highest expressed genes, gradually decreasing toward the 
middle of the gene and increasing back again toward the 3′ end (Figure 2C). Interestingly, 
the lowest expressed genes display lower H3K4me3 and H3K9ac at the beginning of the 
gene (Figure 2D). The particular enrichment of H3K9ac and H3K4me3 at the 5′ end of active 
genes is suggestive of promoter-specific marking by relative enrichment as observed in the 
closely related Toxoplasma gondii (Gissot et al. 2007). 
 
H3K4me3 and H3K9ac gene patterns are dynamically regulated throughout the P. 
falciparum iRBC cycle 
To further assess the role of histone PTMs in relation to gene expression, we set out to 
analyze genes that are constitutively in/active and genes that change expression throughout 
the iRBC cycle. RNA and chromatin were collected from ring parasites 14–18 h post-invasion 
and from mature schizonts ≈4 h preegression. Expression analysis and ChIP and ChIP-on-
chip experiments were carried out in parallel. Reverse transcriptase-PCR shows that our ring 
parasites indeed displayed high mRNA levels of the ring-specific marker kahrp, whereas the 
schizont sample contains high levels of msp2 and actin (supplementary Figure S6). Global 
gene expression analyzed on the same microarray corroborates and extends that the 2 
populations display differential gene expression (supplementary Figure S6) (Bozdech et al. 
2003; Le Roch et al. 2003).  
Next, we examined the epigenetic marking over the 500 highest and least expressed 
genes in rings (prereplication) and mature schizonts (post-replication). In rings, the marks are 
evenly distributed across the genes with a minor increase over active as compared with 
inactive genes (Figure 3A and B).  
 
Figure 3. Distinct epigenetic marking of genes in the ring and schizont stages.  
A. Composite profiles of H3K4me3/H3 and H3K9ac/H3 ratios of the 500 most active genes in rings. 
Each ORF was divided into 20 bins of equal size. Only genes larger than 0.8 kb with upstream gene-
free region larger than 0.8 kb were taken for the analysis.  
B. The 500 least-active genes in rings;  
C. 500 most-active genes in schizonts;  
D. 500 least active genes in schizonts.  
E. Schizonts profile of genes that are active in rings and remain active in schizonts, and of F., genes 
that are active in rings and turn inactive in schizonts.  
G. Schizont profile of genes that are inactive in rings and became active in schizonts and of H., genes 
that are inactive in rings and remain inactive in schizonts.  
I. and J. Ring profiles of genes as they switch from schizonts to rings, as described from E.–H.  
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Remarkably, the profile in schizonts differs significantly from that in rings. H3K4me3 and 
H3K9ac are found specifically enriched toward the 5′ end of highly active genes (Figure 3C), 
similar to the small increase observed in the asynchronous mixed stages (Figure 2C). Genes 
inactive in schizonts lack this 5′ end marking but display a slight enrichment of the histone 
marks toward the 3′ end (Figure 3D), as also observed in the analysis of the mixed 
population (Figure 2D). This H3K4me3 and H3K9ac enrichment at the 5′ end of active genes 
in schizonts was confirmed by qPCR analysis of constitutive active and inactive genes as 
shown in supplementary Figure S7. 
Given the important differences in the marking between ring and schizont stages, we 
analyzed the expression and histone marks of the genes that are differentially or 
constitutively expressed in rings and schizonts. For clarity, only genes belonging to the top 
(active) and bottom quartiles (inactive) of gene expression are included in the analysis. 
Genes active in ring (Figure 3A) that remain very active as the cycle progresses into the 
schizont stage (223/500) gain elevated H3K4me3 and H3K9ac at the 5′end characteristic of 
active genes in the schizont stage of the parasite cycle (Figure 3E). Genes active in rings 
and switched off in schizonts display a nearly flat level at the 5′ end (49 genes) (Figure 3F). 
Inactive ring genes (Figure 3B) that become highly expressed in schizonts (86 genes) also 
display enrichment of H3K4me3 and H3K9ac at their 5′ end (Figure 3G). Importantly, genes 
that are inactive in rings and that remain inactive in schizonts (291) lack enrichment of the 
marks at their 5′ end (Figure 3H). Following the fate of the 500 most active schizont genes 
(Figure 3C) into the ring stage reveals loss of the distinct marking at the 5′ end. The PTMs 
are found almost evenly distributed along the length of the gene with very little differences in 
the profile between active (225 genes) (Figure 3I) and silent genes (140 genes) (Figure 3J). 
Likewise, inactive schizont genes that became strongly activated in the ring stage (46 genes) 
(Figure 3K) or that remained inactive (387) (Figure 3L) are marked in the ring stage 
seemingly independent of their gene expression level. Thus, gene expression in rings does 
not correlate to a specific pattern of H3K4me3 and H3K9ac such as is found at the schizont 
stage. The specification of active genes by H3K4me3 and H3K9ac at the 5′ end in the 
schizont stage is lost at the ring stage, where these marks spread evenly across the genes. 
These findings suggest that the P. falciparum epigenome is unique, highly dynamic, and 
stage-specific. 
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Discussion 
 
To decipher the epigenetic component of gene regulation, we first identified histone PTMs 
and subsequently analyzed their distribution genome-wide in mixed asexual stages. The 
characterization of H3 and H4 PTMs by Western blot analysis and MS (supplementary 
Figure S1) supports the conclusion that P. falciparum histones are highly enriched in 
euchromatin-associated histone PTMs and low in heterochromatin marks, as seen with other 
unicellular eukaryotes (Garcia et al. 2007).  
Our epigenome profiling of histone H3 marks reveals a restricted epigenetic marking 
characterized by hypoacetylation and hypertrimethylation of H3K9 over ≈9% of the parasite 
genome that encompasses VSA genes, exported proteins, and other hitherto unrelated 
genes. H3K9me3 marking has been reported before on individual var genes (Chookajorn et 
al. 2007; Lopez-Rubio et al. 2007). Our genome-wide findings are in good agreement with a 
very recently published study reporting the localization of H3K9me3 (Lopez-Rubio et al. 
2009). Both studies have been conducted using a NimbleGen platform with different array 
designs. Due to low sequence complexity and a high AT content, neither of the 2 arrays has 
sufficient probes and hence discriminatory power in the IGRs. Therefore, we restricted our 
comparative analysis of the 2 H3K9me3 datasets to the ORFs, which revealed largely 
identical gene lists. We obtained high recoveries of H3K9me3 only when using NChIP, 
indicating that a protein(s) may be tightly associated with H3K9me3, which upon cross-
linking masks the mark. In higher eukaryotes, H3K9me3 is a hallmark of heterochromatin 
and recruits HP1; recent data have shown that a chromodomain protein related to HP1 also 
recognizes this mark in P. falciparum (Perez-Toledo et al. 2009). 
H3K4me3 and H3K9ac have been correlated to the active var gene state (Lopez-
Rubio et al. 2007). It is important to note that our study cannot be compared directly to the 
active var2csa gene study, because we used parasites in which var expression is not 
characterized. Moreover, due to the repetitiveness of the var upstream regions, our analysis 
lacks the power to discriminate among individual promoters. We provide evidence that the 
average silent var gene is decorated with H3K9me3, whereas H3K9ac is low (Figure 1 and 
supplementary Figure S3). Contrasting with the findings of Lopez-Rubio et al. (2009), loci 
with high H3K9me3 also display high H3K4me3. We cannot at present exclude that the 
presence of these opposing marks is due to variegated expression in unselected parasite 
populations. How the highly localized and well delineated hypermethylated/hypoacetylated 
islands (Figure 1) are generated and insulated may be the subject of future investigations. 
Interestingly, only 8 genes with this distinctive heterochromatic makeup are conserved in all 
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sequenced Plasmodium spp. H3K9me3 does not appear to be present at other P. falciparum 
inactive genes outside of the heterochromatic blocks. For instance, H3K9me3 is not 
detectable at transcriptionally inactive genes such as the csp and ssp2 genes, indicating that 
H3K9me3 is not a general mark of transcriptional inactivity in the parasite. Other layers of 
transcriptional repression may be involved in the silencing of blood stage-specific genes and 
genes expressed at other stages of the parasite cycle. In our MS analysis, we detect K9me3 
along with the replication-linked K56ac exclusively on H3 and not H3.3. Extending from 
studies in yeast (Ozdemir et al. 2006; Li et al. 2008), we speculate that the acquisition of 
H3K56ac occurs during or soon after DNA replication. 
Our study uncovers a predominantly euchromatic P. falciparum epigenome 
characterized by high overall levels of H3K4me3 and H3K9ac, generally enriched over IGRs 
and lower at ORFs in mixed asynchronous parasite cultures. This euchromatic marking 
extends to 91% of the genome (Figure 2). In yeast, H3K4me and histone acetylation are 
positively correlated with transcription and are found to be enriched not only at the promoter 
but also at the 5′ end of the coding regions of transcribed genes (Ng et al. 2003; Liu et al. 
2005; Pokholok et al. 2005). Analyses of the IGRs in P. falciparum did not reveal convincing 
differences between active and inactive genes by either ChIP-qPCR or microarray analysis in 
nonsynchronized cultures. Analysis of synchronized stages reveals that at the ring stage, the 
PTMs are distributed rather homogenously along the length of the gene. Genes most highly 
expressed in the ring stage display only marginally higher H3K4me3 and H3K9ac as 
compared with genes that are lowest or not transcriptional active (Figure 3 A, B, and I-L). 
Thus, the extent of H3K4me3 and H3K9ac does not appear to correlate with transcription in 
the ring stage of the parasite. This occurrence of active marks on inactive genes is 
unexpected and contrary to the currently held view that gene activity correlates with the 
presence of H3K4me3 and H3K9ac at promoters. 
Unlike in the ring stage, active genes in schizonts are enriched for H3K4me3 and 
H3K9ac specifically at the 5′ end of ORFs (Figure 3 C, E, and G), whereas inactive genes 
lack this marking (Figure 3 D, F, and H). This H3K4me3 and H3K9ac marking is acquired 
primarily in a stage- rather than a gene-specific manner. In rings, ring-specific, constitutively 
active but also inactive genes (Figure 3 I–L) display a similar evenly spread profile over the 
gene. In schizonts, constitutively expressed (Figure 3 E and H) and schizont-specific genes 
(Figure 3 F and G) display elevated levels of H3K4me3 and H3K9ac at their 5′ ends, 
reminiscent of active promoters in other eukaryotes (Schubeler et al. 2004; Schneider et al. 
2004; Bernstein et al. 2005; Liu et al. 2005; Pokholok et al. 2005).  
Previous studies of gene regulation in P. falciparum have supported the view that 
epigenetic modifications and chromatin changes are critical players in the control of gene 
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expression (Hakimi and Deitsch 2007). In this study, we report the existence of distinct 
stage-specific epigenetic marking of genes in the parasite, indicating that the epigenome is 
dynamically regulated during the parasite blood cell cycle. The distinctive marking of genes 
in rings and schizonts might be the result of differential availability of the components of the 
epigenetic machinery at different stages of the parasite cycle. The similarity between the 
profiles of genes active in yeast and genes active in the schizont stage is striking, suggesting 
that temporarily expressed modifiers may be shaping the profiles post-replication. The 
histone deacetylase containing Rpd3S complex in yeast has been involved in removing 
transcription-related acetylation toward the 3′ end of active genes (Carroza et al. 2005). 
Whether a related complex is present in P. falciparum specifically in the post-replicative 
stage of the life cycle remains to be investigated. Our discovery of the lack of association of 
H3K4me3 and H3K9ac with gene expression in the ring stage supports a model of concerted 
integration of different levels of control (Coleman and Duraisingh 2008; Horrocks et al. 2009).  
Taken together, the striking differences in the marking of genes in the ring and 
schizont stages uncovers that the process of epigenome marking is dynamic and changes 
throughout the course of RBC infection. The challenge that lies ahead is to generate 
quantitative transcriptome and epigenetic maps at mononucleosomal resolution throughout 
all stages of the RBC life cycle. These detailed maps may be instrumental in understanding 
parasite growth, control of gene expression, in particular of pathogenicity genes, and disease 
development. Excitingly, given the observed differences in the epigenetic code compared 
with all other organisms studied, including humans, this knowledge will open new avenues 
for therapeutic interference using Plasmodium-specific epigenetic enzymes inhibitors.  
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Supplementary Methods 
 
Histones extraction 
Nuclei (from parasites or HeLa cells) were prepared by addition of a 10mM Tris-HCl pH 8.0, 
3 mM MgCl hypotonic buffer plus NP-40 0.2% in the presence of a protease inhibitor cocktail 
(PI) and phosphatase inhibitors (2 mM MgCl2, 1 mM sodium pyrophosphate, 10 nM sodium 
orthovanadate, 5 mM sodium fluoride, 100 nM microcysteine, 0.5 mM PMSF) and 
homogenization by douncing (pestle B). Nuclei were layered onto the same buffer containing 
sucrose 0.25M, and collected by centrifugation. Two pellet washes were done with the same 
lysis buffer.  Nuclei were resuspended in 0.5M NaCl, 10mM Tris-HCl pH 8.0, 1 mM EDTA 
and PI, incubated for 10 minutes on ice and pelleted. Histones were acid-extracted by 
suspending the nuclei in HCl 0.25 M with brief sonication. The suspension was rotated for 1 
hour at 4ºC and the histone-enriched supernatant cleared by centrifugation at 13.000 rpm. 
 
LC-MS/MS identification of histone modifications 
Histone PTMs from parasites and human host were mapped in parallel experiments.  
Histones were resolved by SDS-PAGE under denaturing conditions and prepared for MS-
analysis by in-gel tryptic digestion (Shevchenko et al. 1996). LC-MS/MS was performed 
using a nanoflow-HPLC coupled to either a Waters Q-TOF Ultima or a Thermo LTQ-FT. Raw 
data were processed (background subtraction, smoothing, centroiding) and subjected to 
database dependent searches using MASCOT (Matrix Science Ltd.) or VEMS (Matthiesen et 
al. 2005). The data was searched against a combined human-malaria-mosquito database. All 
spectra assigned to a modified peptide were manually inspected. 
 
RNA Extraction and RT-PCR 
For experiments on asynchronous cell cultures, total RNA was extracted with 10 pellet 
volumes of Trizol (GIBCO), DNAse treated and cleaned up through RNAeasy columns 
(Qiagen). For experinments in synchronous ring and schizont stages, total RNA was 
extracted using the RNAeasy columns (Qiagen) following manufacturer’s instructions. 
Reverse transcription reactions were done on 1-5µg of total RNA using N6 and polyT primers 
and SuperScript III (Invitrogen). For RT-PCR reactions, cDNA was amplified by using 
oligonucleotides mapping around the start of the CDS. All reactions included negative 
controls where reverse transcriptase was omitted. 
 
Chromatin Immunoprecipitation 
Crosslinked chromatin was prepared by adding 1% formaldehyde to the culture for 5 min 
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followed by addition of glycine to 0.125M final concentration. After saponin lysis, nuclei were 
isolated by homogenization in 10mM Tris at pH 8.0, 3.0mM MgCl2, 0.2% NP-40, collected on 
a 0.25M sucrose-buffer cushion and suspended in SDS buffer (1% SDS, 50mM Tris pH 8.0, 
10mM EDTA, protease inhibitors). Chromatin was sheared by sonication in a Bioruptor UCD-
200 (Diagenode) for 10 min at 30s intervals, power setting high, to a size of 300-800 bp. 
Chromatin samples were frozen and stored at -80°C. ChIP was performed as described 
elsewhere (Brinkman et al. 2006). Quantitative PCR was performed in MyIQ sequence 
detector (Biorad) using primer sets described on supplementary Table S2 (available at 
http://www.pnas.org/content/suppl/2009/06/02/0902515106.DCSupplemental/0902515106SI.
pdf). PCR products were cloned and sequenced to confirm their identities. For native ChIP, 
fresh nuclei were collected and washed in MNase digestion buffer (50mM Tris pH 7.4, 4mM 
MgCl2 1mM CaCl2). 15ng/µl chromatin was digested with 0,5U MNase (Worthington) for 10 
min at 37C. Reactions were stopped by adding 10mM EDTA followed by centrifugation at 
13k for 5 min. Chromatin was extracted subsequently in 10mM Tris pH 7.4, 1mM EDTA and 
1mM Tris pH 7.4, 0.2mM EDTA. Supernatants were pooled and diluted twice to 50mM NaCl, 
20mM Tris pH7.4, 5mM EDTA, 0.5% Triton-X100, 0.05% SDS. ChIP was performed 
immediately and washed with 400 µl of 50mM Tris pH 7.5, 10mM EDTA, 0.5% Triton X-100, 
0.05% SDS,  with subsequent 100 to 150 and 250mM NaCl. Detergents were excluded from 
the last wash. 
 
Oligonucleotides selection for microarray analyses 
Initial oligos were selected at 4bp interval in clusters of 10 oligos. Masking for repetitive 
elements was done by generating a histogram of 15-mer frequency in the genome and 
removing oligos with an average 15-mer frequency greater than 100. Oligos were of variable 
length (45bp to 83bp, median length of 56bp) and the median Tm was 68.7°C. Uniqueness 
was ascertained by determining the number of exact 45-mer matches of each oligo in the 
genome. The best oligo from each cluster of 10 was selected based on average 15-mer 
frequency, uniqueness, Tm, and base pair composition rules. The final set of oligos was 
arranged using ArrayScribe array design software (NimbleGen Systems Inc.). Arrays were 
constructed as described previously (Singh-Gasson et al. 1999). 
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Supplementary Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure S1. Histones H3 and H4 PTMs from P. falciparum and human.  
A. Western blot analysis of histones from P. falciparum iRBC and human HeLa cells. Equal amounts 
of acid-extracted histones were loaded and verified with the H3core antibody. Since Plasmodium H3 
and H4 are almost identical in amino acid sequence to their eukaryote counterparts, a series of 
antibodies that recognize H3 and H4 PTMs were used.  
B. Diagram of P. falciparum H3 and H4 PTMs identified by high-accuracy Mass Spectrometry. 
Peptides unique to H3 or H3.3 are indicated. The size of the boxes indicates the relative abundance of 
the PTM (based on peptide extracted ion currents). H4 was heavily acetylated at K5, K8, K12 and 
K16, sites that are acetylated from yeast to man. H4K20me2 and -me3 peptides were detected at low 
levels.PfH3 and PfH3.3 were highly enriched in euchromatin-associated PTMs and modified similarly 
with the exceptions of very low levels of K56ac and K9me2 and -me3 that were only detected in PfH3.  
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Supplementary Figure S2. Comparison of genome amplification methods for ChIP-on-chip studies in 
P .falciparum.  
A. GC content (%) of 7 P. falciparum representative genomic regions (~80bp) used for qPCR analysis.  
B. LM-PCR Amplification. The graph depicts the difference in Ct values obtained between amplified 
DNA (blue line) and un-amplified DNA (red line) which was set to 0. X axis: primer sets. Y axis: 
positive and negative values indicate the over and under-amplification, respectively, of a DNA 
sequence as compared to the input (non-amplified).  
C. as in B using T7-random nonamers priming amplification.  
D. as in B using T7 Linear amplification (TLAD). 
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Supplementary Figure S3. H3K9me3-heterochromatin is present at var genes.  
A. Comparison of Native ChIP (N-ChIP) vs. B. Crosslinked ChiP (X-ChIP) for the detection of 
H3K9me3 in P. falciparum chromatin. A and B show the distribution of H3K9me3 and H3K9ac over 
hsp70 and var genes. C ChIP analysis of H3, H3K4me3 and H3K9ac at var genes (ups A, B, C and D 
types), at the actively transcribed hsp70 gene. Primer sets unique to var genes were used (Salanti et 
al. 2003). D. Computed average modification profile for the 58 var genes in the array. Probes located 
within 1.4kb upstream of the ATG were assigned into 5 bins of equal length. Exon 1 was divided into 
20 bins.  
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Supplementary Figure S4. H3K4me3 and H3K9ac analysis at active and inactive genes in asexual 
stages. A. Box plot distribution of ChIP-qPCR analysis of H3, H3K4me3 and H3K9ac on a subset of 
constitutively active (n=24) and silent (n=17) genes in the RBC cycle. Primer sets were designed in 
the intergenic/upstream region and the ORF. Values as percentage of input were determined and 
grouped as IGRs or ORFs for both active and inactive genes. Box plots were chosen to represent the 
dispersion of the data and to allow median value comparisons.  
B. H3 ChIPs over the active hsp70 and hsp86 genes as well as inactive ssp2 and csp genes. 
C. as in B for H3K4me3. D. as in B for H3K9ac. A schematic representation of the primer location is 
given. Arrows indicate solely the sense of transcription. The results are the average of several 
biological replicas. Standard deviations are shown. 
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Supplementary Figure S5. A. ChIP/re-ChIP analysis. H3K4me3 and H3K9ac are depleted from the 
chromatin after the first immunoprecipitation. The ChIP analysis was performed as usual and after 
binding of the specific DNA-protein-antibody complexes to protein A beads (1st ChIP), the unbound 
fraction was incubated again with the respective antibody and the immunoprecipitated DNA analyzed 
(2nd ChIP).  
B. Carrier ChIP approach. ChIP analysis of H3K4me3 and H3K9ac in mixtures of parasite and host 
chromatin. ChIP analysis was performed on mixtures of P. falciparum and HeLa chromatin at 100:1 
ratio to partially compensate for the genome size difference. Human active promoters gapdh and rpl39 
showed high levels of H3K4me3 and H3K9ac while they were absent from an intergenic region (IG_1) 
and the exon 2 of the inactive myoglobin gene (myo2).  
C. Native ChIP on MNase digested chromatin. H3K9ac ChIP analysis of parasite sequences far 
upstream the transcriptionally active hsp70 and inactive ssp2 loci. Both the active and inactive loci 
showed high levels of H3K9ac at their IGRs.  
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Supplementary Figure S6. Gene expression analysis in Ring and Schizont parasites. cDNA samples 
were obtained from either ~10-14h rings or ~4h-pre-egreess schizonts.  
A. Gene expression by real time-quantitative PCR (RT-qPCR) of constitutive highly expressed hsp70 
and hsp86 genes. B. Constitutive low expressed sar1 and pfck1 genes. C. Ring-specific kahrp. D. 
Schizont-specific actin and msp2. E. A subset of var genes, one with promoter subtype A, one with 
promoter subtype B and two with promoter subtype C. F. Sporozoite-specific genes: 2 hypothetical 
proteins, csp and ssp2. G. Global gene expression measured using NimbleGen arrays. The graph 
depicts a hierarchical clustering of steady RNA levels for P. falciparum genes. The dendrogram shows 
the similarity of expression profile between rows (genes) that are linked to each other by nodes.  
cDNA samples were hybridized with genomic DNA obtained from the early ring stage. 
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Supplementary Figure S7. Comparisons of the fold change of H3K4me3 and H3K9ac from the 5’ end 
of to the middle of active and silent genes as measured in rings and schizonts. Primer sets were 
designed that cover the 5’ end and the middle of constitutively active and silent genes. ChIP 
recoveries were normalized to H3 and used to calculate the “5’ to middle of the gene ratio”.  
A. H3K4me3 5’end to middle ratios in Rings and Schizonts for the active dnaj sec 63 homologue 
(PF13_0102), falcilysin (PF13_0322), pre-mrna splicing factor (PFD0265w), pfatp6 (PFA0310c) and 
silent ctrp (PFC0640w) and  dynein heavy chain (MAL7P1.162) genes.  
B. H3K9ac ratios for the same genes as described in A. The graphs validate the enrichment of 
H3K4me3 and H3K9ac at the 5’ end of active genes in the schizont stage. 
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Abstract 
 
In the search for promising drugs to combat malaria, inhibitors of chromatin modifying factors 
have started to obtain attention. P. falciparum histone deacetylases enzymes (HDACs) are 
seen as promising targets for antimalarial drugs in spite of the extensive conservation of 
parasite and human HDACs. HDAC inhibition is expected to affect chromatin structure and 
the patterns of gene expression. Several studies have described candidate compounds 
which can interfere with parasite growth throughout the erythrocytic cycle; in some cases 
without exhibiting toxicity to human cells. Here, we treated parasites at different stages in the 
erythrocytic cycle with a small panel of HDAC inhibitors. Suberoyl-anilide hydroxamic acid 
(SAHA) treatment resulted in reversible inhibition of parasite growth and accumulation of 
histone acetylation. To gain insight into the molecular responses that underlie the effect of 
SAHA treatment, we subjected synchronous ring cultures to 7h treatment. Global mRNA 
expression analysis showed that SAHA had minor effects on the global transcriptome. This 
includes 126 upregulated genes which are normally expressed at other stages of the parasite 
cycle and that were induced up to 50 fold. Remarkably, the compound specifically 
upregulates the expression of as many as 9 ApiAP2 transcription factors and a number of 
host-cell invasion related factors such eba-165 which is epigenetically regulated. We propose 
that the AP2 transcription factors that are upregulated in response to SAHA are at least 
partially, responsible for the induced transcriptional changes. Here we provide a first insight 
into the molecular mode of action of SAHA and suggest this HDACi as an important tool in 
deciphering parasite gene regulatory networks. 
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Introduction 
 
Chromatin is highly dynamic and its accessibility is strictly regulated and maintained by 
chromatin-modifying factors. Unravelling the complexity of epigenetic events in the parasite is 
essential for our understanding of how we can combat malaria. In humans, alterations in 
chromatin modifying pathways lead to the appearance of diseases, such as cancer (Mai and 
Altucci 2009). Cancer epigenetic therapy aims at reversing these alterations by means of 
small chemical inhibitor compounds which target enzymes involved in establishing and 
maintaining chromatin modifications such as histone post-translational modifications (PTMs). 
Histone and other proteins can be post-translationally modified by the addition of a variety of 
chemical groups (i.e. acetyl, methyl, phosphoryl, ubiquityl). Histone acetyltransferases 
(HATs) are chromatin regulators that catalyze the addition of an acetyl group to lysine 
residues, thereby reducing the degree of chromatin compaction and making the DNA more 
accessible to regulatory proteins. In turn, histone deacetylases (HDACs) catalyze the 
removal of acetylation resulting in chromatin condensation. HAT and HDAC activities 
maintain a dynamic equilibrium of histone acetylation across the epigenome. The particular 
recruitment of HAT and HDAC containing complexes to specific DNA regulatory elements 
has been correlated to the patterns of transcriptional activation and silencing in a variety of 
eukaryotes. 
Amongst the best-documented examples of epigenetic therapy is the inhibition of 
histone deacetylases enzymes (HDACs) that are categorized into four different classes 
according to similarity to yeast HDACs. Classes I, II and IV are zinc-dependent and their 
activity can be inhibited by binding in the zinc-containing active site of the enzyme. Class III 
HDACs are NAD+ dependent, commonly named sirtuins as they are related to the yeast 
silencing information regulator 2 (Sir2). The Plasmodium falciparum homologue of Class I, 
PfHDAC1 (PFI1260c) was shown to mainly localize in the parasite nucleus (Joshi et al. 
1999). Recombinant Class III Sir2A (PF13_0152) has the ability to deacetylate H3K9, H3K14 
and H4 N-tail and carries ADP-ribosylation activity (Merrick and Duraisingh 2007) and Sir2A 
and Sir2B (PF14_0489) cooperate to regulate the expression of the antigenic variation genes 
involved in pathogenesis (Tonkin et al. 2009). The HDAC homologues of the Class II 
(PF14_0690 and PF10_0078) remain to be studied. HAT and HDAC transcripts have been 
found with variable expression through the infected red blood cells (iRBC) and mosquito-
specific stages (Bischoff and Vaquero 2010). 
Trichostatin A (TSA) was the first potent tumor differentiating and antiproliferative 
chemical compound that proved to inhibit HDACs in vitro and in vivo (reviewed by Mai and 
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Altucci 2009). Suberoylanilide hydroxamic acid (SAHA), structurally related to TSA, induces 
differentiation of a variety of cancer cell types (Mai and Altucci 2009). The strong anti-
proliferative effect of HDAC inhibitors has also been shown in malaria parasites. The 
antiproliferative effect of the naturally occurring compound Apicidin against Plasmodium and 
the demonstration of its histone hyperacetylating effect suggested HDACi as potential 
antimalarials (Darkin-Rattray et al. 1996). It has been shown that the human HDACi 
suberohydroxamic acid (SBHA) has antimalarial activity against P. falciparum and P. berghei 
(Andrews et al. 2000). There is evidence that TSA and SAHA inhibit the growth of P. 
falciparum at low micromolar concentrations (Mai et al. 2004; Andrews et al. 2008), albeit 
with poor selectivity for parasites over mammalian cells (Andrews et al. 2008). These lead 
compounds, which have a demonstrated effect on PfHDAC1 (Patel et al. 2009), have led to 
the synthesis of a variety of novel HDAC inhibitors such as hydroxamate derivates (thus 
related to TSA and SAHA) (Mai et al. 2004; Andrews et al. 2008; Dow et al. 2008; Patel et al. 
2009) and cyclic tetrapeptides (apicidin-related) (Bougdour et al. 2009). The efficiency of 
these newly developed compounds in surmounting the constraints of the ‘previous 
generation’ inhibitors is under intense investigation (reviewed by Andrews et al. 2009). In 
vitro tests have shown improved parasite selectivity (Andrews et al. 2008; Patel et al. 2009; 
Weathley et al. 2010). Nevertheless, the compounds have been ineffective in in vivo tests in 
mice and monkeys unless combined with the conventional anti-malarial chloroquine (Dow et 
al. 2008), indicating the long road ahead for their progression into anti-malarial drugs. These 
studies underscore the need for the identification of new compounds and better 
understanding of their mechanism of action. 
In the chapter presented here, we explored the cellular and molecular changes 
induced by effective mammalian HDACi during the P. falciparum intraerythrocytic cycle. We 
set out to identify genes which are mis-regulated by interfering with HDAC-activity to gain 
insight into the roles of histone modifications in the parasite epigenome. Our previous 
epigenome profiling data revealed that H3K9ac is mostly absent from genomic regions 
encoding variant surface antigen multigene families such as var, rifin and stevor but also 
other small gene families encoding diverse functions such as those involved in host-cell 
invasion (Salcedo-Amaya et al. 2009). These H3K9 hypoacetylated genes cluster at 
chromosomal ends and some chromosome-internal regions and are marked by the 
interaction of H3K9me3 and the heterochromatin protein HP1 (Flueck et al. 2009; Lopez-
Rubio et al. 2009; Salcedo-Amaya et al. 2009). Accordingly, we tested the hypothesis that 
inhibition of HDAC activity could result in important changes in the transcriptional patterns of 
heterochromatic genes. 
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Material and Methods 
 
Parasite culture and treatment 
P. falciparum NF54 strain was cultured using a semi-automated culture system. Parasites 
were maintained synchronously by sequential rounds of 5% Sorbitol and 63% Percoll. 
Previous to drug treatment experiments, parasites were allowed to grow a complete infection 
cycle without further synchronization. Experiments for evaluation of growth effect were 
carried out in 6-well plates containing 2 ml of culture with either inhibitor or solvent dimethyl 
sulfoxide (DMSO). Untreated controls were made in parallel. Cultures were incubated at 
37°C under reduced oxygen pressure. Growth was monitored by Giemsa-stained smears 
observing and counting 20 fields under a light microscope. Drug stock solutions were stored 
at -20°C in DMSO and diluted to final concentration in culture medium as follows: MS-275 
50mM stock diluted to 5µM, SAHA 50mM stock diluted to 5µM, UVI5008 50mM stock diluted 
to 5µM, Sirtinol 100mM stock diluted to 50 µM and EX-527(Alexis) 10mM stock diluted to 1 
µM. For Experiments Exp I and Exp II in which we simultaneously investigated growth, 
histone acetylation, transcriptome changes and ChIP, two 15 ml cultures of synchronous ring 
parasites were incubated with SAHA 5µM for 7 hours, in parallel to DMSO-treated controls, 
under shaking and controlled temperature and air mix conditions. The starting parasitemia for 
Exp I was 12% and for Exp II 13%. Additional H3K18ac ChIP assays were carried out in 
synchronous ring parasites from the strain 3D7-UpsC-hdhfr (Voss et al. 2006). 
 
Western blot 
4 ml aliquots of DMSO control, SAHA 5µM and UVI5008 5µM treated parasite cultures from 
Exp I were used. Parasites were released from erythrocytes by treatment with saponin 0.06% 
and washed with cold PBS until the supernatant was clear. Nuclei were prepared by 
homogenization in 10mM Tris pH 8.0, 3.0mM MgCl2, 0.2% NP-40, protease inhibitor cocktail, 
layered onto the same buffer containing 0.25M sucrose and collected by low centrifugation. 
Nuclei were directly resuspended in HCl 0.25 M, rotated from 1h to overnight at 4ºC and the 
histone-enriched supernatant cleared by high centrifugation. H2AZ antibodies were raised 
against a lysine-rich N-terminal peptide of H2AZ in its unmodified and acetylated form. H2AZ 
synthetic conjugated peptides ATA-KVIGGKVGGKVGG  (H2AZ) and ATA-
VIGGK[Ac]VGGK[Ac]VGG (H2AZac) were crosslinked to KLH and raised in rabbits at the 
Centraal Dieren Lab, Nijmegen. The specificity of obtained sera was verified and the sera 
were further affinity purifed by Diagenode. The H2AZ acetyl (H2AZac) antibody recognizes 
with high specificity the acetylated peptide, whilst the H2AZ antibody has 4 fold higher affinity 
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for the unmodified peptide (H2AZ: Bartfai et al. 2010, H2AZac: data not shown). Commercial 
antisera were used against H3 (Abcam 1791), H3K9ac (Upstate 06942) and H3K18ac 
(Abcam ab1191). 
 
RNA extraction, cDNA preparation and microarray analysis 
Total RNA was directly extracted from 11.5 ml aliquots of the cultures described above, using 
the Trizol method according to manufacturer’s instructions and cleaned up using the RNeasy 
kit (Qiagen). Reverse transcription reactions were done on 5µg of total RNA using 2µg oligo 
dT 12-18, 10µg random hexamers and SuperScript III (Invitrogen). All reactions included 
negative controls where reverse transcriptase was omitted. For transcriptome analysis, 2µg 
of treated and untreated cDNA samples and early ring stage sonicated gDNA were directly 
labelled (no amplification) using 5’-Cy3 or Cy5 labelled random heptamers. Samples were 
hybridised onto the NimbleGen whole genome microarrays described in Salcedo-Amaya et 
al. 2009. After scanning and RMA normalization log2 ratios were computed for each sample 
pair (Control cDNA (DMSO) vs gDNA and cDNA SAHA treatment vs gDNA) and normalized 
using Tukey bi-weight (affy-package version 1.6.7 from Bioconductor). 
 
Transcriptome data analysis 
Gene expression values were calculated by averaging the log2-ratio value of all probes 
falling within the coding sequences (CDS) of the open reading frame (ORFs), thus removing 
introns. Genes which showed a 2 fold or greater change in expression were selected as 
differentially expressed genes. Scatterplots of probe intensity signal were generated in R. 
Scatterplots of gene expression values were generated in Spotfire. Data on stage and time of 
maximal expression were obtained from www.plasmodb.org based on the Winzeler and 
DeRisi data sets. Gene Ontology annotation was obtained from www.plasmodb.org. 
Additional transcript and protein expression, as well as additional gene annotations were 
manually checked based on the following studies data sets: Ansari et al. 2008, Baker et al. 
2006, Bischoff and Vaquero 2010, Bozdech et al. 2003, Doerig et al. 2008, Flueck et al. 
2009, Lasonder et al. 2008, Le Roche et al. 2003, Mair et al. 2010, Martin et al. 2005, 
Salcedo-Amaya et al. 2009, Sargeant et al. 2006, Silvestrini et al. 2010, Tarun et al. 2009, 
van Ooij et al. 2008 and Young et al. 2005. 
 
Chromatin Immunoprecipitation 
The ChIP assays were carried out as previously described in Salcedo-Amaya et al. 2009, 
under crosslinking conditions and using 11 ml of the cultures described above. Primers used 
are described in the supplementary Table 1. 
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Results 
 
Screening of HDAC inhibitors effect in P. falciparum growth 
We tested the growth effect of a small panel of inhibitors specific to either class I, I/II or III 
mammalian HDACs against P. falciparum. As our objective was to screen for compounds 
that interfere with parasite growth, we used them at concentrations that have a demonstrated 
antiproliferative effect in mammalian cells. We treated asynchronous parasite cultures for 24 
and 48 hours with 5µM MS-275 (HDACi of class I), 5 µM SAHA (HDACi of class I and II), 
5µM UVI5008 (HDACi class I/II/III, Nebbioso et al. 2011), 50 µM Sirtinol (HDACi of class III) 
and 1 µM EX-527 (HDACi class III, Napper et al. 2005; Solomon et al. 2006). Solvent DMSO 
treated cultures were carried out in parallel. Apart from SAHA, the compounds did not show 
any effect on parasite growth after 24 or 48 hours incubations. Our findings are in agreement 
with the very modest antiproliferative activities of MS-275 and Sirtinol against P. falciparum 
reported by Andrews et al. 2008. In addition, in vitro studies on recombinant PfSir2A have 
shown that the enzyme is neither inhibited by 50 µM Sirtinol nor by other Saccharomyces 
cerevisae Sir2 inhibitors such as splitomycin, isonicotinamide and resveratrol (Merrick and 
Duraisingh et al. 2007). 
 
SAHA reversibly inhibits growth of young and mature erythrocytic stages 
SAHA has a demonstrated in vitro antiproliferative effect against blood stages of P. 
falciparum (Mai et al. 2004; Andrews et al. 2008; Patel et al. 2009), with observable growth 
inhibition after 24h treatment (Andrews et al. 2008). The 50% inhibitory concentration (IC50) 
of SAHA was initially reported ranging from 0.9 to 1.8 µM (Mai et al. 2004) but later shown to 
be at around 110 to 300 nM (Dow et al. 2008). We visualized the growth effects of SAHA on 
P. falciparum at three points in the erythrocytic cycle using thin blood smears. Treatment of 
ring cultures (~10h p.i.) (Figure 1A) with SAHA for 48h resulted in growth inhibition 
evidenced by accumulation of late trophozoite stages and absence of parasites entering 
schizogony (Figure 1C), whereas control parasites progressed as expected and entered a 
new infection cycle (Figure 1B).  
Culturing trophozoites (~25h p.i.) (Figure 1D) for 19 hours in the absence of the 
inhibitor yields mature schizonts (Figure 1E). Prolonging the culture for an additional 42 
hours leads to the appearance of new early trophozoites (Figure 1E).  
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Figure 1. Inhibition of parasite development upon SAHA treatment.  
Giemsa-stained thin smears of treated (SAHA 5uM) and control (DMSO) P. falciparum cultures.  
A. Treatment was initiated at the ring stage at ~10h p.i. B. and C. and followed after 48h incubation.  
D. Treatment was initiated at the trophozoite stage ~25h p.i. E. to G. and checked after 19h and 42h. 
H. Treatment was initiated at the schizont stage at ~40h p.i. I and K and followed after 26.5h.  
J. and L. and followed after 48h. Growth arrest was microscopically observed. 
R (ring), ER (early ring), T (trophozoite), ES (early schizont), LS (late schizont).  
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Treatment with SAHA for 19 hours resulted in clear stalling at the early schizont stage 
with the appearance of cytoplasm vacuoles typical of crisis forms (Figure 1F) (Nyakeriga et 
al. 2006). Transition from trophozoite to schizont stage was however observed. Prolonging 
treatment to 42 hours revealed the presence of schizonts with increasingly visible damage 
and absence of newly invaded erythrocytes (Figure 1F). To identify whether parasites died 
or were ‘dormant’ but still viable upon 19 hours of SAHA treatment, we removed the drug and 
incubated for an additional 23 hours. We observed that by the end of the incubation period 
without drug, some parasites have proceeded into mature schizonts producing viable 
merozoites that invaded fresh erythrocytes and continued growing into rings (Figure 1G). 
A comparable result was obtained when treating schizonts (~40h p.i.) (Figure 1 H to 
L). Culturing of mature schizonts (Figure 1H) in the absence of the drug for 26 hours yielded 
trophozoites (Figure 1I) and extending this time to 48 hours again yields fully matured 
schizonts (Figure 1J). Exposure of mature schizonts to the HDAC inhibitor for 26 hours 
resulted in newly infected erythrocytes (Figure 1K); however, parasite growth was halted at 
the ring stage. This ring-arrest was reversed upon drug removal as evidenced by the 
appearance of schizonts after further culturing for 22 hours (Figure 1L). 
Our end-point experiments showed that exposure of parasites to a high dose of the 
class I/II HDAC inhibitor SAHA led to inhibition of parasite growth. Importantly, this growth 
inhibition was observed throughout the intraerythrocytic stages. Since we did not follow up 
the effect of drug treatments consistently, we could not ascertain whether SAHA treatment 
resulted in slow-down of growth rate or in strict cell cycle arrest. The single experiment in 
which this was monitored (Figure 1F) suggests the parasite growth is stalled. Interestingly, 
upon SAHA treatment parasites still progressed to the next phase of the intraerythrocytic 
cycle and then arrested. Removal of SAHA restored cycle progression suggesting that 
parasites were not committed to cell death or irreversibly blocked and supports that SAHA 
has a cytostatic effect in P. falciparum. 
 
SAHA causes mild to strong accumulation of acetylated H3 and H2AZ 
It has been reported that global hypoacetylation of H4 is a hallmark of human tumors (Fraga 
et al. 2005) and that exposure to HDAC inhibitors causes increase in histone acetylation (Gui 
et al. 2004). The accumulative effect of TSA on H4 acetylation has previously been described 
in P. falciparum (Andrews et al. 2008). Here, we tested the accumulation of histone 
acetylation upon treating late ring parasites for 7 and 24h with DMSO, SAHA at 5µM and 
UVI5008 at 5µM. Acid-extracted histones from 4 ml aliquots of treated parasite cultures were 
analyzed by WB using commercially available (H3, H3K9ac and H3K18ac) and in-house 
made H2AZ and H2AZac antibodies (Figure 2).  
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We found mild increase of H3K9ac and strong increase in H3K18ac after 7h 
treatment (Figure 2A). UVI5008 did not cause H3 hyperacetylation in P. falciparum, not even 
after 24h incubation. After 24h SAHA treatment parasite growth was significantly reduced 
compared to controls and consequently the loading of the SAHA treated sample is of a 
reduced amount (Figure 2B). Nevertheless, very strong accumulation of H3K9ac and 
H3K18ac was detected. A strong increase in H2AZac was also evidenced along with a 
number of protein bands of higher molecular weight (Figure 2B). 
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Figure 2. Histone hyperacetylation induced by SAHA.  
A. and B. Histones were extracted from equal amounts of parasite cultures treated with either DMSO 
control, SAHA 5µM or UV15008 5µM after 7h (A) and 24h (B). Histones were separated, blotted and 
tested against a panel of commercially available histone acetylation antibodies (H3, H3K9ac and 
H3K18ac) and the in-house made H2AZ and H2AZac antibodies. H3 visualization is used as the 
loading control. Each blot was probed only once. 
 
 
Transcriptional alterations upon SAHA treatment 
To explore the transcriptional events which underlie the HDACi-growth arrest observed in P. 
falciparum, we examined the global changes in gene expression after a short 7h incubation 
with DMSO control, SAHA 5µM and UVI5008 5µM. We carried out two experiments on 
synchronized ring parasites: for Exp I treatment began at 10 to 18h p.i. and for Exp II 
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treatment began at 5 to 10h p.i. After 7 hours treatment, no detectable changes in growth 
rate or cellular effects were observed. As even small variations in parasite maturation 
between cultures can cause differences in gene expression we analyzed cDNA abundance in 
experiment I and II separately. At probe level, we observed an excellent correlation of probes 
ratio values between DMSO and SAHA treated samples (R2=0.836) in Exp I (Figure 3A). 
The strong similarity observed at the probe level is obviously mirrored in the transcriptome 
data (R2=0.83) implying that only a small number of genes are differentially expressed 
(Figure 3B). Exp II showed more and stronger variation between SAHA and DMSO at both 
probe (R2=0.554) (Figure 3A) and gene level (R2=0.723) (Figure 3B). The compound 
UVI5008 neither affected growth nor acetylation in P. falciparum. UVI5008 treated versus 
DMSO showed a near perfect correlation of probe ratio values (Figure 3A, R2=0.977), 
indicating that UVI5008 had no measurable effect.  
Next, we defined genes that showed at least 2-fold change in expression. SAHA 
altered the expression of 4% of the genes in Exp I (225/5373 genes) and 13% in Exp II 
(694/5373 genes) (Figure 3B). In both experiments the majority of these genes (~65%) were 
upregulated (UR) (146 and 436, respectively). We observed good reproducibility of the 
transcriptome alteration in response to SAHA treatment: 126 of the total 146 SAHA UR 
genes identified in Exp I, were also upregulated in Exp II (86%), whereas 49 of the 79 genes 
downregulated in experiment I were also downregulated in Exp II (62%) (Figure 3C). These 
common differentially expressed genes (126 UR and 49 DR) displayed wide-ranging 
amplitudes of transcript alteration (Figure 3D): as many as 38% of the UR genes showed 
induction ranging from 4 -50 fold.  
The majority of differentially affected transcripts (UR and DR) are reportedly 
expressed within the intraerythrocytic cycle (80%) (Le Roche et al. 2003, Bozdech et al. 
2003), while the rest are reported to be expressed during the gametocyte and sporozoite 
stages (Le Roche et al. 2003; Young et al. 2005; Tarun et al. 2008) (Figure 3E). About 25% 
of the genes induced by SAHA in rings are maximally expressed in schizonts (i.e sera5, 
etramp4, DNA replication licensing factor mcm5, aquaglyceroporin, eba181 and sera4) and 
~25% are maximally expressed in gametocytes (i.e. etramp 10.3 and pfg27, etramp8, actin-
related protein arp1 and hydrolase phosphatase, which was the highest induced gene upon 
SAHA treatment) (supplementary Table 2, available online). SAHA induced the expression 
of 21 sporozoite-expressed genes, many of which are amongst the most abundant 
transcripts in sporozoites of P. falciparum and P. yoelii: csp, etramp10.3 (or uis4), phistc 
pfb0105c, etramp13 (or uis3), actin depolymerizating factor, the conserved proteins pfl0065w 
and pfi1555w, the fatty acid synthesis enzyme dihydrolipoamide acetyltransferase and the 
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Figure 3. Treatment with the HDAC inhibitor SAHA causes differential expression of a subset of the 
genes in ring stages. 
A. Scatter plots of all probe values in DMSO control and SAHA treatment for Experiment I (Exp I), 
Experiment II (Exp II) and the HDAC inhibitor compound UVI5008.  
B. Correlation of transcript expression values between DMSO and SAHA for Exp I and Exp II. The plot 
highlights transcripts that are differentially expressed at least 2 fold as response to treatment.  
C. Venn diagram charts showing the number of 2 fold or more upregulated (UR) and downregulated 
DR genes for Exp I and II.  
D. Bar diagram indicating the strength of the alteration (fold) for the pool of common UR and DR genes 
from Exp I and Exp II. E. Pie charts depicting the typical stage of maximal expression of common UR 
and DR genes. The number refers to the percentage of genes that are maximally expressed at a given 
stage. R: ring, T: trophozoite, Sch: schizont, M: merozoite, G: gametocyte, Spz: sporozoite. 
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rhomboid protease rom4. Thus, the transcriptional effect observed upon SAHA treatment 
appears stochastic, leading to the upregulation of genes from other parasitic stages. 
Of the 49 transcripts with decreased expression upon SAHA treatment (DR group) we 
encountered 35 (76%) ring and trophozoite transcripts (Figure 3E), such as ribosomal 
proteins and the T-complex protein 1 components (supplementary Table 2), potentially 
reflecting the lack of normal progression of the parasite cycle. A third of the downregulated 
genes (17) have been found expressed at various stages of the cycle (iRBCs, gametocytes, 
sporozoites) and have general housekeeping functions.  
 
Differentially expressed transcription factor genes 
We analyzed predicted gene functions by gene ontology (GO) annotations based on 
plasmodb.org and published studies (see material and methods) (Figure 4) (Table 1 and 2).  
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Figure 4. Functional gene categories affected by SAHA treatment.  
A, Pie chart showing the functional categories in which genes upregulated (UR) upon 7h of SAHA 
treatment were classified. The number refers to number of genes in each category. B. As in A. for the 
downregulated genes (DR). The 41 UR and 6 DR genes with unknown function are not depicted. 
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Table 1. List of SAHA upregulated genes 
Function Genes 
TAPs 
2 STF Zn Fingers, TAP partner pfl1010c, caf1, ccr4-not, 9 ApiAP2 TFs (pfd0985w, 
pff0670w, pf10_0075, pf11_0091, pf11_0404, pfl1900w, pf13_0267, pf14_0271, 
pf14_0533) 
Invasion and 
Motility 
tubulin beta chain, dynein light chain 1, actin depolymerizing factor, protein kinase, 
myosin a, clag 9, rom4, eba-181 jesebl, eba-165 paebl, mcp1, mtip, myosin 
Biosynthesis 
Aquaglyceroporin, steroid dehydrogenase, delta-aminolevulinic acid synthetase, 
dihydrolipoamide S-acetyltransferase, inorganic pyrophosphatase, biotin 
carboxylase, phosphoenolpyruvate carboxykinase, ethanolamine kinase, acbp1, 
serine C-palmitoyltransferase, acyl CoA binding protein, dihydroorotase 
Exportome 2 phistc, exported protein pfl0070c, 3 rifin, dnaj_III pfa0675w, phistb, stevor 
Transmission 
csp, conserved protein mal8p1.66, pfg 27, arp1, slarp, conserved protein 
mal13p1.313, developmental protein pfi0300w, conserved protein pfi0140w 
ETRAMP etramp 8, 10.3, 4, 13, 10.2 
SERA sera-9, -2, -5, -4 
Kinome pfgsk3, CamK family protein, pfcrk-4, cdpk CamK family 
Ribosome 
mitochondrial large ribosomal subunit, mitochondrial ribosomal protein S8 
precursor, sun-family protein, Ribosomal protein L7Ae 
Surfin surfin pseudogene, surfin 4.1, surfin 1.1 
Transport Pfmpc, zinc transporter, transporter pfa0245w 
DNA replication DNA replication licensing factor mcm5, DNA repair pfe0270c 
Other functions glutamyl-tRNA(Gln) amidotransferase subunit A, CAS/CSE protein 
RNA binding 2 RNA-binding proteins 
Hydrolase hydrolase phosphatase pfl1260w 
 
 
Table 2. List of SAHA downregulated genes 
Function Genes 
Ribosome 
60S ribosomal protein L18-2, L18, L11a, L23; hmgp NHP2; 40S ribosomal protein 
S3A, S3, S4, S5; NOP10-like 
Other functions 
GTP-binding protein, adenylate kinase, s-adenosylmethionine-dependent 
methyltransferase, Rpr2, RWD domain-containing protein 
Exportome 
dnaj_III pf14_0013, phistc, pf70 protein_hyp16, phista, piesp2 erythrocyte surface 
protein 
RNA splicing U2 snRNP,U5 snRNP, Ser/Arg-rich splicing factor, snRNP 
Biosynthesis purine nucleotide phosphorylase, carbamoyl phosphate synthetase, pfacs6 
Chaperone T-complex protein 1 beta, gamma, epsilon subunits. 
Hydrolase 
26S proteasome regulatory subunit 7, BIS(5'-nucleosyl)-tetraphosphatase, haloacid 
dehalogenase-like hydrolase 
TAPs GTF btf3, bromodomain protein, prmt1 
ETRAMP etramp 2, 11.1 
Kinome 2 fikk kinases 
Transport nucleoside transporter 1, vacuolar ATP synthase subunit D 
RNA degradation lsm6 
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 The largest group of activated genes encodes transcription-associated proteins 
(TAPs, Bischoff and Vaquero 2010), amongst which 9 are ApiAP2 transcription factors (AP2 
TFs) (Figure 4A, Table 1). AP2 TFs are differentially expressed at the RNA level during 
different stages of the life cycle and have been proposed as central regulators of transcript 
expression during RBC infection (De Silva et al. 2008). However, few have been confirmed at 
protein level (Bischoff and Vaquero 2010) and only a few have been confirmed as regulators 
of stage-specific gene expression (AP2-O active in ookinetes, Yuda et al. 2009; AP2-Sp 
active in sporozoites, Yuda et al. 2010), while Ap2 SIP2 appears involved in heterochromatin 
formation (Flueck et al. 2010). The DNA sequence motifs bound by AP2 TFs and their 
putative predicted target genes (ranging from ~300 to 1000 genes per factor) have been 
reported (De Silva et al. 2008; Campbell et al. 2010). In our study, SAHA caused 
upregulation of as much as one third (9/27) of the full AP2 repertoire (listed in Table 1). The 
highest induced AP2 transcription factor pfl1900w and pf13_0267 are preferentially 
expressed in sporozoites. The other SAHA upregulated AP2 TFs have indication of 
expression in iRBCs (Campbell et al. 2010). However, detection of a AP2 TF transcripts at a 
particular stage is not directly indicative of its functionality at that stage. Moreover, there is 
evidence that AP2 TFs are subject to regulation at the translational level: AP2-O mRNA 
present in schizont and gametocyte is only detectable at the protein level in ookinetes (Yuda 
et al. 2009). It is tempting to speculate that SAHA-induced hyperacetylation affects the 
patterns of gene expression by activating or inducing a series of AP2 transcription factors 
which in turn might be, at least partially, responsible for the deregulation of other genes. 
 
Differentially expressed host invasion genes 
Host cell invasion proteins are expressed at the parasite surface and require proteolytic 
cleavage to function as adhesins that engage host-cell receptors. Genes involved in the 
process of erythrocyte invasion are small gene families located at subtelomeric regions which 
undergo clonal variation and appear to be epigenetically regulated (Cortes et al. 2007), 
reminiscent of var genes. Transcripts of erythrocyte invasion genes typically transcribed in 
late schizogony and merozoites such as those of eba-165 (paebl) and eba-181 (jesebl) were 
upregulated upon SAHA treatment. Similarly, the rhomboid protease rom4 is expressed in 
schizogony but also at gametocytes and sporozoites (Le Roch et al. 2003). ROM4 is 
responsible for the cleavage of eba-181, among other adhesins (Baker et al. 2006). clag9, a 
component of the rhoptry protein complex which contributes to the host cell remodeling 
immediately post- invasion (Ling et al. 2004) was also upregulated, however, other members 
of this complex were not affected. Closely related to the process of host cell invasion, a 
number of proteins with motor activity related to invasion actin myosin motors (mcp -
The effects of SAHA in Plasmodium falciparum 
 89 
merozoites cap protein 1-, myo a and mtip -myo A tail domain interacting protein) as well as 
actin depolymerizing factor, myosin and microtube motors (dynein light chain 1 and tubulin 
beta chain) were upregulated. SAHA-induced invasion and motility related genes are 
maximally expressed in RBC during schizogony, and some proteins (7/12) are found in 
mosquito stages (Lasonder et al. 2008). Recently, ~400 Plasmodium genes were predicted 
as erythrocyte invasion factors based on an interaction network constructed from genes co-
expressed under drug perturbations (Hu et al. 2010). SAHA upregulated the expression of 22 
of these genes which apart those mentioned above, include the ApiAP2 pfd0985w, arp1, 
kelch-repeat and TLD containing proteins, etramp4, phistc, surfin 4.1, Ca-dependant kinase 
pf13_0211 and 6 conserved proteins. It is tempting to speculate that these genes are 
activated by a common factor that is upregulated by SAHA. 
 
Transmission-related genes 
Under the denomination of transmission-related genes we grouped all those SAHA 
upregulated genes that are essential to development of sexual differentiation and subsequent 
development in the mosquito (Mackinnon et al. 2009) such as csp, the gene with the highest 
expression in P. falciparum sporozoites (Le Roch et al. 2003). Upregulation of csp is most 
intriguing as its induced expression and translation could result in exposure of this antigen to 
the immune system. The most advanced malaria vaccine, the RTS/S, is based on the highly 
immunogenic circumsporozoite protein CSP. CSP protein expression upon SAHA treatment 
remains to be determined. Other genes that belong to the transmission category are the early 
gametocyte marker pfg27, slarp (a gene that is involved in sporozoite infectivity (Silvie et al. 
2008)), arp1 and the conserved protein mal8p1.66 (essential for sporozoites formation within 
the oocyst, Lasonder et al. 2008). The conserved proteins mal13p1.313, oocyst enriched and 
pfi0140w, salivary gland sporozoites enriched (10 fold up), as well as the developmental 
protein pfi0300w have unknown function but were detected in the mosquito stages proteome 
(Lasonder et al. 2008) and therefore tentatively assigned to this group. SAHA induced the 
expression of a similar number of genes grouped under functional categories such as 
exportome, ETRAMPs, SERA proteases, protein kinases and diverse biosynthetic processes 
(Figure 4A), which are discussed in the supplementary Information. 
  
Genes that were downregulated upon SAHA treatment included such involved in RNA 
related processes including 10 ribosomal proteins, 4 RNA splicing and 1 mRNA decay (lsm6) 
(Figure 4B, Table 2). In addition, two of the enzymes involved in ribonucleotide synthesis: 
the uridine phosphorylase involved in post-transcriptional regulation (Mair et al. 2010), and 
the acyl CoA synthetase pfacs6. 
Chapter 4 
 90 
 
SAHA treatment increases H3K9ac levels independent of transcriptional status 
To test whether the global increase in H3K9 and H3K18 acetylation levels caused by SAHA 
(Figure 2) correlates to the observed changes in gene expression, we measured the histone 
modifications of a number of induced and unresponsive genes in SAHA treated rings (Figure 
5A). We previously showed that H3K9ac levels measured at the 5’end of the gene coding 
sequence, did not reflect the transcriptional status of genes at ring stages (Salcedo-Amaya et 
al. 2009). Chromatin immunoprecipitation (ChIP) assays on SAHA and DMSO controls 
showed that nucleosomal occupancy remained unchanged after 7h treatment (Figure 5B). 
H3K9ac and H3K18ac ChIP assays showed that SAHA increases the global levels of 
acetylation at upstream regions and in particularly at gene bodies (Figure 5C and 
supplementary Figure 1). This prominent increase of acetylation over gene bodies 
demonstrates that SAHA inhibited (directly or indirectly) HDAC activity. Importantly, the 
histone marking of genes strongly activated upon SAHA treatment (slarp, conserved protein 
pfl0070c and csp) is indistinguishable from non-responsive genes (Figure 5C and 
supplementary Figure 1). Others have also failed to find a positive correlation between 
H3K9 hyperacetylation at the 5’ end of gene bodies and gene activation in apicidin-induced 
genes in schizonts (Chaal et al. 2010). It is plausible that H3K9ac levels are even higher at 
specific genomic elements (i.e. gene promoters) that were not detected within the genomic 
regions studied here (supplementary Table 1). Indeed, it was recently shown that 
enrichment of H3K9 acetylation measured upstream of genes (800 bp) correlates with gene 
expression levels in rings but also at other intraerythrocytic stages in P. falciparum (Bartfai et 
al. 2010). Whether hyperacetylation at other histone residues is involved in the 
activation/repression of SAHA affected genes remains to be investigated (i.e SAHA-induced 
global H4 hyperacetylation in P. falciparum, Andrews et al. 2008). It is conceivable that 
SAHA also triggers acetylation of a protein(s) other than histones e.g. a transcription factor 
that is involved in regulation of the subset of responsive genes.  
 
 
The effects of SAHA in Plasmodium falciparum 
 91 
A
B
C
SAHA
R e
la
tiv
e
 
a
m
ou
n
t o
f c
DN
A
in 
SA
HA
 
vs
 
DM
SO
 
 
 
En
ric
hm
en
t o
f H
3
 
SA
HA
 
vs
 
DM
SO
 
 
 
En
ric
hm
en
t o
f H
3K
9a
c
 
SA
HA
 
vs
 
DM
SO
10
250
50
650
450 DMSO
SAHA
slarp pfl0070c    csp   kahrp     sar1   pfck1   aspartyl
 protease
  var a   var a   var c
 G   I
   1
   2
   5
  10
  20
  15
 G   I  G   I  G   I  G   I  G   I  G   I  G  G  G
slarp pfl0070c    csp   kahrp     sar1   pfck1   aspartyl
 protease
  var a   var a   var c
 G   I  G   I  G   I  G   I  G   I  G   I  G   I  G  G  G
SAHA
 
 
 
Figure 5. SAHA increases H3K9 acetylation levels independent of gene expression. 
A. RT-qPCR analysis of the expression levels of a set of genes in untreated (DMSO) and treated 
(SAHA) parasites, represented as SAHA-over-DMSO ratios. Results are presented as relative amount 
of cDNA in SAHA vs the DMSO control (=1). 
B. Relative H3 ChIP enrichment-ratio of SAHA-over-DMSO at the upstream intergenic region (I) and 
gene body (G) of the genes depicted above. The graph shows the ratio of the percentage of H3 
recovery in SAHA over DMSO. 
C. As in B. for the relative ChIP enrichment of H3K9ac.  
slarp: sporozoite asparagine-rich protein, pfl0070c: Plasmodium exported protein, unknown function, 
csp: circumsporozoite protein, kahrp: knob associated histidine rich protein, sar1: small GTP-binding 
protein, pfck1: casein kinase 1, var a: pf08_0141and pfa0015c, var c: pf07_0048. 
 
 
 
Other common features of SAHA affected genes 
We investigated other common features of SAHA-upregulated genes such as i) presence of 
common DNA elements in the promoters, ii) genomic position and iii) conservation across 
Plasmodium species. To identify common sequence motifs, we used the GimmeMotifs 
finding program (van Heeringen et al. 2010) but failed to identify any statistically significant 
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common DNA motif in the 1 kb upstream of the ATG for the upregulated and downregulated 
groups. A set of 30 sporozoite-specific genes sharing the CATGCAN motif (Young et al. 
2008) was used as positive control for the searches.  
A chromosomal positioning map visualizes genes upregulated (top blue) and 
downregulated (bottom red) upon SAHA treatment in relation to the euchromatin and 
heterochromatin compartments (Figure 6). SAHA altered preferentially euchromatic located 
genes (91% of the altered genes) and showed no preferential chromosomal location but were 
rather spread all over the 14 chromosomes of the parasite (Figure 6). There is no gene 
clustering among SAHA affected genes, apart from occasional contiguous genes. 
Interestingly, SAHA treatment affected the expression of only a few heterochromatin located 
genes: 12 genes were upregulated including 2 surfins and the erythrocyte binding antigens 
eba-165 and eba-181 which are at the borders of heterochromatic boundaries as well as 3 
downregulated genes (supplementary Table 2).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Chromosomal localization of SAHA-deregulated genes.  
Upregulated genes (blue) are depicted above the chromosomal axis, downregulated genes (red) 
below the axis and heterochromatin regions (gray) across the axis. The asterisk * indicate the few 
heterochromatin-associated genes which were either UR or DR upon SAHA treatment. 
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The great majority of genes with altered expression upon SAHA treatment are largely 
conserved across Plasmodium species (107 of the UR and 42 of the DR), whilst only a small 
percentage is unique to P. falciparum. These unique genes are mainly exported proteins 
(rifin, stevor, phista, phistb, phistc, fikk, dnajIII, pfg27). This observation may be important as 
it suggests that the potential benefits of using broad HDAC inhibitors as therapy might be 
extrapolated to other Plasmodium species. A number of conserved protein genes found here 
have been described to function during sporozoites development and maturation (Lasonder 
et al. 2008). These genes contain orthologs in all other Plasmodium species, which is not 
surprising considering that sporozoites of different species employ similar processes of 
maturation and invasion (Lasonder et al. 2008). Around 80% of the affected genes do not 
have paralogs, except for genes such as clag9, the sera family, surfin, dnajIII, stevor, acbp1 
and rifin. 
 
 
Discussion 
 
HDAC inhibitors are known to have a strong cytotoxic effect in a variety of cancer cells and 
are therapeutically used in cancer patients. Here, we carried out a preliminary investigation 
on the molecular changes preceding the cytostatic effect caused by SAHA. Although it was 
previously known that SAHA causes growth inhibition, here we show that these effects are 
reversible upon drug removal. This is an interesting aspect when evaluating the potential of 
other HDACi against Plasmodium. In spite of the limited experimental setup (2 biological 
replicas), we describe for the first time the transcriptome changes of P. falciparum exposed 
to a hydroxamate compound.  
At present, it is unknown whether transcriptional deregulation of genes by SAHA is 
due to a primary or secondary response to the disruption of deacetylation. It is important to 
keep in mind that the extent at which SAHA slowed down parasite development is unknown, 
and thus some of the transcriptional changes could be reflection of a possible difference in 
growth rate rather than being uniquely a consequence of HDAC inhibition  
Investigating the transcriptional responses to specific HDAC inhibitor treatment will 
hint to candidate genes that are likely controlled by regulatory pathways involving the 
targeted HDAC(s). In P. falciparum, transcriptome approaches have already been performed 
to measure transcripts changes under a variety of antimalarial drug treatments. Although the 
used drugs and antimetabolites may be suspected to have very specific molecular targets, 
most studies have failed to detect significant transcriptional changes within the metabolic 
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pathway targeted by the drug (see for example Le Roch et al. 2008, Ganesan et al. 2008, 
Natalang et al. 2008). Instead, these authors detect low amplitude transcriptome alterations 
of mainly unrelated genes such as subtelomeric and surface proteins (Le Roch et al. 2008; 
Natalang et al. 2008) or the induction of a number of gametocyte-specific genes in the 
absence of gametocyte formation (i.e. after 24h treatment with a T4 choline analog, Le Roch 
et al. 2008). Some of SAHA-affected genes are also found altered in the above-mentioned 
studies (see supplementary Table 3). Parasites treated with lethal doses of artesunate and 
non-lethal SAHA display a significant number of common deregulated genes (20%) that are 
not biased towards any specific functional category and could potentially reflect a general 
stress response.  
During preparation of this chapter, two studies addressing the transcriptional changes 
induced by HDAC inhibitors apicidin and TSA in P. falciparum were published. In contrast to 
our data using SAHA, Chaal and colleagues showed that apicidin causes large transcriptome 
alterations throughout the intraerythrocytic cycle (i.e. 42% of altered genes after 6 hours 
treatment of rings) (Chaal et al. 2010). In parallel, Hu and colleagues showed that apicidin 
caused misregulation of ~18% of the genes in trophozoites and schizonts, while TSA altered 
more than 50% of the transcriptome in schizonts (Hu et al. 2010). Both studies agree that the 
transcriptional response to apicidin is a general de-regulation of the tight program of 
intraerythrocytic gene expression by activation of genes which are normally suppressed. 
Apicidin-treated rings abundantly express typical trophozoite expressed TCA cycle genes 
and apicidin-treated trophozoites express invasion-related genes which are typically 
expressed in schizonts (Chaal et al. 2010). Alike SAHA, genes upregulated by apicidin 
included gametocyte and sporozoite expressed genes, as well as 8 members of the APiAP2 
transcription factors (Chaal et al. 2010). 
HDAC class I/II inhibitors commonly altered genes are possibly regulated by HDAC-
dependent transcriptional mechanisms or at least reflective of HDAC inhibitory effects. 
Comparing our SAHA 7h treated rings to apicidin 6h treated rings (Chaal et al. 2010) shows 
80% overlap (136) with representatives of all functional categories previously described for  
SAHA (data not shown). Given the large number of altered genes in the Chaal study, the 
significance of such overlap is questionable. Indeed, comparing to the smaller set of altered 
genes upon 6 hours apicidin in trophozoites from Hu et al. shows a mere 20% overlap. It is 
worth mentioning that genes which are highly expressed in sporozoites (csp, phistc, 
pfb0105c, etramp 13, pfi0140w, dihydrolipoamide acetyltransferase) were exclusively 
activated by HDACi treatments SAHA and apicidin (Chaal et al. 2010) and not by TSA (Hu et 
al. 2010) and other unrelated drugs (mentioned above). Finally, it is difficult to nail down, with 
the very broad transcriptional response to apicidin, that the common SAHA-apicidin genes 
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described here are specific to HDAC inhibition. Most of the SAHA-artesunate commonly 
affected genes were also affected by apicidin (31 out of 36). It is possible that those genes 
are part of general drug responses. Measurements of transcript alterations along earlier time 
points could help to refine primary from secondary responses to HDACi treatment. Given that 
the detailed apicidin study has a collection of time points, we compared the gene lists of 
SAHA 7 hours with that of the earliest time point of apicidin treatment (30 min). Upon 30 min 
of apicidin there are >400 up and >400 down regulated genes, most of which (2/3 of the up 
and a 1/4 of the down) remain as such after 6h apicidin (Chaal et al. 2010). 38 common 
genes between SAHA 7h and apicidin 6h were altered after only 30 min apicidin treatment. 
This overlapping group of genes could be a random event, but could also come close to the 
putative early responders to HDAC inhibition. Interestingly, these include 7 transcription 
associated proteins among which 5 are AP2 TFs (pf14_0533, pff0670w, pf14_0271, 
pf11_404, pfl1900w and 2 conserved proteins pfl1010c and pfi1335w), emphasizing the 
quick activation of transcriptional regulators upon drug stimuli.  
The transcriptional profile of treated ring parasites was very similar to the normal 
transcriptional progression of untreated parasites (Figure 3), leading us to tentatively 
conclude that SAHA has rather low impact on the parasite transcriptional program. The 4% of 
reproducibly induced/repressed genes could be presumably, but not exclusively, regulated by 
HDAC associated mechanisms. Importantly, SAHA induced the expression of several 
ApiAP2 transcription factors, indicating that directly or indirectly HDAC inhibition results in 
misregulation of the expression of specific transcriptional regulators. Thus, we hypothesize 
that the altered ApiAP2 transcription factors are likely responsible for the activation of other 
upregulated genes upon SAHA treatment. 
Finally, P. falciparum HDAC inhibitor studies provide support to their future anti-
malarial therapeutic use. The transcriptome explorations of the effects of HDAC inhibition 
have shown that different inhibitors impact differently on the expression of genes highlighting 
the mechanistic complexity of the control of gene expression in the parasite. Contrasting to 
SAHA, the HDAC Class I and II inhibitors TSA and apicidin cause dramatic transcriptome 
alterations (Chaal et al. 2010; Hu et al. 2010). Apicidin did not increase but instead decrease 
the global H3K9ac levels in rings (Chaal et al. 2010), which might indeed be indicative of 
distinct mechanisms of action. However, all studies support the essential role of chromatin 
players in the parasite cycle progression and regulation of stage-specific gene expression. 
Biochemical and proteomic approaches aimed at identifying and functional characterize the 
histone and non-histone complexes in which HDACs reside, and are chemically inhibited, is 
an absolute necessity. This knowledge is fundamental to develop and tune effective and 
selective drugs against malaria. 
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Supplementary Information  
 
Supplementary Table 1. List of primers 
 
Gene_ID 
 
 
Gene name 
Position 
(to ATG 
in bp) 
 
Sequence 5 - '3' 
PF11_0480 slarp (-)970 ATGAGGAACATATTGAATTTT and AAGTATGTGGCATATGAGG 
  (+)3422 CTCAACACATGCCTTCA and TCTTCCTTATGACCATTCA 
PFL0070c hypothetical protein (-)1205 ATATACAATTTTCATGTAGCAAC and AGAACATCCTATACTGCTTAAA 
  (+)633 ATATCTGAAAAAAGTGCTGAT and TAAGGTATTTGATGTCTTTAGG 
PFC_0210c csp (-)636 GAGGGGTAAAGGGGGGCTTAA and 
AACATTATATGCTTCCTTAAGAACATATAGTGAAT 
  (+)211 TCACTTGGAGAAAATGATGATGGA and CCATCCGCTGGTTGCTTTA     
  (+)984 GGCTCTGCTAATAAACCTAAAGACGAA and CACTGGAACATTTTTCCATTTTACAAA 
MAL8P1.6 etramp8 (-)504 TTACAATATAGTAATACTTGTTGAGTT and AATAAGCACGTACTTTCTATGA 
  (+)607 TTCAGAAATAAATGATACACTTT and TGTATTTCCTTGATTCACTG 
PFB0100c kahrp (-)1042 AAACTGCATGTAGTGTAGT and TAGTAGTTATGTTTTGTCGT 
  (+)1562 CAGGAGCAAGTACTAATG and GTTGCTTCTTTAGAAGTAC 
PFD0810w sar-1  (-)690 CCCGTATATCCTAGATTTTC and AATATCCACGTCACATGAA 
  (+)887 ATTCGATTTAGGAGGACAT and AAACTACAGCATCTACAGCA 
PF11_0377 pfck1 (-)1648 AAAAGGAAACCAATTTGAA and TATGTAAAAATTTGTATGACTCG 
  (-)387 TGATGATTATATGAACAGTGTTT and TCGAGCTTGCACTTTTAT 
  (+)1169 AGATTCAAGATCACATACTCATA and TATCTTGCTGTTCCTGTTAA 
PF13_0133 aspartyl protease  (-)518  AGCTACGCATATCTTGTAT and TTCTATCCATTGTCCACTT 
  (+)657  TCTACATCAACAAGCCAC and ATTAATTCACCTCCATGCT 
PF11_0301 spermidine synthase  (-)982 CTTGTTTCATTCGGAAAT and TGTGTAAGATATGGTTATTATGTT 
  (+)458 ACTAACCGAAAAAGATGAAT and TTAGAAACAGTCATAGGAACAT 
PFL0030c  var2csa  (-)2580  ACATATATTTGGTGTTACATAATT and TCTGAAAATAAAGTACAAACATA 
  (+)1341  GAAGTGTGCTCAATTACGCATA and ATGTATCACACATAGCTCCATAAAAG 
  (+)5350   CATCACAATCATCAGCACCTT and GGAATAGCCAAACCTCAATTTATA 
 
 
Supplementary Table 2. List of SAHA differentially expressed genes, available online at 
http://mb03.extern.umcn.nl/adriana_supplementary_table_2 
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Supplementary Figure 1. SAHA increases H3K9 and H3K18 acetylation levels independent of gene 
expression.  
A. RT-qPCR analysis of the expression levels of a set of genes in untreated (DMSO) and treated 
(SAHA) parasites, represented as SAHA-over-DMSO ratios. Results are presented as relative amount 
of cDNA in SAHA vs the DMSO control (=1).  
B. Relative H3 ChIP enrichment-ratio of SAHA-over-DMSO at the upstream intergenic region (I) and 
gene body (G) of the genes depicted above. The graph shows the ratio of the percentage of H3 
recovery in SAHA over DMSO.  
C. As in B. for the relative ChIP enrichment of H3K9ac.  
D. As in B. for the relative ChIP enrichment of H3K18ac.  
slarp: sporozoite asparagine-rich protein, pfl0070c: Plasmodium exported protein, unknown function, 
csp: circumsporozoite protein, etramp8: erythrocyte transmembrane protein 8, sar1: small GTP-
binding protein, pfck1: casein kinase 1, aspartyl protease, var2csa: var encoding the adhesion 
receptor which binds chondroitin sulphate A. 
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Functional classification of SAHA upregulated genes 
The reported parasite ‘exportome’ (Sargeant et al. 2006) or ‘secretome’ (van Ooij et al. 2008) 
contains genes encoding proteins predicted to be exported to erythrocytes. The increased 
expression of genes associated with host parasite interaction (such as chaperones and 
exported proteins) has been previously reported in other drug treatment studies and has 
been speculated to be a response to damage or to avoid further drug intake (Natalang et al. 
2008). SAHA caused UR of some of these genes: 2 phistc, 1 phistb (a resa-like chaperone), 
1 dnaj III (hsp40 chaperone), 3 rifin, 1 stevor. A number of other genes which are not 
described as part of the exportome but are also exported to the surface of either the parasite 
(etramp8 -10.3, -13), like the parasitophorous vacuole membrane (uis3: liver-stage 
parasitophorous vacuole membrane (PVM) resident protein) or the RBC membrane (3 surfin, 
1 steroid dehydrogenase) were induced following SAHA treatment. 
The 13 members of the early transcribed membrane protein ETRAMP family are 
involved in rupture of the parasitophorous vacuole (PV) membrane and egress from host 
cells (Spielmann et al. 2003). 7 out of its 13 members were misregulated by SAHA. etramp4 
and etramp10.2 (expressed in iRBCs at ring to trophozoite transition), etramp8 and etramp13 
(not expressed in iRBCs) and etramp10.3 (sporozoites) were upregulated. In contrast, 
etramp2 and -11.1 typically expressed in rings (Spielmann et al. 2003) were downregulated.  
The serine repeat antigen (SERA) genes are a 9 member family of cysteine 
proteases encoding membrane protein antigens which are likely involved in host cell egress 
and invasion. sera2, -4, -5 and -9 were upregulated. These genes have reported expression 
in the schizont stage, with sera5 having the highest expression (Miller et al. 2002). The 
protein product of sera5 is an asexual blood stage vaccine candidate, as antibody titers in 
people living in malaria endemic areas in Uganda correlated with protection against infection. 
The P. falciparum kinome is constituted by several protein kinases belonging to 3 
classes (ePKs, FIKK and aPKs) (Ward et al. 2004). SAHA induced 4 kinases of the 
eukaryotic protein kinase type ePK (65 members): one member of the GSK3 family, which 
are part of the major regulators of cell proliferation and appears to be exported to host 
erythrocytes (Doerig et al. 2008), and the so far unstudied pfcrk-4 and calcium dependant 
kinases pf13_0211 and pf14_0227. The apicomplexan specific FIKK kinases are an 
expanded subtelomeric P. falciparum family of proteins exported across the parasitophorous 
vacuole which have been recently suggested to phosphorylate membrane skeleton proteins 
of infected erythrocytes (Nunes et al. 2010). Out of the 21 members, fikk10.1 (PF14_0733) 
typically expressed in rings and trophozoites, and fikk14 (PF10_0160) with typical low RBC 
expression, were downregulated. Functional studies of these genes have not been reported.  
Genes involved in metabolic processes grouped here under the function 
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‘Biosynthesis’ account for 14 % of the UR genes including lipid metabolism, fatty acid 
biosynthesis: dihydrolipoamide S-acetyltransferase (pf10_0407), biotin carboxylase 
(pf14_0664) and steroid dehydrogenase (pfd1035w). Remarkably most of the biosynthesis 
genes are expressed in gametocyte and sporozoite stages (8/12). Indeed, the P. yoelii 
orthologues of 3 enzymes involved in the fatty acid synthesis in sporozoites and liver stages 
were also upregulated: dihydrolipoamide S-acetyltransferase (or pdh2) which is part of the 
pyruvate dehydrogenase complex which synthesizes the precursor acyl coA, and two acyl 
CoA binding proteins pf10_0015 and pf14_0749, important for fatty acid activation (Tarun  et 
al. 2009). 
 
Supplementary Table 3. List of SAHA mis-regulated genes which are found in other 
unrelated drug studies  
 
Drug studied 
 
Mis-regulated genes 
 
WR99210 Ganesan et al. 
2008 
 
Common UR: etramp 4, inorganic pyrophosphatase and 
conserved proteins pf14_0588 and pf14_0131. 
 
T4 choline anlog  
Le Roch et al. 2008 
 
 
Common UR: sera4, clag-9, steroid dehydrogenase pfd1035w, 
phistc pfb0905c, conserved proteins pfb0765w, pfc0680w, 
mal13p1.129 and pf14_0338 and hypothetical protein pf14_0708;  
Common DR: diadenosine tetraphosphatase 
SAHA UR- T4 choline anlog DR: dihydrolipoamide S-
acetyltransferase and conserved protein pf14_0631. 
 
Artesunate  
Natalang et al. 2008 
 
 
Common UR: hydrolase phosphatase, sera 9, AP2 TFs pfd0985w, 
pf11_0091 and pf13_0267, dihydroorotase, biotin carboxylase 
ethanolamine kinase, mitochondrial ribosomal protein S8, 3 
exported proteins (mal7P1.7, pfa0675w, pfl0070c), 10 conserved 
proteins (pfb0650w, pfc0680w, pfe1245w, pf11_0186, pfl0470w, 
mal13P1.313, pf14_0338, pf14_0588, pf14_0631, pf14_0644), 
and 3 hypothetical proteins (pf14_0706,  pf14_0708, pf14_0735). 
Common DR: etramp 2 and 11.1, RNA degradation lsm6, purine 
nucleotide phosphorylase, 60s ribosomal protein L23, the 
transporters vacuolar ATP synthase and nucleoside transporter 1 
and conserved protein pfc0486c. 
SAHA UR- Artesunate DR: gametocyte marker pfg27,  
actin depolymerizing factor, myosin A tail domain interacting 
protein mtip. 
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Abstract 
 
The epigenetic contribution to the regulation and maintenance of gene expression patterns 
by histone modifications is well established in eukaryotes. In Plasmodium falciparum, the 
mechanisms and factors regulating gene expression during progression through its infected 
red blood cell cycle (iRBC) and underlying mutually exclusive expression of antigenic 
variation genes involved in immune evasion are far from understood. Recently, the first 
comprehensive analyses of the P. falciparum chromatin landscape at different iRBC stages 
have been performed. These studies uncovered the existence of well-defined 
heterochromatic regions within a generally euchromatic epigenome. Notably, silencing of 
genes encoding for virulence determinants such as var genes, appears to be orchestrated by 
the concerted action of the Sir2 and HP1 orthologs and the presence of the histone mark, 
H3K9me3. Epigenetic speciation could make the parasite exquisitely vulnerable to epigenetic 
drug treatment, unless this deadly parasite still has a number of tricks up his sleeves.  
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Introduction 
 
The World Malaria Report 2009 announced 243 million cases of malaria which led to death 
of an estimated 843,000 people in 2008. Malaria is thus still one of the most threatening 
diseases around the world. It is caused by species of a protozoan parasite of the genus 
Plasmodium which infects human and mosquito. Underlying the virulence of P. falciparum, 
responsible for the most severe and lethal forms of the disease, are sophisticated 
mechanisms that enable the parasite to modify the RBC surface by expressing cell adhesion 
molecules such as PfEMP1. PfEMP1 is encoded in the genome by the family of 60 var genes 
that are expressed in a mutual exclusive manner. Switches between var family members 
allow the parasite to display different antigenic forms and thus survive, prolong and repeat 
infection of its human host (Pasternak and Dzikowski 2008).  
During P. falciparum infection of erythrocytes, parasites multiply and establish the 
clinical disease. Development in RBCs from rings, through trophozoites to schizonts and 
release of merozoites requires the expression of different sets of proteins, which is enabled 
by a precise and timely program of gene regulation (Bozdech et al. 2003). The molecular 
machinery for control of gene expression is conserved to some extent in Plasmodium 
(reviewed by Horrocks et al. 2009). However, transcription factors (TFs) and their binding 
sequences are less conserved and therefore more difficult to identify (Balaji et al. 2005). The 
epigenetic component of gene regulation in Plasmodium has gained a lot of attention in 
recent years. The epigenome is the sum of all chemical modifications and protein factors 
associated with the genome. Epigenomes are established and modulated at distinct levels 
such as DNA methylation, non-coding RNAs, nucleosome density and remodeling, histone 
post-translational modifications (PTMs) and incorporation of histone variants. Extensive 
surveys confirmed that the P. falciparum genome lacks DNA methylation (Choi et al. 2006) 
and the RNA interference machinery (Baum et al. 2009). Chromatin remodelers and histone 
modifying enzymes appear however well represented in the genome (Sullivan and Hakimi 
2006). Their contributions to the control of the developmental program during iRBC and to 
the parasite’s ability to evade the immune response are just beginning to be deciphered. In 
this review we will focus on the genome-wide aspects of epigenetic regulatory mechanisms 
in P. falciparum and will only briefly mention the control of antigenic variation that has been 
extensively reviewed by Scherf et al. (2008), Dzikowski and Deitsch (2009). 
 
Post-translational modifications and variants of malaria histones 
The core unit of the epigenome is the nucleosome, around which approximately 150bp of 
DNA is wrapped. Each nucleosome consists of two copies of histones H2A, H2B, H3 and H4. 
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Histones are subject to numerous covalent PTMs that affect chromatin properties or serve as 
interaction platforms for chromatin modifying and transcription regulatory factors. Accurate 
characterization of the full complexity of histone PTMs is an ideal first step towards an 
understanding of their role in cellular events. P. falciparum histones have been identified by 
mass spectrometry (MS) (Miao et al. 2006; Trelle et al. 2009). Most major types of PTMs 
identified on histones of evolutionary distinct eukaryotes are also found in P. falciparum 
(Figure 1). H3 and H4 PTMs related to the transcriptional permissive or active state of genes 
(i.e. H3K4me3, H3K9ac, H3K14ac and H4ac) were predominant over silencing related marks 
(i.e. H3K9me3 and H4K20me3) (Trelle et al. 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. P. falciparum histone PTMs. The size of the bars indicates the relative abundance of each 
PTM based on extracted ion counts. Part of the figure is published at PNAS 2009;106:9655–60. The 
numbering of the H2AZ acetylated lysines has been updated from Trelle et al. (2009) by removing the 
–N-terminal Met.  
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Notably, the repressive H3K27me and the transcription-linked H3K79me were not detected. 
PTMs relevant for heterochromatin formation (H3K9me3) and DNA replication (H3K56ac) in 
other eukaryotes are only found on H3 but not H3.3 (Trelle et al. 2009). Histone variants can 
further expand the epigenetic regulatory potential but their functions in Plasmodium are 
completely unknown. In the protozoan parasite Trypanosoma brucei, H2AZ and H2Bv are 
deposited at nucleosomes surrounding the transcription start site of polycistronic units 
providing a demarcation system that ‘compensates’ for the lack of classic TFs binding motifs 
(Seigel et al. 2009). In P. falciparum, the histone variants H2AZ and H2Bv are expressed in 
iRBCs and display heavily modified N-tails, contrasting with their canonical counterparts 
(Trelle et al. 2009, Figure 1). It is tempting to speculate that different chromatin 
environments are made up by associations of histone variants and fulfill specific functions in 
gene regulation.  
 
Roles of epigenetic modifications in defining euchromatic regions 
Plasticity in the epigenome is brought about by the dynamic activity of enzymes that place 
and remove histone PTMs. Deciphering the presumed correlation between histone 
modifications and the parasite’s global transcription program would greatly facilitate the 
development of drugs to fight the disease. Exploratory surveys of asynchronous iRBCs 
revealed defined heterochromatic regions, marked by H3K9me3, within a general 
euchromatic epigenome depleted of H3K9me3 (Lopez-Rubio et al. 2009; Salcedo-Amaya et 
al. 2009) (Figure 2). At euchromatic regions, a rather homogenous enrichment of H3K4me3 
and H3K9ac is present in intergenic regions. The PTMs are enriched towards the 5’ and 3’ 
end of genes and are at lower levels within gene bodies (Salcedo-Amaya et al. 2009). 
Although this pattern of PTMs distribution did not reveal a correlation with the level of 
expression of genes, it was the first indication that the chromatin is in an open configuration 
for the greater part of the (epi)genome. Accordingly, recent quantitative transcriptome 
analyses using Next Generation Sequencing increased the fraction of transcribed genes in 
iRBC to 90% (Otto et al. 2010; our unpublished data). Such open chromatin may facilitate, 
but is unlikely to instruct, the swift changes in gene expression during the iRBC cycle. 
Analysis in synchronous parasites led to the notion that epigenomic marking is indeed 
subject to changes during the iRBC. In ring stage parasites, active and inactive genes 
display a homogeneous pattern of H3K4me3 and H3K9ac over the gene body. In schizonts, 
however, active genes are more extensively marked at their 5’end (Salcedo-Amaya et al. 
2009) (Figure 2). These observations imply that the correlation between these histone PTMs 
and transcription hitherto universally observed (Campos and Reinberg 2009) may not hold 
for all stages of Plasmodium iRBCs. It will be of interest to detail PTMs changes at more 
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points throughout the cycle to uncover possible epigenomic ‘check points’ (erasure and 
marking) and interfere with the underlying mechanism. Interestingly, the lack of active gene 
marking in rings (Salcedo-Amaya et al. 2009) coincides with the very low transcriptional 
activity found at this stage (Sims et al. 2009). The peak in transcriptional activity at late 
trophozoite and schizont stages may eventually relate to the extensive 5’end gene marking. 
The nucleosomal packaging of DNA influences the accessibility of the underlying 
DNA for transcription and every other nuclear process. Recently, it has been reported that in 
P. falciparum nucleosome positioning is dynamic through the cycle with increased relaxation 
through the ring and trophozoite and compaction at schizont (Ponts et al. 2010). Moreover, a 
relative depletion of nucleosomes at intergenic regions has been reported as opposed to 
transcribed regions (Westenberger et al. 2009; Ponts et al. 2010). These findings are 
puzzling considering the clear enrichment of H3K4me3 and H3K9ac at intergenic regions 
reported by Salcedo-Amaya and coworkers (Salcedo-Amaya et al. 2009; Westenberger et al. 
2009). It is however possible that a less stable, but heavily modified, nucleosome subtype is 
positioned at intergenic regions, enabling a distinction between coding and non-coding 
sequences. Indeed, nucleosomes with reduced stability have been reported in other 
organisms and were found to associate with gene promoters (Jin et al. 2009). 
 
Roles of epigenetic alterations in heterochromatin and antigenic variation 
In eukaryotes, transcriptional dormant heterochromatic domains exhibit a number of 
hallmarks: DNA methylation, histone hypoacetylation, H3K9me3 and H3K27me3. These 
marks facilitate the recruitment of factors, such as heterochromatin protein 1 (HP1) that 
initiate and spread chromatin compaction (reviewed in Campos and Reinberg 2009). H3K9 
hypoacetylation, H3K9me3 (Lopez-Rubio et al. 2009; Salcedo-Amaya et al. 2009) and HP1 
(Flueck et al. 2009; Perez-Toledo et al. 2009) have been described to play a role in 
heterochromatin formation in P. falciparum, which is confined to subtelomeric regions as well 
as to a number of sharply separated intra-chromosomal islands (Figure 2). The H3K9me3-
HP1 marked regions encode var genes and other multicopy gene families such as rifin, 
stevor and pfmc-2tm which undergo expression switching. Notably, the region upstream of 
the single actively transcribed var gene is typically marked by histone PTMs such as 
H3K4me2,-me3 and H3K9ac while H3K9me3 marks the stably repressed var genes (Lopez-
Rubio et al. 2007). Importantly, in P. falciparum H3K9me3 is exclusively present on canonical 
H3 (Trelle et al. 2009). Its variant, H3.3 has been reported to replace H3 at actively 
transcribed genes in many organisms (see i.e. in Tetrahymena, Cui et al. 2006).
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Figure 2. Plasmodium falciparum chromatin landscape.  
A. Nuclear architecture studies have shown that in P. falciparum heterochromatin domains are 
clustered in chromatin dense regions at the nuclear periphery (dark brown), while transcriptionally 
engaged euchromatic regions locate more centrally (light brown).  
B. At the chromosomal level, these heterochromatic and euchromatic structures can be distinguished 
by the localization of histone PTMs and associated proteins. Subtelomeric and intra-chromosomal 
heterochromatic domains are characterized by elevated H3K9me3 (blue), HP1 (green) and depletion 
of H3K9ac (red).  
C. Zooming to the molecular level, to the transcriptional silent chromatin: Sir2A and Sir2B and possibly 
other HDACs are likely candidates to remove acetylation (red) from H3K9 which in turn can be tri-
methylated (dark blue) by a lysine methyltransferase (KMT) (predicted as SET3). This mark is 
subsequently recognized by effector proteins (i.e. HP1 and likely by histone modifying complexes) that 
orchestrate the compaction of the chromatin. When and how the formation of these heterochromatic 
domains is initiated is unknown but may involve PfSIP2. Boundaries between dense, antigen variant 
family encoding, to open chromatin are indicated by a purple square that could be “nailed down” by 
DNA elements and associated factors or could be loosely defined by opposing enzymatic activities.  
D. H3K9ac (red) and H3K4me3 (blue) localize to euchromatic intergenic regions established by the 
opposing activities of histone acetyl transferase (HATs, GCN5) and deacetylases (HDACs) or lysine 
methyltransferase (KMT) and demethylases (KDM). Intergenic regions of both expressed and silent 
genes harbor increased H3K9ac and H3K4me3 levels with somewhat clearer marking of the 5’ end of 
active genes at schizonts. 
 
It is tempting to speculate that the activation of a single var gene in the midst of a repressive 
heterochromatic environment is at least in part facilitated by H3 exchange and consequently 
the removal of H3K9me3-HP1 from an inactive var gene. The almost perfect colocalization of 
(over)expressed HP1 protein with the H3K9me3 sites suggests that the spreading of 
heterochromatin is tightly controlled (Flueck et al. 2009) but DNA sequences and factors that 
maintain eu- and heterochromatin boundaries are elusive in P. falciparum. Recently, it was 
shown that an ApiAP2 DNA-binding protein, coined PfSIP2, binds to tandem repeats present 
at subtelomeric regions and could be involved in heterochromatin formation and 
chromosome end biology via recruitment of other factors (e.g. KMTs, HDACs, SNF2L) 
(Flueck et al. 2010). The general lack of PfSIP2 at intrachromosomal heterochromatic 
domains suggests that PfSIP2 is not the only candidate that could initiate heterochromatin 
formation. Although some factors required for heterochromatin formation and/or maintenance 
have been identified, we still lack insights in the sequence of events orchestrating the 
silencing of antigenic variation genes. 
var genes are situated in the nuclear periphery at chromatin dense regions where 
also the Silencing Information Regulator Sir2 is localized. Recently, a direct role of PfSir2 in 
virulence gene silencing has been shown. Different subsets of var and rifin genes displayed 
increased transcription in knock-out parasite lines lacking either one of the two Sir2 paralogs 
(Tonkin et al. 2009). Sir2A has been shown to deacetylate H3K9, H3K14 and H4 N-tail 
(Merrick and Duraisingh 2007). Thus, it is likely that in vivo the hypoacetylated status of the 
var and rifin gene families (Salcedo-Amaya et al. 2009) is maintained by the deacetylase 
activity of PfSir2A and PfSir2B. However, H3K9me3-HP1 also decorate P. falciparum-
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specific multigene families whose expression was not altered by the Sir2 knock-outs. 
Whether their function is somehow related to antigenic variation and pathogenicity remains 
subject of investigation. Furthermore, P. falciparum genes that are inactive in iRBCs such as 
mosquito- and hepatocyte-specific genes are not associated with H3K9me3-HP1, indicating 
that H3K9me3 is not a general mark of gene silencing (Flueck et al. 2009; Salcedo-Amaya et 
al. 2009). Likely other PTMs or transcriptional co-repressors are involved in maintaining their 
very low level of expression in iRBCs.  
 
Conclusions and perspectives 
 
In light of the emerging resistance against currently employed anti-malarials, there is an 
urgent need for new strategies to combat the parasite. Enzymes involved in epigenetic 
regulation are likely drug targets as epigenetic changes are readily reversible. Although the 
Plasmodium enzymes share their overall domain structure with their human counterparts, 
they are not identical at the aminoacid level and thus (epi)drugs that selectively target the 
malaria enzymes could be developed. Evidence that HDAC inhibitors are effective anti-
malarials in mice or cultured parasites has been reported (reviewed by Andrews et al. 2009). 
Moreover, the mechanism of action of a cyclic tetrapeptide HDAC3 (PfHDAC1) inhibitor has 
been deciphered in the closely related Toxoplasma gondii (Bougdour et al. 2009). The 
enzymes involved in the distinct heterochromatic marking of chromosomal regions encoding 
antigenic variation genes and the dynamic epigenetic patterns throughout the iRBC cycle 
may provide good targets for epi-drugs. The variety of histone types and the multiplicity of 
histone PTMs utilized by P. falciparum stress the need to elucidate their function. In-depth 
analysis of corresponding enzymes (complexes) will be essential to identify key pathways to 
be deregulated via administration of epi-drugs. While much remains to be uncovered, our 
current knowledge suggests that the epigenome is a “weak spot” unless the parasite has 
additional tricks up his sleeves.   
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CHAPTER 6 
 
 
General Discussion 
 
 
 
The application of effective measures to fight Malaria has expanded in recent years thanks to 
financial aid and political commitment to implement them. A rapid scale-up in preventing 
transmission has been established as one of the main targets. Insecticide-treated mosquito 
nets and indoor insecticide spraying have been essential measures, but not sufficient and 
more importantly, dependant on a single class of insecticide. The recent emergence of 
resistance to Artemisins, the most potent medicines reducing parasite numbers in humans, is 
an alarming threat as substitute drugs with the same efficacy and tolerance are no due to 
arrive in the immediate future. To limit the spread of artemisins-resistance, parasitological 
confirmation should precede artemisinin-based combination therapy (see World Malaria 
Report 2010). Moreover, the development of an antimalarial vaccine has been elusive due 
among others, to the genetic variability of parasite surface antigens. The lack of fully effective 
vaccines and the spread of drug resistance make the search for alternative effective drugs 
an imperative global health priority.  
Chromatin is reversibly modified to regulate gene expression. Changes in DNA 
methylation, post-translational histone modifications, nucleosome position and expression of 
non-coding RNAs without alteration of the primary DNA sequence are examples of different 
types of epigenetic changes. In recent years, evidence linking specific epigenetic changes to 
disease, in particular to cancer has emerged (Jones and Baylin 2002; 2007). Research has 
lead to the discovery of chemical compounds that target chromatin regulators, such as 
histone deacetylases, that undo cancer-associated epigenetic changes in humans (reviewed 
by Mai and Altucci 2009). These therapeutically relevant chemicals have been referred to as 
epi-drugs. Experiments in Plasmodium have demonstrated that interfering with histone 
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deacetylases is indeed lethal to the parasite (Darkin-Rattay et al. 1996; Mai et al. 2004; 
Andrews et al. 2008; Patel et al. 2009). Therefore, it is conceivable that epi-drugs could be 
used in vivo to interfere with fundamental parasite-specific and chromatin associated 
processes resulting in either parasite clearance or disruption of the mechanisms of host 
immune system evasion. Mechanistic insight into parasite chromatin modifications thus 
drives the development and therapeutic application of "epidrugs" against Malaria. 
This thesis was an effort to begin to understand chromatin-based regulation in the 
malaria parasite by means of defining Plasmodium histone post-translational modifications 
(by mass-spectrometry) and exploring the insights obtained with respect to gene expression 
(by ChIP-on-chip). Our studies on the P. falciparum epigenome were pioneering in the 
malaria field from the technical and biological points of view, and brought to light the 
existence and distribution of a few of these histone modifications. We used the ChIP-on-chip 
method to provide evidence regarding epigenetic signatures and strictly controlled for 
interfering factors such as GC-bias induced by standard LM-PCR amplification methods. 
Unlike a contemporary epigenetic study in malaria using low resolution arrays designed for 
transcriptome studies with few probes per gene (Cui et al. 2007), we used a whole-genome 
array with overlapping probes containing in average 20 probes per gene (average gene size 
1kb). Although the experiments resulted in highly reproducible profiles (i.e. 4 biological 
replicas), we recognize the limitations in the study. First, chromatin immunoprecipitation 
relies on antibodies whose specificity may vary from batch to batch. i. e. we observed 
occurrence of H3K9me3 and H3K4me3 at the same genes in a number of experiments. 
Further tests established that H3K4me3 is indeed not present in heterochromatin. In spite of 
the level of stringency used for probe selection, the degree of cross-hybridization is likely 
substantial due to the low sequence complexity and extreme AT-content of intergenic 
regions. As a result, we limited the crucial analysis of histone modification in relation to gene 
expression to gene bodies. 
 Major and variant histones N-terminal tails of P. falciparum intraerythrocytic stages 
are vastly acetylated. The effect of charge neutralization by acetylation is proposed to affect 
the chemical properties of nucleosomes reducing histone tail contacts with neighbouring 
nucleosomes thereby favoring transcriptional activity (Waterborg 2002; Shogren-Knaak et al. 
2006; Henikoff and Shilatifard 2011). H3K4me3 and H3K9ac are the most abundant histone 
modifications in P. falciparum H3. These modifications are simultaneously associated with 
about 90% of the intergenic regions of the genome, upstream and downstream of genes, 
strongly suggesting a euchromatic state or a state of active nucleosomal processes (high 
rate of nucleosome exchange or remodelling) for the majority of the epigenome. In eukaryotic 
model organisms like yeast, gene activity is correlated with increased levels of H3K4me3 and 
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H3K9ac at the 5′ end of the gene (Rando 2007). A similar enrichment was apparent for the 
highest expressed genes in asynchronous intraerythrocytic parasites. Comparative 
exploration of homogenous populations of rings and schizonts showed H3K9ac and 
H3K4me3 associating to the 5’end of active genes in schizonts but not in rings. This finding 
supported a developmental stage specificity of histone modifications likely as a result of 
stage-specific nucleosome remodelling or exchange. Recent work in our lab using in parallel 
ChIP-seq and RNA-seq at several stages of the intraerythrocytic cycle confirmed that 
H3K9ac and H3K4me3 are present at euchromatic intergenic regions of the genome 
throughout the intraerythrocytic cycle (Bartfai et al. 2010). Importantly, the superior accuracy 
of sequencing technology at intergenic regions uncovered that i) H3K9ac increases at gene 
promoters of active genes throughout the developmental stages; it correlates with shifting 
RNA levels, and ii) H3K4me3 levels increase during the late stages of trophozoite and 
schizont at which the modification occurs in combination with H3K9ac (Bartfai et al. 2010).  
 P. falciparum H3 and H4 are scarce with respect to histone modifications associated 
with silenced chromatin such as H3K9me3, similarly to other unicellular eukaryotes (Garcia 
et al. 2007). We and others (Lopez-Rubio et al. 2009; Flueck et al. 2009) have shown that 
H3K9me3 and heterochromatic protein HP1 define P. falciparum heterochromatic domains. 
These include clusters of subtelomeric and some chromosome internal P. falciparum-specific 
virulence gene families such as var genes. In eukaryotes, HP1 is proposed to mediate 
heterochromatin formation by bridging nearby H3 tails that carry K9me3 (Canzio et al. 2011). 
The Silencing Information Regulators, Sir2A and Sir2B, participate in mutually exclusive var 
expression by repressing subsets of var genes (Duraisingh et al. 2005; Tonkin et al. 2009). In 
humans, the Sir2 homologue SIRT1 promotes heterochromatin formation through a number 
of events including recruitment of the enzyme responsible for H3K9me3 (Vaquero et al. 
2007). Whether a similar interplay occurs in the parasite is unknown. To date, evidence 
merely supports a role of Sir2A in virulence gene regulation (Lopez-Rubio et al. 2009). We 
approached histone deacetylases (HDAC) inhibition expecting to interfere with the histone 
acetylation/deacetylation balance and thus altering the transcription of H3K9me3-HP1 
associated genes. Contrary to our expectation, inhibition of HDAC activity by the small 
inhibitor SAHA resulted neither in changes in the transcriptional patterns of virulence genes 
nor in alteration of the hypoacetylated state of these genes. With few exceptions, the genes 
affected are outside heterochromatin domains. Others have shown that interfering with 
histone deacetylases alters gene regulation in P. falciparum (Chaal et al. 2010; Hu et al. 
2010) and confirmed the insensitivity of virulence and heterochromatin-located genes to 
treatment. Identifying the enzymes and factors that contribute to setting specific epigenetic 
marks such as the ones described in this thesis, and uncovering the subsequent players that 
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regulate transcriptional silencing or activation will allow us to use existing or develop new 
inhibitors that may become effective candidate epi-drugs against Malaria. 
Our studies of chromatin modifications provide a static picture of histone chromatin 
events taken at a point in time when the cells were fixed and/or chromatin extracted. 
Biochemical studies (i.e. purifying tagged-histone modifiers and immunoprecipitating binders) 
to gain insight into functional interpretation of these maps are a priority. Methods to study 
chromatin dynamics such as CATCH-IT-covalent attachment of tags to capture histones and 
to identify turnover (Deal et al. 2010)- together with genetic and biochemical studies of other 
components of the epigenome, will provide a deeper understanding of chromatin function in 
relation to transcriptional regulation in the parasite. This will bring the field closer to the goal 
of understanding how the epigenome orchestrates the genome to give the specific patterns 
of gene expression that define the different parasitic phenotypes and ultimately to interfere 
with such programs.  
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SUMMARY 
 
 
Malaria epigenome: How histone post-translational modifications 
contribute to gene expression in Plasmodium falciparum 
 
 
P. falciparum is the unicellular parasite that causes the most virulent form of human Malaria. 
In just 48 hours a full cycle of infection is completed within erythrocytes in which parasites 
undergo drastic morphological changes leading to new progeny. The regulatory mechanisms 
that control timely expression of P. falciparum genes are just starting to be understood. 
Evidence suggests that stage-specific gene expression is controlled by the concerted action 
of specific transcription factors and repressors, translational repression and epigenetic 
mechanisms. The aim of this thesis was to characterize the latter by defining the post-
translational modifications of histones and exploring the possibility that some of these 
modifications affect the regulation of gene expression. 
We observed that a number of unique epigenome features occur in the parasite 
emphasizing the potential significance of epigenetic control. We mapped in P. falciparum 
most of the major types of histone modifications identified on histones of evolutionarily 
distinct eukaryotes. P. falciparum histones are extensively acetylated, particularly at the N-
tails of histone variants H2AZ and H2Bv (Chapters 2, 3 and 5). Several of the histone 
modifications found in P. falciparum H3 and H4 localize to transcriptionally permissive 
chromatin in other eukaryotes. Among these, trimethylated lysine 4 of histone 3 (H3K4me3) 
and acetylated lysine 9 of histone 3 (H3K9ac) associate to euchromatic intergenic regions, 
upstream and downstream of genes, and undergo reorganization during the parasite 
intraerythrocytic cycle (Chapter 3). Inactivating chromatin modifications were not abundant. 
Parasite heterochromatin, as defined by H3K9me3 and the binding of Heterochromatin 
protein HP1, is restricted to subtelomeric and some chromosome internal domains that 
contain virulence gene families and represent about 10% of the epigenome (Chapter 3). 
Thus, our experiments suggest that chromatin modifications are important in maintaining 
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chromosomal domains and to some extent the transcriptional state of genes during the 
intraerythrocytic cycle. In addition, we highlight the capacity of a histone deacetylases 
inhibitor to arrest parasite growth while interfering with the abundance and distribution of 
acetylation (Chapter 4). This study generated technical and biological tools essential for the 
study of the P. falciparum epigenome. The combination of catalogues of histone post-
translational modification and their genome-wide distribution maps are at the basis in 
understanding how the epigenome orchestrates the genome to give raise to specific patterns 
of gene expression. 
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SAMENVATTING 
 
 
Het epigenoom van de malaria parasiet: De rol van histon post-
translationele modificaties in de controle van genexpressie in 
Plasmodium falciparum 
 
 
De dodelijkste variant van malaria wordt veroorzaakt door een eencellige parasiet, 
Plasmodium falciparum. Infectie van de rode bloedcellen van een humane gastheer 
veroorzaakt de ziekteverschijnselen van malaria. In dit stadium van infectie vermenigvuldigen 
de parasieten zich gedurende een cyclus van ongeveer 48 uur, waarin ze verscheidene 
drastische morfologische veranderingen ondergaan. Essentieel voor het doorlopen van deze 
cyclus is de expressie van de juiste genen en de productie van de juiste eiwitten op het juiste 
moment. Echter, de mechanismen voor controle van genexpressie in P. falciparum zijn 
slechts in beperkte mate bekend. Verschillende onderzoeken tonen aan dat genexpressie 
gecontroleerd wordt door een combinatie van verschillende processen waarbij specifieke 
transcriptiefactoren, specifieke repressoren, translationale repressie en epigenetische 
mechanismen betrokken zijn. Het doel van dit proefschrift is om deze epigenetische 
mechanismen  te ontrafelen. Allereerst zijn we begonnen met de karakerisatie van post-
translationele modificaties van de histon-eiwitten, die aan de basis staan van de 
epigenetische markering van het genoom. Vervolgens hebben we bestudeerd hoe sommige 
van deze modificaties een rol kunnen spelen bij de controle van genexpressie. 
 Het onderzoek beschreven in dit proefschrift laat zien dat het epigenoom van de 
malaria-parasiet een aantal unieke eigenschappen bezit in vergelijking met zijn humane 
gastheer en andere modelorganismen. In P. falciparum komen de belangrijkste  histon-
modificaties voor die eerder in modelorganismen zijn ontdekt. Echter, de histonen van P. 
falciparum zijn ongewoon rijk aan acetyl-groepen, voornamelijk geplaatst op de staarten van 
de histon varianten H2AZ en H2Bv (zie hoofdstuk 2, 3 en 5). Sommige van de modificaties 
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die wij vonden op histon H3 en H4 van de malaria-parasiet bevinden zich in chromatine dat 
veelal transcriptioneel actief is in modelorganismen (zogenaamd euchromatine). 
Bijvoorbeeld, zowel tri-methylering van het vierde aminozuur van histon H3 (lysine 4, 
H3K4me3) als acetylatie van het negende aminozuur van histon H3 (lysine 9, H3K9ac) 
bevinden zich in stroomopwaarts en -afwaarts van genen en in  intergene gebieden van het 
euchromatine. Deze markeringen zijn bovendien niet stabiel, maar ondergaan dynamische 
verandering gedurende de ontwikkelingscyclus van de parasiet in de rode bloedcellen (zie 
hoofdstuk 3). Zogenaamde ‘inactieve’ histon-modificaties zijn nauwelijks aanwezig op P. 
falciparum histonen. In overeenstemming met deze ontdekking is het inactieve chromatine 
(heterochromatine) van de malaria-parasiet beperkt tot slechts 10% van het genoom en 
codeert het voor genfamilies die betrokken zijn bij virulentie van de P. falciparum parasiet. 
Deze genen bevinden zich in de sub-telomere gebieden en beperkte chromosoom-interne 
‘eilanden’ van het genoom. Dit inactieve chromatine wordt gekarakteriseerd door tri-
methylering van lysine 9 van histon H3 (H3K9me3) en binding van het eiwit 
‘Heterochromatine protein 1 (HP1)’ (zie hoofdstuk 3). Samenvattend tonen onze resultaten 
aan dat histon-modificaties betrokken zijn bij de verdeling van het genoom in verschillende 
gebieden en dat sommige markeringen correleren met de transcriptionele status van genen. 
Tot slot laten we in hoofdstuk 4 van dit proefschrift experimenten zien die aantonen dat 
remmers van  histone deacetylases  de ontwikkeling van de malaria-parasiet in de rode 
bloedcel stoppen en veranderingen in de hoeveelheid en de distributie van histone acetyl-
modificaties veroorzaken. In dit proefschrift worden zowel nieuwe inzichten beschreven, als 
technische en biologische technieken ontwikkeld voor bestudering van het epigenoom van 
de malaria-parasiet. Onze karakteristatie van de post-translationele histon-modificaties  en 
de lokalisatie van deze markeringen door het gehele genoom van P. falciparum vormen een 
solide basis voor het ontrafelen van epigenetische processen in de malaria-parasiet. Dit 
verschaft inzichten naar hoe deze markeringen een bijdrage leveren in de organisatie van 
het genoom en de genexpressie  van deze ziekteverwekker. 
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RESUMEN 
 
 
El Epigenoma de Malaria: Cómo las modificaciones post-
traduccionales de las histonas contribuyen a la expresión génica en 
Plasmodium falciparum 
 
 
P. falciparum es el parásito unicelular que causa la forma más virulenta de Malaria en 
humanos. El ciclo infeccioso dentro de los glóbulos rojos se completa en tan sólo 48 horas, 
en las cuales el parásito sufre cambios morfológicos drásticos que resultan en su 
multiplicación. Los mecanismos reguladores que controlan la expresión oportuna de los 
genes de P. falciparum apenas están comenzando a entenderse. Existen evidencias que 
sugieren que la expresión génica estadio-específica está controlada por la acción 
concertada de factores de transcripción y represores específicos, represión traduccional y 
mecanismos epigenéticos. El propósito de esta tesis fue el de caracterizar estos últimos 
definiendo las modificaciones post-traduccionales de las histonas y explorando la posibilidad 
de que algunas de estas modificaciones afecten la regulación de la expresión génica. 
Los experimentos descritos en esta tesis permitieron observar algunos rasgos 
característicos del epigenoma del parásito enfatizando el potencial significativo del control 
epigenético. P. falciparum posee la mayoría de modificaciones de histonas que han sido 
identificadas en histonas de eucariotas evolutivamente alejados. Las histonas de P. 
falciparum están ampliamente acetiladas, particularmente en los extremos N-terminal de las 
histonas variantes H2AZ y H2Bv (Capítulos 2, 3 y 5). La mayoría de las modificaciones de 
histonas encontradas en las histonas H3 y H4 de P. falciparum están presentes en la 
cromatina transcripcionalmente permisiva de otros eucariotas. Entre éstas, la lisina 4 
trimetilada de la histona 3 (H3K4me3) y la lisina 9 acetilada de la histona 3 (H3K9ac) se 
asocian a regiones intergénicas eucromáticas, tanto aguas arriba como aguas abajo de los 
genes, y están sometidas a reorganización durante el ciclo intraeritrocítico del parásito 
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(Capítulo 3). Las modificaciones post-traduccionales de histonas que se asocian 
generalmente con la cromatina transcripcionalmente inactiva fueron escasas. La 
heterocromatina del parásito, definida por H3K9me3 y la presencia de la proteína de unión a 
heterocromatina HP1, está restringida a los subtelómeros y algunos segmentos internos de 
los cromosomas que contienen familias de genes virulentos y representan alrededor del 10% 
del epigenoma (Capítulo 3). Así, nuestros experimentos sugieren que las modificaciones de 
la cromatina son importantes en el mantenimiento de los dominios cromosomales y en algún 
grado, en el estado transcripcional de los genes durante el ciclo intraeritrocítico. Por último, 
destacamos la capacidad de un inhibidor de enzimas deacetiladoras de histonas para 
arrestar el crecimiento del parásito mientras interfiere con la abundancia y distribución de la 
acetilación (Capítulo 4). La investigación presentada en esta tesis generó herramientas 
técnicas y biológicas esenciales para el estudio del epigenoma de P. falciparum. La 
combinación de catálogos de modificaciones post-traduccionales de las histonas y sus 
mapas de distribución a lo largo del genoma forman parte de la base de nuestro 
entedimiento de cómo el epigenoma orquesta el genoma para alcanzar patrones específicos 
de expresión génica. 
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